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ABSTRACT  
   
Gold nanoparticles have emerged as promising nanomaterials for biosensing, 
imaging, photothermal treatment and therapeutic delivery for several diseases, including 
cancer. We have generated poly(amino ether)-functionalized gold nanorods (PAE-GNRs) 
using a layer-by-layer deposition approach. Sub-toxic concentrations of PAE-GNRs were 
employed to deliver plasmid DNA to prostate cancer cells in vitro. PAE-GNRs generated 
using 1,4C-1,4Bis, a cationic polymer from our laboratory demonstrated significantly 
higher transgene expression and exhibited lower cytotoxicities when compared to similar 
assemblies generated using 25 kDa poly(ethylene imine) (PEI25k-GNRs), a current 
standard for polymer-mediated gene delivery. Additionally, sub-toxic concentrations of 
1,4C-1,4Bis-GNR nanoassemblies were employed to deliver expression vectors that 
express shRNA ('shRNA plasmid') against firefly luciferase gene in order to knock down 
expression of the protein constitutively expressed in prostate cancer cells. The roles of 
poly(amino ether) chemistry and zeta-potential in determining transgene expression 
efficacies of PAE-GNR assemblies were investigated. The theranostic potential of 1,4C-
1,4Bis-GNR nanoassemblies was demonstrated using live cell two-photon induced 
luminescence bioimaging. The PAE class of polymers was also investigated for the one 
pot synthesis of both gold and silver nanoparticles using a small library poly(amino 
ethers) derived from linear-like polyamines. Efficient nanoparticle synthesis dependent 
on concentration of polymers as well as polymer chemical composition is demonstrated. 
Additionally, the application of poly(amino ether)-gold nanoparticles for transgene 
delivery is demonstrated in 22Rv1 and MB49 cancer cell lines. Base polymer, 1,4C-
1,4Bis and 1,4C-1,4Bis templated and modified gold nanoparticles were compared for 
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transgene delivery efficacies. Differences in morphology and physiochemical properties 
were investigated as they relate to differences in transgene delivery efficacy. There were 
found to be minimal differences suggestion that 1,4C-1,4Bis efficacy is not lost following 
use for nanoparticle modification. These results indicate that poly(amino ether)-gold 
nanoassemblies are a promising theranostic platform for delivery of therapeutic payloads 
capable of simultaneous gene silencing and bioimaging. 
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CHAPTER 1 
INTRODUCTION 
In several diseases, including cancer diseases, there is an urgent need for 
formulating platforms that are capable of addressing 1) diagnostics, 2) treatment, and 3) 
determination of therapeutic effect (therapeutic response)(Young, Figueroa, & Drezek, 
2012). Diagnostics involves the specific labeling of malignant tissues so that its 
localization can be differentiated from that of healthy tissue. Following labeling and 
localization of the malignant tissue, treatment encompasses a wide range of possible 
options. One such option is the targeted delivery of a therapeutic payload, including 
chemotherapeutic drugs or biologicals, for treatment of the disease. In addition to 
targeted delivery, in many cases, control of the payload release via an external stimulus, 
as opposed to passive release, may be desirable. This doubly ensures that the payload 
reaches the desired targeted tissue and will only be released in its specific location. 
Following treatment, determination of the therapeutic effect is also desirable and may be 
accomplished in a similar way as the initial labeling. The challenge to encompass these 
needs in a single treatment modality has resulted in a push towards the formulation of 
theranostic treatment options, wherein a single platform can address multiple or all of 
these needs. Recent investigations in nanotechnology have made it possible to develop 
single-platform theranostics options. More specifically, photoresponsive nanoparticles 
have demonstrated potential as viable theranostic platforms. Light absorption and surface 
modification properties of these nanoparticles can be exploited for targeting and labeling 
diseased tissues via multiple imaging modalities. In addition, their ability to absorb 
specific wavelengths of light has been exploited for photothermal ablation of malignant 
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tissue, controlled release of treatment payloads, and combination treatments resulting in 
synergistic therapeutic options. 
Gold Nanoparticles 
Plasmonic gold nanoparticles exhibit unique optical and photothermal properties. 
Surface plasmon resonance of gold nanoparticles allows them to strongly absorb and 
scatter incident light significantly higher when compared to molecular dyes(Link & El-
Sayed, 1999). Thus, they have emerged as promising contrast agents for biological 
imaging. Some classes of gold nanoparticle are also able to convert resonant energy to 
heat. Following exposure of near infrared (NIR) electron-phonon and phonon-phonon 
interactions can convert incident light into heat (Jain, Haung, El-Sayed, & El Sayed, 
2007; Oldenburg, Jackson, Westcott, & Halas, 1999).  Several classes of gold 
nanoparticles with the ability to absorb NIR light have been synthesized using 
chemical(J. Y. Chen et al., 2006; Jana, Gearheart, & Murphy, 2001a, 2001b; Jana, 
Gearheart, Obare, & Murphy, 2002; Nikoobakht & El-Sayed, 2003; Oldenburg, Averitt, 
Westcott, & Halas, 1998; Oldenburg, Jackson, et al., 1999; Oldenburg, Westcott, Averitt, 
& Halas, 1999; Skrabalak, Au, Li, & Xia, 2007; Y. G. Sun, Mayers, & Xia, 2002), and 
electrochemical(Burdick, Alonas, Huang, Rege, & Wang, 2009; Chang, Shih, Chen, Lai, 
& Wang, 1999; Martin, 1994; Y. Y. Yu, Chang, Lee, & Wang, 1997) methods. These 
nanoparticles have been widely investigated for uses in bioimaging, nucleic acid and drug 
delivery, and photothermal ablation.       
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Bioimaging and disease detection/diagnostics.Non- and minimally invasive 
bioimaging techniques are invaluable tools for clinical diagnostics of diseased tissue. 
Currently, bioimaging techniques, from the molecular to the tissue scale are employed for 
detection of early-stage cancer, guiding drug and biological therapies, and surgery. Gold 
nanoparticles are attractive as contrast agents since they can be engineered to overcome 
limitations of chemical and photostability, detection limits, and compatibility across 
various imaging modalities, typically associated with conventional contrast agents(Hahn, 
Singh, Sharma, Brown, & Moudgil, 2011). The use of imaging modalities based on NIR 
lasers has been increasingly investigated since NIR light can penetrate tissue at greater 
depths compared to visible light, in addition to minimal tissue scattering, and reduced 
phototoxicity. Thus, gold nanoparticles, tuned to absorb NIR light, have been widely 
explored for use in multiple imaging modalities(Durr et al., 2007; J.-L. Li & Gu, 2010; H. 
F. Wang et al., 2005). 
Optical coherence tomography (OCT) is an NIR-based interferometer imaging 
modality that uses optical scattering media to provide cross-sectional subsurface images. 
Using NIR irradiation for maximal light penetration into tissue, images are formed based 
on differences between the absorption to scattering profiles of the medium, with 
resolution in the micrometer range at penetration depths of 2-3 mm (Fercher, Drexler, 
Hitzenberger, & Lasser, 2003). Using mouse xenograft colon tumor models, Gobin et al. 
(Gobin et al., 2007) injected poly(ethylene glycol) (PEG)-conjugated gold nanoshells 
(PEGylated gold nanoshells) via tail vein. Following 20 h after the injection, OCT images 
were acquired and accumulation of the gold nanoshells in the tumor resulted in enhanced 
brightness. Similarly in mouse xenograft epidermoid tumor models, Kah et al. (Kah et al., 
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2009) demonstrated that antibody-functionalized PEGylated gold nanoshells increased 
that fractional concentration of injected gold nanoshells in tumor regions compared to 
untargeted nanoshells. A reduction in time from 6 to 2 hours was also observed for 
delivery of nanoshells to the tumor site. Although OCT has deeper tissue penetration 
compared to that observed with confocal microscopy, there are still limitations for the 
application of gold nanoparticle OCT in deep tissue imaging(H.-C. Huang, S. Barua, G. 
Sharma, S. K. Dey, & K. Rege, 2011). 
Two-photon luminescence (TPL) imaging uses femto- to pico- second pulsed, 
high intensity NIR Ti:S lasers in order to deliver a high photon flux to specimens of 
interest(Perry, Burke, & Brown, 2012).  Due to their surface plasmon resonance property, 
noble metal nanoparticles have emerged as viable contrast agents for TPL. TPL is a serial 
process in which photons are sequentially absorbed and electrons from the d-band are 
excited to unoccupied states of the sp-conduction band. Luminescent emission results 
from the relaxation of the electron-hole pair. Gold nanorods (GNRs) have emerged as 
particularly appealing for TPL due to facile synthesis, tunable longitudinal plasmon 
absorbance in the NIR region, and reduced plasmon dampening(Durr, et al., 2007). In a 
study performed by Wang et al.(H. F. Wang, et al., 2005) picomolar concentrations of 
sulfide-treated gold nanorods were injected into mice tail vein and visualized flowing 
through the mouse earlobe vessels in real-time using TPL imaging.  
Photoacoustic tomography (PAT) utilizes short-pulsed laser beams that elicit 
thermoexpansion of an absorber. This results in pressure or photoacoustic (PA) waves 
that are detected by a wideband ultrasonic detector which allows for 3-dimensional 
reconstruction of the optical absorption properties of the internal tissue structure. Gold 
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nanoparticles have proven to be useful contrast agents for PAT due to their unique optical 
absorption properties(Mallidi et al., 2009; X. Yang, Stein, Ashkenazi, & Wang, 2009). In 
a study performed by the Wang group(Y. W. Wang et al., 2004) PEGylated gold 
nanoshells were utilized as PAT contrast agents for imaging rat brain vasculature and 
demonstrated up to 63% enhancement in optical absorption of brain vasculature 
following three sequential nanoshell treatments. Additionally, 80% enhancement in 
cerebral cortex absorption was found following systemic injection of PEGylated gold 
nanocages (X. M. Yang, Skrabalak, Li, Xia, & Wang, 2007). In a rat model study 
performed by the Xia group, PAT was used to quantitatively evaluate gold nanocage 
transport in the lymphatic system and uptake in the lymph nodes. This also enabled 
mapping of sentinel lymph nodes up to 3.3 cm below skin surface. Gold nanocages were 
transported to the second and third axillary lymph nodes, which can have potential 
implications for use in metastatic lymph node mapping. Bioconjugated gold nanocages 
were employed for active targeting to subcutaneous inoculated melanomas in mouse 
models, resulting in 300% higher signal enhancement compared to PEG-gold nanocages 
which demonstrate passive targeting due to the EPR effect(C. Kim et al., 2010).    
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Drug and Nucleic Acid delivery. The emergence of novel nanomaterials, including 
gold nanoparticles, has led to new options for delivery of therapeutic agents(Chinnaiyan 
et al., 2006; Cho, Wang, Nie, Chen, & Shin, 2008; Ghosh, Han, De, Kyu Kim, & Rotello, 
2008; Heath & Davis, 2008; H. C. Huang, S. Barua, G. Sharma, S. K. Dey, & K. Rege, 
2011; Jabr-Milane et al., 2008; Smith, Duan, Mohs, & Nie, 2008). Due to various 
controlled delivery mechanisms such as pulsed laser induced gold-thiol bond cleavage 
(Lu et al., 2010; You, Zhang, & Li, 2010), acidic environment induced release (W. T. 
Wu, Zhou, Berliner, Banerjee, & Zhou, 2010), diffusion release (Cheng et al., 2010), 
photothermal modulation and surface coating shrinkage (Sershen, Westcott, Halas, & 
West, 2000), gold nanoparticles have been extensively investigated as drug and gene 
delivery vehicles.   
Cetuximab (C225) is an FDA approved anti-EGFR antibody for treatment of EGFR-
positive colorectal cancer and is currently in different phases of clinical trials for other 
malignancies(Herbst, Kim, & Harari, 2001; Hynes & Lane, 2005). Gold nanoparticles 
using Cetuximab as a targeting agent for delivery of low doses of gemcitabine showed 
significant tumor growth inhibition in an orthotopic model of pancreatic cancer(Patra et 
al., 2008). AuriTax is a multivalent nanosystem composed of tumor necrosis factor 
(TNF), paclitaxel, and PEG assembled on 25 nm gold nanoparticles (GNPs). Similarly, 
Aurimune-T is assembled on a 25 nm GNP with only TNF and PEG. Aurimune-T 
demonstrated a ten-fold increase in reducing tumor burden compared to TNF alone in 
animal studies (Paciotti et al., 2004; Patra, Bhattacharya, D., & Mukherjee, 2008).  
Gold nanoparticles are promising vectors for non-viral transgene delivery primarily 
due to the availability of facile surface-modification methods(X. Huang, Neretina, & El-
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Sayed, 2009). Surface functionalization of gold nanoparticles allows for tuning of 
hydrophobicity and charge, which can enhance transgene expression and decrease 
cytotoxicity(Ghosh, et al., 2008). Additionally, their high surface area-to-volume ratios 
facilitate high payload carrying capabilities. Gold nanoparticles have been extensively 
investigated for in vitro transgene(A. C. Bonoiu et al., 2009; Ow Sullivan, Green, & 
Przybycien, 2003; Sandhu, McIntosh, Simard, Smith, & Rotello, 2002; M. Thomas & A. 
M. Klibanov, 2003) delivery and expression and siRNA(A. C. Bonoiu, et al., 2009; 
Mahajan et al., 2012; W. Zhang et al., 2011)  / shRNA(Ryou et al., 2010) delivery for 
gene silencing. 
Folate receptor-targeted hollow gold nanospheres where used for NIR-induced 
delivery of siRNA against NF-κB p65 subunits both in vitro and in vivo(Lu, et al., 2010). 
NIR irradiation induced a shape transformation in the gold nanoparticles resulting in 
siRNA release into the cytosol. This photothermal transfection resulted in down 
regulation of NF-κB only in tumors irradiated with NIR light. This down regulation of  
NF-κB was exploited to sensitize tumors to the chemotherapeutic drug, irinotecan, 
resulting in growth inhibition. In a study done by Bonoiu et al.(A. Bonoiu et al., 2011) 
gold nanorods with electrostatically bound siRNA were used to silence approximately 
70% of the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in 
the CA1 hippocampal region of the rat brain at >10 days post-injection. The Prasad 
group(Masood et al., 2012) demonstrated that down-regulation of the anti-apoptotic 
sphingosine kinase (Sphk1) gene in head and neck squamous cell carcinoma in 
subcutaneous tumors grown in mice resulted in radiosensitization and over 50% tumor 
regression compared to control treatments. In these cases, the down-regulation was 
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achieved using gold nanorod-siRNA ‘nanoplexes’. Additionally, tumor regression was 
possible with radiation doses much lower than those commonly used in clinical settings. 
Ryou et al.(Ryou et al., 2011) reported studies in which mice with subcutaneous 
xenograft human colon carcinoma tumor models were subcutaneously injected with 
shRNA-conjugated gold nanoparticles for silencing the Mcl-1L gene. A decrease in 
tumor size of approximately 36% was observed when compared to control treatments 
following direct administration into the tumor every 3 days for 30 days, indicating that 
shRNA treatment reduced tumor growth.  
Thermo-chemotherapy.Thermal or hyperthermic therapy is an attractive alternate or 
co-approach for the ablation of diseased (e.g. cancer) tissue. Due to their unique optical 
properties several classes of gold nanoparticles have been engineered for use in NIR and 
radio-frequency (RF)-based hyperthermic therapy(Chatterjee, Diagaradjane, & Krishnan, 
2011; El-Sayed, Huang, & El-Sayed, 2005, 2006; Glazer & Curley, 2010; Huang-Chiao 
Huang, Barua, Kay, & Rege, 2009; H.C. Huang, K. Rege, & J.J. Heys, 2010; Kennedy et 
al., 2011; Ma et al., 2009). Externally tunable control of NIR irradiation can be employed 
to achieve hyperthermic temperatures (>43o) at localized sites, which possesses 
significant advantages over whole-body hyperthermia. As a result, gold nanoparticles 
(GNPs) have received increased attention for localized administration of hyperthermia for 
ablation of cancer cells (Cao, 2004) and bacteria(Cortie, 2004).  
Pancreatic carcinoma growth in nude balb/c mice xenografts was inhibited for up to 7 
weeks following treatment with intraperitoneal-injected gold nanospheres in concert with 
radio-frequency field exposure(Glazer et al., 2010). Gold nanoshells consisting of a 
dielectric core surrounded by an ultra-thin gold shell demonstrate photothermal responses 
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that are tunable in the NIR region(Averitt, Westcott, & Halas, 1999). Nanoshells are 
often coated with PEG and in cancer therapy investigations can preferentially localize to 
tumor sites due to the enhanced permeability and retention (EPR) effect(Maeda, Wu, 
Sawa, Matsumura, & Hori, 2000). In female non-obese diabetic mice, Hirsch et al. 
(Hirsch et al., 2003) interstitially injected PEGylated gold nanoshells and following NIR 
laser irradiation demonstrated irreversible thermal destruction of xenograft canine 
transmissible venereal tumors. O’Neal et al.(O'Neal, Hirsch, Halas, Payne, & West, 
2004) injected PEGylated gold nanoshells intravenously into female albino mice bearing 
murine colon carcinoma tumors. The mice were tumor free for at least a month following 
NIR laser irradiation. In a related study, PC3-tumor bearing mice were intravenously 
injected with PEGylated gold nanoshells and demonstrated 93% tumor regression 3 
weeks after NIR laser irradiation. Currently, the most advanced application using gold 
nanoshells for photothermal therapy is currently in early clinical trials for ablation of 
recurrent head and neck cancer("Pilot Study of AuroLase(tm) Therapy in Refractory 
and/or Recurrent Tumors of the Head and Neck,"). 
Cylindrical gold nanorods possess a transverse absorption at 520nm as well as a 
longitudinal absorption that is tunable in the NIR region. PEGylated gold nanorods 
injected intratumorally in nude (nu/nu) mice with subcutaneous squamous cell carcinoma 
xenographs demonstrated over 96% decrease in average tumor growth following NIR 
laser irradiation; more than 74% decrease in average tumor growth was observed 
following intravenous injection(Dickerson et al., 2008). In murine colon cancer models, 
intravenous injection of PEGylated gold nanorods and NIR irradiation resulted in 
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survival of approximately 44% of the initial mice population 60 days after treatment 
(Goodrich et al.).    
Hyperthermic treatment is limited by cellular thermotolerance, whereby cells are able 
to maintain viability due to an array of cell survival responses(Cherukuri, Glazer, & 
Curley, 2010; Hildebrandt et al., 2002).  Combinatorial / synergistic treatments for cancer 
therapy can be developed by engineering nanoparticles that simultaneously deliver 
chemotherapeutic drugs in concert with hyperthermic treatment for enhanced ablation of 
cancer cells. In addition, hyperthermia has been shown to increase tumor tissue perfusion, 
which allows for easier and deeper absorption of chemotherapeutic drugs in tumor tissue, 
resulting in greater efficacies between the two treatments. Hyperthermia also lowers 
tumor resistance to various chemotherapeutic drugs including doxorubicin, cisplatin, 
bleomycin, nitrosoureas, and cyclophosphamide(Dayanc, Beachy, Ostberg, & Repasky, 
2008; Kampinga, 2006; Martirosyan, 2012). As such, potential for higher efficacies of 
cancer cell ablation can be realized by combining the drug delivery and photothermal 
therapy properties on gold nanoparticles via a photo-chemotherapy approach. Multiple 
studies have employed different gold nanoparticle platforms for dual delivery of cancer 
cell-targeted chemotherapeutics and NIR light-based induction of hyperthermia. For 
example, the antineoplastic drug doxorubicin, has been loaded into hollow gold 
nanospheres (J. You, R. Zhang, C. Xong, et al., 2012; J. You, R. Zhang, G. Zhang, et al., 
2012), hollow gold nanoshells(C. Wu, Yu, & Chu, 2011), and poly(ethylene glycol)–
poly(lactic-co-glycolic acid)–Au half-shell nanoparticles(S.-M. Lee et al., 2011; Park et 
al., 2009) for simultaneous delivery of the drug and NIR photothermal therapy. 
Additionally, gold nanoshells on silica nanorattles(H. Liu et al., 2011) have been 
11 
investigated for delivery of docetaxel along with simultaneous NIR photothermal 
therapy. Elastin-like polypeptide (ELP)-gold nanorod nanocomposites have also been 
investigated for dual delivery of the anti-cancer drug, 17-AAG simultaneously with NIR 
photothermal therapy(H-C. Huang, Yang, Nanda, Koria, & Rege, 2011). 
Doxorubicin (DOX)-loaded thermally sensitive micelles/liposomes were found to 
accumulate greater in xenograft MDA-MB-49 human tumors in mice following GNR-
mediated hyperthermia. Additionally, DOX molecule release was triggered via the 
hyperthermia, and it was found that the combination of the two treatments resulted in 
higher tumor growth suppression compared to hyperthermia alone and hyperthermia plus 
free DOX controls(J. H. Park et al., 2010). In murine fibrosarcoma-bearing mice, tail vein 
injection was used to administer PEG-grafted gold nanospheres covalently linked with 
tumor necrosis factor alpha (TNF-α). After hyperthermic treatment (by exposure or tumor 
and surrounding tissue to water bath), it was found that tumor recession was increased 
when compared to each treatment alone. More recently, PEG-grafted gold nanospheres 
have been used for delivery of recombinant Tumor Necrosis Factor-alpha (rhTNF a.k.a 
CYT-6091) in phase I clinical trials; phase II clinical trials are currently in 
progress(Libutti et al., 2010).    
Although promising, one major limitation of administering hyperthermic treatment is 
the depth of penetration of NIR light. Currently, penetration depths in soft tissue are 
limited to approximately 2 cm in the most advanced NIR laser systems(Gu, Chen, Xia, 
Jeong, & Liu, 2005). This results in applications limited to topical or near-surface 
conditions. However, alternative techniques have been investigated in order increase 
potential treatment depths. This includes the use of minimally invasive interventional 
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techniques, where fibers inserted directly into tumors / tissues are used for administration 
of laser-based hyperthermic treatment. This approach has been applied to hyperthermic 
treatment for primary and metastatic liver cancer(Gough-Palmer & Gedroyc, 2008; Vogl, 
Straub, Eichler, Sollner, & Mack, 2004; Vogl, Straub, Zangos, Mack, & Eichler, 2004) as 
well as in lung metastases(Rosenberg et al., 2009).  
Silver Nanoparticles 
Though not as widely studied as gold nanoparticles, applications of silver 
nanoparticles (AgNPs) in biomedicine have also been explored(Arvizo et al., 2012). 
AgNPs have been found to be plasmonically superior to gold, however their uses have 
been limited due to their potential toxicity(S. Singh et al., 2010; Sotiriou & Pratsinis, 
2011). However, recent investigations have involved the encapsulation of AgNPs within 
nanothin silica coatings in order to increase their biocompatibility for increased 
use(Sotiriou et al., 2011; Sotiriou et al., 2010).   
  The antibacterial activity of nanoscale silver has resulted in investigations in 
hospital treatment against microbial infections, burns, diabetic skin ulcers, and medical 
devices. The antimicrobial spectrum of AgNPs is broader than that of most common 
antibiotics(C. You et al., 2012). This activity is most widely attributed to release of 
positively charged silver ions that then bind with negatively charged proteins, RNA, 
and/or DNA which can limit cell replication(Silver, Phung, & Silver, 2006).  
Encapsulating silver(1) carbene complexes in nanofibers has shown promising results for 
sustained and effective silver ion delivery over a long periods of time. This provides 
bactericidal activity and have primarily been applied for wound-or burn-
13 
dressings(Butorac, Al-Deyab, & Cowley, 2011). Nano-Ag sepiolite, which is a soda-lime 
glass powder containing monodispersed AgNPs with a low melting point possesses high 
antibacterial activity as well as antifungal activity(Esteban-Tejada, Malpartida, Esteban-
Cubillo, Pecharroman, & Moya, 2009). Additionally, AgNPs have been found to be 
effective virucidal agents against cell-free and cell-associated viruses. For example, 
AgNPs have been found to exert anti-HIV activity at early stages of the viral replication. 
Additionally, they inhibit the post-entry stages of the HIV-1 life cycle(Panacek et al., 
2009).    
Further studies into the cytotoxicity, antibacterial mechanisms, bio-distribution, organ 
accumulation, degradation and adverse effects due to AgNP treatment are still needed. It 
was been widely accepted that AgNPs in high concentrations can cause apoptosis in 
mammalian cells(L. Wei et al., 2010). This toxicity is attributed to AgNPs facilitating 
generation of intracellular reactive oxygen species (ROS) that result in oxidative damage 
to proteins and DNA(Boonstra & Post, 2004; Hsin et al., 2008; Vanwinkle et al., 2009). 
Despite this, AgNPs have great promise for future applications in biomedicine. They 
show great antimicrobial properties with no report of resistance effect when used in the 
clinic to date(C. You, et al., 2012). As characterization and continued investigation into 
the application of AgNPs progress, it is anticipated that they will find significant 
application in the biomedicine. 
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CHAPTER 2 
TRANSGENE DELIVERY USING POLY(AMINO ETHER)-GOLD NANOROD 
ASSEMBLIES 
Several novel nanomaterials, including gold nanoparticles, are currently being 
investigated as carriers for delivery of therapeutic agents (Chinnaiyan, et al., 2006; Cho, 
et al., 2008; Ghosh, et al., 2008; Heath & Davis, 2008; H. C. Huang, et al., 2011; Jabr-
Milane, et al., 2008; Smith, et al., 2008). The plasmonic properties of gold nanorods 
make them attractive for application in biosensing (Castellana, Gamez, & Russell, 2011; 
L. Guo, Zhou, & Kim, 2011), imaging (Ding et al., 2007; Ha, Carson, Agarwai, Kotov, & 
Kim, 2011; Pan et al., 2010), photothermal therapy (Choi et al., 2011; X. H. Huang, El-
Sayed, Qian, & El-Sayed, 2006; von Maltzahn et al., 2009), and gene and drug 
delivery(Braun et al.; C. Chen et al., 2006; Salem, Searson, & Leong, 2003). Effective 
delivery of exogenous genes using appropriate vehicles is a promising approach towards 
correction of diseases that are genetic in origin. Despite their high efficacies as delivery 
vectors, viruses suffer from several limitations including immunogenicity, insertional 
mutagenesis, and high production costs. Non-viral strategies, particularly those that can 
simultaneously enable delivery and imaging (‘theranostics’), are attractive alternatives to 
viral vectors in gene therapy applications (Garnett, 1999; Glover, Lipps, & Jans, 2005; 
Yi, Hahm, & Lee, 2005).  
Gold nanoparticles are promising vectors for non-viral transgene delivery due to 
their unique optical properties and the ability to modify their surfaces using facile 
methods (X. Huang, et al., 2009). In addition, gold nanoparticles possess high surface 
area-to-volume ratios which can facilitate high payload (transgene) carrying capabilities. 
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Surface functionalization of gold nanoparticles allows for tuning of hydrophobicity and 
charge, which can enhance transgene expression and decrease cytotoxicity (Ghosh, et al., 
2008). Polymers have been investigated for functionalization of gold nanoparticles in 
several applications, including transgene delivery (A. C. Bonoiu, et al., 2009; Ow 
Sullivan, et al., 2003; Sandhu, et al., 2002; M. Thomas & A. M. Klibanov, 2003). 
Polymer-functionalized gold nanoparticles demonstrate increased stability, controllable 
surface properties, and the capacity for additional surface functionalization which further 
increases their potential for use in therapeutic applications (Q. Wei, Ji, & Shen, 2008). 
We previously employed a cationic polymer synthesized in our laboratory (S. 
Barua et al., 2009b; Kasman, Barua, Lu, Rege, & Voelkel-Johnson, 2009a) primarily for 
enhancing the colloidal stability of gold nanorods in biological media (H. C. Huang, K. 
Rege, & J. J. Heys, 2010). In this study, we describe an investigation into polymer type, 
plasmid DNA loading, and physicochemical properties of poly(amino ether)-
functionalized gold nanorods in determining the efficacy of transgene delivery and 
expression using these vehicles. Poly(amino ether) or PAE-functionalized GNR (PAE-
GNR) assemblies were generated by depositing polyelectrolyte multilayers on 
cetyltrimethyl ammonium bromide based gold nanorods (CTAB-GNRs); candidates from 
a cationic poly(amino ether) library recently synthesized in our laboratory were employed 
in the current study (S. Barua, et al., 2009b). PAE-GNRs are stable in cell culture media, 
and are also able to bind plasmid DNA by means of electrostatic interactions. PAE-GNRs 
were employed to successfully deliver plasmid DNA expressing the luciferase reporter 
protein to human prostate cancer cells; PAE-GNRs based on 1,4C-1,4Bis, a cationic 
polymer generated in our laboratory demonstrated higher transgene (luciferase) 
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expression efficacies, and lower or comparable cytotoxicities compared to assemblies 
generated using 25 kDa poly(ethylene imine) (PEI25k), a current standard for polymer 
mediated gene delivery. 
MATERIALS AND METHODS  
Gold Nanorod (GNR) Synthesis. The seed-mediated method (Nikoobakht & El-
Sayed, 2003) was used for the synthesis of the gold nanorods (CTAB-GNRs). Briefly, a 
seed solution was prepared by adding 5 ml of 0.2 M cetyltrimethyl ammonium bromide 
(CTAB) to 5 ml of 0.0005 M auric acid (HAuCl4.3H20). The addition of 0.6 ml of iced 
water-cooled 0.01 M sodium borohydride was used to reduce the solution. The growth 
solution was prepared by adding 5 ml of 0.001 M auric acid to 5 ml of 0.2 M CTAB 
containing 250 µl of 0.004 M silver nitrate. The growth solution was reduced by the 
addition of 70 µl of 0.0788 M L-ascorbic acid. Seed solution (12 µl) was added to the 
growth solution and continuously stirred for four hours to allow for the generation of the 
gold nanorods. CTAB-GNRs, with absorbance maxima at different wavelengths between 
750-900 nm, were generated by modulating the silver nitrate concentration in the growth 
solution.    
Polymer Synthesis. Polymer synthesis was carried out as described previously 
(S. Barua, et al., 2009b). Briefly 1,4-cyclohexanedimethanol diglycidyl ether (1,4C) and 
1,4-bis(3-aminopropyl) piperazine (1,4Bis), neopentylglycol diglycidyl ether (NPDGE) 
and diethylenetriamine (DT), and 1 4 butanediol diglycidyl ether (1,4BDGE)  and 1,4Bis 
were reacted in equimolar amounts at room temperature in order to generate 1,4C-1,4Bis, 
NPGDE-DT, and 1,4BDGE-1,4Bis cationic polymers, respectively. The polymerization 
reaction was carried out in 20 ml glass scintillation vials for 16 hours. Following the 
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reaction, polymers were dissolved at a concentration of 10 mg/mL in phosphate-buffered 
saline (0.01 X PBS) and the solution pH was adjusted to 7.4 using 30% hydrochloric acid 
in deionized (DI) water in order to compensate for the basicity of the cationic polymer. 
The extent of polymerization was determined by comparing reactive amine 
concentrations at initial mixing of monomer reagents (time – 0h) and after 16 hours 
polymerization using the ninhydrin assay as described previously (S. Barua, et al., 2009b; 
Kasman, et al., 2009a).  
Polymer Molecular Weight Determination. Molecular weights (MWs) of 
polymers were measured by gel permeation chromatography (GPC) system (Waters 
1515) with a refractive index detector (Waters 2414) with ultrahydrogel column (Waters 
linear) at a flow rate of 1 ml/min at 35°C. Water containing 0.1% trifluoroacetic acid and 
40% acetonitrile was used as a mobile phase. Poly (2-vinylpyridine) standards (MW: 
3000; 7,000; 12,000; 35,000; 70,000) were used to calibrate the GPC instrument for 
molecular weight determination. 
Generation of Poly(amino ether)-functionalized Gold Nanorod (PAE-GNR) 
Assemblies. Dispersions of GNRs with an optical density of 0.5 in 1.5 mL 
microcentrifuge tubes were centrifuged at 6000 rcf for 10 minutes using a Microfuge 18 
centrifuge (Beckman Coulter) in order to remove excess CTAB surfactant. The 
supernatant was removed and the GNRs were redispersed in 100 µL of a poly(styrene 
sulfonate) (PSS) solution (10 mg/mL in 0.01XPBS; ~1.5 mM salt concentration). This 
dispersion was immediately sonicated for 30 minutes to allow for the formation of PSS-
coated GNRs (PSS-CTAB-GNRs). Excess PSS was removed by centrifugation at 6000 
rcf for 10 minutes. PSS-CTAB-GNRs were then redispersed in 300 µL of nanopure water 
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and 200 µL of different poly (amino ethers) (10 mg/mL in 0.01XPBS) were added to 
these dispersions which were immediately sonicated for 30 min to allow for the 
formation of the PAE-coated-PSS-CTAB-GNRs or PAE-GNRs. The PAE-GNRs were 
finally resuspended in serum-free media in order to monitor their stability and for use in 
in vitro experiments.  
Determination of PAE-GNR Stability in Media. PAE-GNRs were prepared as 
described above and dispersed in serum-free media (SFM). Absorption spectra from 400-
999 nm were determined at different times using a temperature-controlled plate reader 
(BioTek Synergy 2) for up to 48 hours.  
 
Generation and Characterization of Plasmid DNA-loaded PAE-GNR 
Assemblies. Plasmid DNA. The pGL3 control vector (Promega Corp., Madison, WI), 
which encodes for the modified firefly luciferase protein under the control of an SV40 
promoter, was used for transgene expression studies. E.coli (XL1 Blue) cells containing 
the pGL3 plasmid DNA were cultured overnight (16 h, 37 °C, 150 rpm) in 15 mL tubes 
(Fisher) in 5 mL of Terrific Broth (MP Biomedicals, LLC). The cultures were then 
centrifuged at 5400g and 4°C for 10 min. Plasmid DNA was purified according to the 
QIAprep Miniprep Kit (Qiagen) protocol and DNA concentration and purity were 
determined based on absorbance at 260 and 280 nm, determined using a NanoDrop 
spectrophotometer (ND-1000; NanoDrop Technologies). Plasmid DNA concentrations of 
200-300 ng/µL were typically obtained and volumes were adjusted in order to load 
between 10-200 ng of plasmid DNA on PAE-GNRs prior to transfections. 
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Plasmid DNA Loading on PAE-GNRs. PAE-GNRs (optical density 0.25 a.u.) 
were incubated with different amounts (10-200 ng) of pGL3 plasmid DNA in the 
presence of serum-free media for 30 min leading to the formation of PAE-GNR-pGL3 
assemblies. These were centrifuged at 6000 rcf for 10 min, redispersed in serum-free 
media, and monitored for colloidal stability using the GNR near infrared (longitudinal) 
absorption peak for up to 6 h (duration of transfection experiments described below) as 
previously described. The amount of plasmid DNA remaining in the supernatant after 
centrifugation was determined using ethidium bromide, a DNA intercalating dye. 
Ethidium Bromide (1 µg of 0.5 mg/ml; Sigma-Aldrich) was added to each sample. 
Solutions were transferred to a black 96 well plate and fluorescence was measured with 
excitation at 320 nm and emission at 600 nm using a plate reader (BioTek Synergy 2), 
similar to methods previously described (Boger, Fink, Brunette, Tse, & Hedtick, 2001; K 
Rege, Shanghui Hu, James A. Moore, Jonathan S. Dordick, & Steven M. Cramer, 2004; 
Rege et al., 2005a). Known plasmid DNA amounts in solution were used as standards for 
calibration of the assay. 
Determination of Zeta Potential of PAE-GNR Assemblies. Stable PAE-GNR 
dispersions in SFM were prepared as described above and set to an optical density of 0.25 
and co-incubated with 0, 50, or 100 ng of pGL3 plasmid DNA. Dispersions were 
transferred into folded capillary zeta cells (Malvern). Zeta potential values were 
determined using a dynamic light scattering machine (Malvern).   
PAE-GNR Mediated Transgene Expression in Human Cancer Cell Lines. 
Cell Culture. The PC3 human prostate cancer cell line was obtained from the American 
Type Culture Collection (ATCC, VA). PC3-PSMA human prostate cancer cells (Gong et 
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al., 1999), were a generous gift from Dr. Michel Sadelain of the Memorial Sloan Cancer 
Center, New York, NY and were used as received. RPMI 1640 with L-glutamine and 
HEPES (RPMI-1640 medium), Pen-Strep solution: 10000 units/mL penicillin and 10000 
µg/mL streptomycin in 0.85% NaCl, and fetal bovine serum (FBS) were purchased from 
Hyclone. Serum-Free medium (SFM) consists of RPMI-1640 medium plus 1% Pen-Strep 
(1000 units/mL penicillin and 1000 µg/mL). Serum containing medium (SCM) consists 
of SFM plus 10% FBS. Cells were cultured in a 5% CO2 incubator at 37
oC using RPMI-
1640 medium containing 10% heat-inactivated FBS and 1% antibiotics (Pen-Strep).  
PAE-GNR Cytotoxicity. Stable PAE-GNR dispersions in SFM were prepared as 
described above and set to an optical density of 0.25. PC3 or PC3-PSMA human prostate 
cancer cells were seeded in 24 well plates at a density of 50,000 cells/well and allowed to 
attach overnight in a 37oC, 5% CO2 incubator. Volumes ranging from 5 µL to 100 µL of 
the PAE-GNRs were added to each well and the final well volume was brought up to 500 
µL with serum-free media, such that the final GNR O.D. in each well ranged from 0.0025 
to 0.125 A.U, in order to carry out a dose-response study. The cells were then incubated 
for 6 hours after which the SFM was replaced with SCM. After incubation, cell viability 
was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) cell proliferation assay kit (ATCC CA# 30-1010k). This assay involves the 
enzymatic conversion of the MTT substrate to purple-colored formazan in metabolically 
active cells. This activity is widely employed as an indicator of cell viability and 
proliferation (Hayon, Dvilansky, Shpilberg, & Nathan, 2003); loss of metabolic activity 
was used as an indirect indicator of loss of cell viability upon PAE-GNR treatment. 
Following addition of the MTT reagent (2 h at 37 °C), cells were treated with a lysis 
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buffer from the kit and kept at room temperature in the dark for 2 h in order to lyse cells 
and solubilize the MTT product. The absorbance of each well was measured using a plate 
reader (BioTek Synergy 2) at 570 nm to assay for the blue MTT product. For data 
analysis, absorbance readouts were normalized to the live (untreated) and dead (5 µL of 
30% hydrogen peroxide treated) controls.  
Transfections. PC3 and PC3-PSMA human prostate cancer cells were cultured as 
described above. Cells were seeded in 24-well plates (Costar) at a density of 50,000 
cells/well and allowed to attach overnight. Sub-toxic amounts of PAE-GNR-pGL3 
plasmid assemblies were added to each well in the presence of serum-free media for 6 h. 
The media was then replaced with serum-containing media for 48 h following which, 
cells were permeabilized with 150 µL of cell lysis buffer (Promega, Madison, WI). The 
luciferase activity in cell lysates was measured using a luciferase assay kit (Promega, 
Madison, WI) in a plate reader (BioTek Synergy 2). The relative light unit (RLU) 
readouts determined from the assay were normalized with respect to protein 
concentration in the respective cell lysates, measured using the Pierce BCA Protein 
Assay Kit (Pierce Biotechnology, Rockford, IL). Transgene expression efficacy was 
based on luciferase activity in cell lysates, which was expressed as relative light units 
(RLU) per milligram (mg) (RLU / mg) of protein. Transfection experiments were 
performed at least in triplicate. 
RESULTS AND DISCUSSION 
We have previously developed a library of cationic polymers and evaluated them for 
plasmid DNA delivery and transgene expression in cancer cell lines (S. Barua, et al., 
2009b; S. Barua & K. Rege, 2010). Interfacing these poly(amino ethers) with gold 
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nanorods can eventually lead to multifunctional nanoassemblies that can be employed in 
transgene delivery, optical / X-Ray CT imaging, and photothermal treatment to cancer 
cells. In the current work, we describe the generation of poly(amino ether)-gold nanorod 
(PAE-GNR) assemblies using a layer-by-layer deposition approach (H. C. Huang, et al., 
2010). Three recently developed cationic polymers, 1,4C-1,4Bis (Mw=5,076 g/mol), 
1,4BDGE-1,4Bis (Mw=16,381 g/mol), and NPGDE-DT (Mw=12,146 g/mol) were 
employed to generate the assemblies in this study. We chose the 1,4C-1,4Bis polymer 
since it demonstrated significantly higher transgene expression efficacies compared to 25 
kDa poly(ethylene imine) when delivered as polymer: plasmid DNA complexes 
(polyplexes) (S. Barua, et al., 2009b; S. Barua & K. Rege, 2010). A previously untested 
but related polymer, 1,4BDGE-1,4Bis, was synthesized and investigated, since the amine 
monomer (1,4 Bis) in this polymer is the same as that in the 1,4C-1,4Bis polymer and the 
cross-linking diglycidyl ethers are different between the two. A third polymer, NPGDE-
DT, was also included for generating PAE-GNR assemblies; the polymer was used as an 
unrelated control, since the two constituent monomers are not related to the 1,4C-1,4Bis 
polymer. We investigated the stability, plasmid DNA loading capacity, and zeta potential 
of these assemblies followed by an evaluation of their cytotoxicity and transgene 
expression efficacies in prostate cancer cell lines. PEI-25k-GNR assemblies were 
investigated as controls in this current study, since this polymer is widely used as a 
standard for polymeric gene delivery. In the following studies, the maximum longitudinal 
(NIR) optical density (O.D.) for the PAE-modified gold nanorod assemblies is used as an 
indication of concentration. Using inductively coupled plasma optical emission 
spectrometry (ICP-OES) we found a linear relationship between O.D. and gold 
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concentration (Figure 2.1) for gold nanorods with a maximum longitudinal absorption 
peak at both 750 and 800 nm, indicating that the peak NIR O.D. was an excellent 
surrogate for gold / GNR concentration. 
 
Figure 2.1. Linear relationship between GNR optical density and concentration 
determined by ICP-OES 
 
Stability of PAE-GNRs. Previous results indicated that GNR-based assemblies 
were less stable in phosphate-buffered saline (PBS) and serum-free medium (SFM) 
compared to DI water and serum-containing media (H. C. Huang, et al., 2010). The 
optical stability of different PAE-GNRs dispersed in serum-free media (SFM, RPMI-
1640) was therefore investigated. As seen in Figure 2.2, minimal loss of the longitudinal 
peak in the NIR region was observed for all PAE-GNR dispersions following the six-
hour incubation period in media, which is particularly promising since cells are 
transfected over this period of time. Less than 20% loss was observed in the longitudinal 
peak after incubating PAE-GNRs for 48h, indicating that PAE-GNRs were generally 
stable in dispersion over this duration; it is possible that a small fraction of PAE-GNR 
assemblies aggregates and precipitates over the 48 h duration. 
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Figure 2.2. Optical stability of (A) PEI25k-GNRs, (B) 1,4BDGE-1,4Bis-GNRs, (C) 1,4C-
1,4BisGNRs (D) NPGDE-DT-GNRs dispersed in serum-free media. Absorbance spectra 
were monitored from 400 to 999 nm for up to 48 h. 
 
PAE-GNR Assemblies Exhibit Similar or Reduced Cytotoxicities Compared 
to PEI25k-GNR Assemblies.The cytotoxicities of the different PAE-GNRs were 
investigated with PC3 and PC3-PSMA human prostate cancer cells; PEI25k-GNR 
assemblies were used as controls. It was found that 1,4C-1,4Bis-GNRs and 1,4BDGE-
1,4Bis-GNRs resulted in lower loss of PC3 cell viability compared to those generated 
with PEI25k (Figure 2.3a). NPGDE-DT-GNRs exhibited a greater loss of cell viability 
compared to PEI25k-GNRs. A similar observation was seen with the PAE-GNRs in PC3-
PSMA cells at lower PAE-GNR concentrations. At lower concentrations, 1,4C-1,4Bis-
GNRs and 1,4BDGE-1,4Bis-GNRs had similar or less loss of cell viability as compared 
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to PEI25k-GNRs (Figure 2.3b), indicating some variability based on the cell line under 
investigation. As was seen in PC3 cells, NPGDE-DT-GNRs exhibited the highest loss of 
cell viability of the PAE-GNR assemblies that were tested. It is important that some 
polymers chosen from our library possess similar if not lesser cytotoxicities than PEI25k 
(Vicennati, Giuliano, Ortaggi, & Masotti, 2008), since it may be possible to deliver 
higher amounts of plasmid DNA with higher doses of these PAE-GNRs. For purpose of 
use in further experiments in this study, a loss of cell viability of 30% was deemed as the 
upper limit of cytotoxicity that could be tolerated. 
 
Figure 2.3 – Cytotoxicity of PEI25k-GNRs and PAE-GNRs towards (A) PC3 and (B) 
PC3-PSMA cells as determined using the MTT assay.  Cell viability is reported as 
percentage of untreated cells (control). 
 
Plasmid DNA Loading onto PAE-GNRs. Cationic polymers have been 
increasingly used as non-viral vehicles for delivering nucleic acids into a variety of 
mammalian cells (Kulkarni, Mishra, Fraser, & Davis, 2005; Lou, Peng, Chen, Wang, & 
W., 2009). Given their ability to deliver plasmid DNA into cells (S. Barua, et al., 2009b; 
S. Barua & K. Rege, 2010), we hypothesized that poly(amino ethers) generated in our 
laboratory would exhibit similar efficacies following functionalization on GNRs. The 
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pGL3 plasmid DNA was incubated with PAE-GNRs for 6 h in order to determine 
plasmid DNA binding efficacies of the assemblies. Following centrifugation, the 
supernatant was tested for plasmid DNA content using an ethidium bromide-based 
fluorescence assay. Ethidium bromide is a DNA intercalating dye which is commonly 
used as a stain for nucleic acids and to determine DNA content (Geall & Blagbrough, 
2000). As seen in Table 2.1, all PAE-GNRs were found to bind and retain greater than or 
equal to 97% of the initially loaded plasmid DNA for plasmid DNA loadings up to 100 
ng. These results indicate that poly(amino ether)-based PAE-GNRs strongly bind plasmid 
DNA and minimal, if any, losses of loaded plasmid DNA are anticipated for the duration 
of the transgene delivery experiments with PAE-GNR assemblies. As a result of these 
high loadings (>97%) in all cases, the amount of pGL3 plasmid DNA loaded on PAE-
GNRs was approximated to be the same as that used initially in the loading experiments 
(i.e. 100% loading was assumed).  
Table 2.1 – Percentage of pGL3 plasmid DNA loading on PEI25k-GNRs and PAE-GNRs 
for initial DNA amounts of 50 ng and 100 ng. Data are presented as mean values ± one 
standard deviation. 
 
Polymer-Modified GNRs 
pGL3 Plasmid DNA Loaded 
(% of initial) 
50 ng 100 ng 
PEI25k-GNRs 97.0 ± 1.3 98.4 ± 0.3 
1,4BDGE-1,4Bis-GNRs 98.1 ± 1.1 99.2 ± 0.9 
1,4C-1,4Bis-GNRs 99.0 ± 0.8 96.9 ± 1.2 
NPGDE-DT-GNRs 100 ± 0.7 98.3 ±1.8 
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 1,4C-1,4Bis-GNRs and 1,4BDGE-1,4Bis-GNRsPAE-GNRs, loaded with different 
amounts of plasmid DNA, were dispersed in SFM and the absorption spectra of the 
assemblies were monitored for 6 h in order to determine their colloidal stability over the 
period that they are incubated with cells for transgene delivery.  Minimal changes were 
observed in the longitudinal peak of PAE-GNRs. In the cases of 1,4C-1,4Bis-GNRs and 
1,4BDGE-1,4Bis-GNRs after loading of 50 ng (Figure 2.4c and b respectively) and 100 
ng plasmid DNA (Figure 2.4g and f respectively), the longitudinal peak was slightly 
higher by approximately 0.01 A.U. at 6 h compared to 0 h. This increase in the 
longitudinal peak is likely within limits of experimental error and may be explained by 
some evaporation of the media during experimental conditions.  In contrast, the maximal 
longitudinal absorption peak decreased and the spectrum broadened in case of PEI25k-
GNRs and NPGDE-DT-GNRs upon incubation for six hours after loading 50 ng (Figure 
3a and d respectively) and 100 ng of plasmid DNA. This is most likely due to 
aggregation of these assemblies following plasmid DNA loading, which leads to a 
reduction in the stabilizing cationic charge due to the surface PAE layer. Despite these 
modest changes in the absorption spectrum following addition of plasmid DNA, the 
stability is sufficient for these assemblies to be useful for transgene delivery.  
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Figure 2.4. Optical stability of PEI25k-GNRs with (a) 50 ng pGL3 DNA, 1,4BDGE-
1,4Bis-GNRs with (b) 50 ng pGL3 DNA, 1,4C-1,4Bis-GNRs with (c) 50 ng pGL3 DNA,  
NPGDE-DT-GNRs with (d) 50 ng pGL3 DNA, PEI25k-GNRs with (e) 100 ng pGL3 DNA, 
1,4BDGE-1,4Bis-GNRs with (f) 100 ng pGL3 DNA, 1,4C-1,4Bis-GNRs with (g) 100 ng 
pGL3 DNA, and NPGDE-DT-GNRs with (h) 100 ng pGL3 DNA. 
 
Zeta potentials of PEI25k-GNRs and PAE-GNR assemblies with and without 
plasmid DNA were determined (Figure 2.5) in order to further investigate their stability. 
In the absence of plasmid DNA, all PAE-GNRs possessed a positive zeta potential 
greater than 10 mV, with 1,4C-1,4Bis-GNR assemblies demonstrating the highest value 
of approximately 17 mV. The positive zeta potential value indicates that the cationic 
polymer coating is in fact on the outermost layer of the PAE-GNRs. Addition of 50 ng 
plasmid DNA resulted in a reduction of zeta potential of all assemblies except those 
based on PEI25k-GNRs. This decrease can be explained by the shielding of the initial 
positively charged coating polymer by negatively charged DNA. Further addition of 
plasmid DNA (100 ng) caused a charge reversal in all PAE-GNRs, except for those based 
on the 1,4C-1,4Bis-polymer which decreased but remained positive. This observation 
suggests that increased coverage of the PAE-GNR surface with plasmid DNA leads to a 
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charge reversal of these assemblies. As shown previously, 1,4C-1,4Bis-GNR assemblies 
bind and retain over 98% of plasmid DNA. Although we did not test this further, the lack 
of charge reversal most likely indicates that higher amounts of plasmid DNA can be 
loaded onto this PAE-GNR. However, it is desirable to have the PAE-GNRs retain a net 
positive charge after addition of plasmid DNA, since excess positive charge can facilitate 
interactions with negatively charged cell surfaces, leading to efficacious cellular uptake 
of the PAE-GNR-pGL3 assemblies and expression of the delivered transgene. 
 
Figure 2.5. Zeta potential measurements of PAE-GNRs and PEI25k-GNRs at an optical 
density of 0.0025 a.u. with and without pGL3 plasmid DNA. As the loaded plasmid DNA 
amount increases zeta potential decreases due to the anionic nature of DNA. 
 
PAE-GNR Mediated Delivery of Plasmid DNA to Prostate Cancer Cells in 
vitro. PC3 and PC3-PSMA human prostate cancer cells were treated with sub-toxic 
concentrations of PAE-GNRs and PEI25k-GNRs loaded with 10-200 ng of pGL3 
plasmid DNA, in order to determine the efficacy of different PAE-GNRs for transgene 
expression. The final GNR O.D. was maintained at 0.0025 in each well since PAE-GNRs 
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were not toxic to cells under these conditions. This was carried out to ensure that only 
plasmid DNA amounts changed, while maintaining the same amount of GNRs across 
these experiments. 
A dose-dependent trend was observed for luciferase expression (absolute 
RLU/mg values) in both PC3 (Figure 2.6a) and PC3-PSMA cells (Figure 2.6b). 
Luciferase expression was found to be maximal typically between 40 ng and 60 ng of 
loaded pGL3 DNA, after which, it declined slightly and leveled off to a lower value. This 
observed trend is likely due to an optimized condition in which both, the amount of 
plasmid DNA, as well as net positive surface charge of the PAE-GNRs allow for 
sufficient cellular interaction and uptake for transgene expression. This is supported by 
the previously described observation; at a loading of 50 ng pGL3 plasmid, all PAE-GNRs 
still exhibited a positive zeta potential. The decline in luciferase expression with pGL3 
plasmid DNA loadings greater than 60 ng correlates with zeta potential data, which 
indicated reduced but positive zeta potential for 1,4C-1,4Bis-GNRs and negative zeta 
potential values for PEI25k-GNRs, 1,4BDGE-1,4Bis-GNRs and NPGDE-DT-GNRs (e.g. 
at 100 ng plasmid DNA in Figure 2.5). This can result in repulsion of PAE-GNR-pGL3 
assemblies from negatively charged cell surfaces leading to reduced uptake and lower 
levels of transgene expression. It is likely that further increase in the amount of plasmid 
DNA on PAE-GNRs may completely shield the positive charges present on the outermost 
layer of the PAE-GNRs resulting in further decline of transgene expression. Although 
PAE-GNRs are able to bind significant amounts of plasmid DNA, increasing loading 
results in decrease in the zeta potential of these nanoassemblies, which reduces their 
efficacies for transgene expression. 
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Figure 2.6 – Absolute values of transgene (luciferase) expression in (A) PC3 and (B) 
PC3-PSMA cells with PEI25k-GNRs and PAE-GNRs at an optical density of 0.0025 a.u. 
loaded with different amounts of pGL3 plasmid DNA (ng). Transgene (luciferase) 
expression in (C) PC3 and (D) PC3-PSMA reported relative to PEI25k-GNRs (* p<0.05; 
** p<0.01; Student t-test). Luciferase expression, in relative luminescence units (RLU) 
was analyzed 48 h post transfection and normalized to total protein content (mg) 
resulting in RLU /mg values. 
 
It was observed that 1,4C-1,4Bis-GNR-pGL3 assemblies exhibited up to 165-fold 
enhanced luciferase expression in PC3 cells (Figure 2.6c) and up to 100-fold enhanced 
luciferase expression in PC3-PSMA cells (Figure 2.6d) compared to those based on 
PEI25k-GNRs. The highest enhancements compared to 25kDa pEI were observed for 
plasmid DNA loadings of 100 ng and 150 ng for PC3 and PC3-PSMA cells, respectively. 
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These statistically significant levels of enhancement in luciferase expression can be 
partially attributed to the zeta potentials of the respective PAE-GNRs. For example, in 
case of PC3 cells, 1,4C-1,4Bis-GNR-plasmid DNA assemblies retain a net positive 
charge compared to those for PEI25k, which exhibit a charge reversal (Figure 2.5). 
Furthermore, these findings are consistent with previous observations that transgene 
expression with 1,4C-1,4Bis-pGL3 polyplexes (polymer-plasmid DNA complexes) was 
higher than that observed with PEI25k (S. Barua, et al., 2009b; S. Barua & K. Rege, 
2010). These results are significant since polymers which demonstrate high efficacies for 
transgene expression as polyplexes can be interfaced with gold nanorods without 
compromise of efficacy. Other PAE-GNRs exhibited similar or statistically significant 
higher levels of luciferase expression compared to PEI25k-GNRs in both, PC3 and PC3-
PSMA cell lines, indicating that polymer candidates from our library result in 
significantly higher or at least comparable efficacies to that seen with PEI25k.   
Higher doses of plasmid DNA-loaded 1,4C-1,4Bis-GNR and PEI25k-GNR 
assemblies were employed  in order to investigate if higher levels of luciferase expression 
could be achieved by increasing the dose of plasmid DNA-loaded PAE-GNRs delivered. 
Doses of up to 0.01 a.u. PAE-GNR optical densities and those that exhibited less than 
30% loss of cell viability in both, PC3 and PC3-PSMA cells, were employed. As 
previously mentioned, the linear relationship between maximum longitudinal O.D. and 
gold concentration facilitates the use of O.D. as a surrogate for GNR concentration under 
these conditions. A ratio of plasmid DNA to PAE-GNR of 50 ng to 0.0025 a.u. (GNR 
optical density in absorbance units) was chosen based on the optimal pGL3 plasmid 
range between 40ng to 60 ng described previously. The 1,4C-1,4Bis-GNR and PEI25k-
33 
GNR concentration and plasmid DNA loaded used were both doubled to 0.005 a.u. and 
100 ng, respectively and quadrupled to 0.01 a.u. and 200 ng plasmid DNA, respectively 
in order to maintain the same optimal PAE-GNR to DNA ratio, while simultaneously 
increasing the amounts of plasmid DNA as well as PAE-GNRs. It was observed that 
increased PAE-GNR concentrations and pGL3 plasmid amount did not result in increased 
luciferase expression for cells treated with 1,4C-1,4Bis-GNRs. However, in case of 
PEI25k-GNR-pGL3 assemblies, luciferase expression rose up by approximately 12- and 
18-fold in PC3 (Figure 2.7a) and PC3-PSMA (Figure 2.7c) cells, respectively compared 
to PEI25k-GNR-pGL3 assemblies with 50 ng plasmid DNA and O.D. of 0.0025 a.u. As a 
result, the expression of 1,4C-1,4Bis-GNRs relative to PEI25k-GNRs showed lower 
values (Figure 2.7b and 2.7). It is likely that transgene expression with PAE-GNRs 
based on the 1,4C-1,4Bis polymer is already at a maximum at the previously used lower 
concentrations, and therefore, higher plasmid DNA amounts do not enhance this efficacy. 
Although higher concentrations of PEI25k-GNRs, resulted in increased transgene 
expression, lower amounts of plasmid DNA were required in case of 1,4C-1,4Bis-GNR 
assemblies compared to PEI25k-GNR assemblies in order to obtain similar levels of 
transgene expression. 
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Figure 2.7 – Transgene expression with higher concentrations of PAE-GNRs used for 
transfection. Luciferase expression values for 1,4C-1,4Bis-GNRs are reported as 
absolute values for (A) PC3 and (C) PC3-PSMA human prostate cancer cells and 
relative to PEI25k-GNRs for (B) PC3 and (D) PC3-PSMA cells. Luciferase expression, in 
relative luminescence units (RLU) was analyzed 48 h post transfection and normalized to 
protein content (RLU /mg). 
 
Plasmid DNA (50 ng pGL3)-loaded 1,4C-1,4Bis-GNRs were evaluated for 
efficacy of transgene expression in serum-containing media. It was found that the 
absolute RLU/mg expression values in SCM decreased by approximately 10-fold of that 
observed in PC3 cells (Figure 2.8a) and by approximately 3-fold in PC3-PSMA cells 
(Figure 2.8b) in the absence of serum. A drop in transgene expression can be expected 
since interactions of these assemblies with serum proteins can result in lower efficacies 
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(H.-C. Huang, et al., 2009). However, the observed levels transgene expression in 
presence of serum indicate that PAE-GNRs may be viable candidates for further 
investigations for combined imaging and transgene delivery in vivo.  
 
Figure 2.8 – Comparison of 1,4C-1,4Bis-GNR mediated luciferase expression in (A) PC3 
and (B) PC3-PSMA cells in serum-containing media (SCM) and serum-free media 
(SFM). The optical density of gold was set at 0.0025 and PAE-GNRs loaded with 50 ng 
pGL3 DNA were employed in all experiments. Values are reported in relative 
luminescence units (RLU) 48 h post transfection and normalized to protein content (RLU 
/mg). 
 
CONCLUSIONS 
 We have synthesized PAE-GNRs using select candidates from a cationic polymer 
library recently synthesized in our laboratory. These PAE-GNRs are stable in media and 
demonstrate the capacity to bind to plasmid DNA. Subtoxic concentrations of PAE-
GNRs demonstrated the ability to mediate transgene delivery and expression in two 
prostate cancer cell lines. PAE-GNRs based on one of our cationic polymers, the 1,4C-
1,4Bis polymer, demonstrated higher transgene expression efficacy and lower 
cytotoxicity when compared to PEI25k-GNR assemblies. Our results indicate that 
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engineering PAE-GNRs leads to a gold-based nanoassembly that combines high 
stabilities, low cytotoxicities, and the ability to deliver transgenes to cancer cells. These 
PAE-GNRs also have the potential to be used for photothermal ablation, photothermally 
enhanced delivery, optical imaging, further surface functionalization, and for carrying 
other anionic (bio)molecules for delivery to cells, making them a powerful theranostic 
platform. 
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CHAPTER 3 
POLY(AMINOETHER)-GOLD NANOROD ASSEMBLIES FOR SHRNA PLASMID-
INDUCED GENE SILENCING 
 
Gene silencing using RNA interference (RNAi) is a promising therapeutic 
approach against several diseases (D. Kim & Rossi, 2009; Y. P. Liu et al., 2009; Pecot, 
Calin, Coleman, Lopez-Berestein, & Sood, 2011), and is a useful tool in biotechnology. 
RNAi involves formation of an intracellular RNA-induced silencing complex (RISC), 
which can execute targeted post-transcriptional gene silencing via sequence-specific 
degradation of mRNAs. Post transcriptional RNAi is characterized by high sequence 
specificity and potency in silencing gene expression, mediated by 21-25 nucleotide 
double stranded small interfering RNA (siRNA). Alternatively, expression cassettes 
(plasmid DNA) can be designed for the intracellular expression of short hairpin RNA 
(shRNA) molecules, which, after cellular processing, result in the formation of an 
antisense strand that is specific to the sequence of the target gene(Grimm et al., 2006; M 
Scherr, Battmer, Ganser, & Eder, 2003). Following delivery of the expression cassette to 
the nucleus, a primary shRNA transcript containing a RNA “hairpin” loop is transcribed 
by RNA polymerase II or III. After nuclear processing, shRNA molecules are exported to 
the cytoplasm where they interact with the dicer protein. Dicer cleaves the hairpin loop, 
resulting in the formation of double stranded RNA molecules. These molecules act in a 
similar fashion to siRNA molecules, which are small (~21 base pair) double-stranded 
RNA molecules. The processed shRNA then interacts with a group of proteins, resulting 
in the formation of the RNA-induced silencing complex (RISC). In cases of both, shRNA 
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transcript formation and cytoplasmic siRNA delivery, RISC formation enzymatically 
cleaves the target mRNA transcript, thus silencing protein expression by preventing 
translation(Rao, Vorhies, Senzer, & Nemunaitis, 2009). Studies have shown the potential 
of RNAi for use in targeting tumor cell growth(Uchida et al., 2004), metastasis(Duxbury, 
Ito, Zinner, Ashley, & Whang, 2004), angiogenesis(Takei, Kadomatsu, Yuzawa, Matsuo, 
& Muramatsu, 2004), and chemoresistance(A. Singh et al., 2008) which are all critical 
components of tumor growth; pre-clinical studies have also showed promise of RNAi for 
silencing cancer-related targets(M. Scherr et al., 2003; G. Yang, Cai, Thompson-Lanza, 
Bast Jr, & Liu, 2004).  
Naked / uncomplexed nucleic acids demonstrate poor efficacies of passive entry 
into cells and are easily degraded by endogenous nucleases, which necessitates their 
delivery via viral or non-viral methods (Bartlett, Su, Hildebrandt, Weber, & Davis, 2007). 
Several delivery methods, including viruses, have been investigated as vehicles for 
silencing genes in mammalian cells. However, safety concerns related to viral vectors 
have prompted discovery and evaluation of non-viral vectors, including those based on 
polymers and nanoparticles, for delivering nucleic acids for gene silencing(A. C. Bonoiu, 
et al., 2009; G. et al., 2009; Kesharwani, Gajbhiye, & Jain, 2012; Yezhelyev, Qi, 
O'Regan, Nie, & Gao, 2008).  
The emergence of novel nanomaterials has led to new options for delivery of 
therapeutic and imaging agents(Ghosh, et al., 2008; H. C. Huang, et al., 2011; T. Wang, 
Mancuso, Kazmi, et al., 2012). Nanoscale vehicles that possess simultaneous delivery 
and imaging capabilities are attractive theranostic vectors for administration of 
exogenous nucleic acids(Garnett, 1999; Glover, et al., 2005; Yi, et al., 2005). Gold 
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nanoparticles have been investigated for delivery of nucleic acids(Conde et al., 2012; Chu 
Hu, Peng, Chen, Zhong, & Zhuo, 2010; S. T. Kim et al., 2012b; Ramos & Rege, 2012b; 
Lucas Vu, James Ramos, Thrimoorthy Potta, & Kaushal Rege, 2012) as well as 
chemotherapeutic drugs(Ramos, Taylor, & Rege, 2012), for different applications in 
biotechnology and medicine. In addition, their optical properties, high surface-area-to-
volume ratios, biocompatibility, and ease of surface functionalization(X. Huang, et al., 
2009) make gold nanoparticles attractive in simultaneous delivery and imaging (i.e. 
theranostics) applications. Functionalization of gold nanoparticles allows for tunable 
control of hydrophobicity, size, and charge, which can enhance payload delivery and 
decrease cytotoxicity(Ghosh, et al., 2008). In particular, polymers are attractive 
candidates for functionalizing surfaces of gold nanoparticles, and have been investigated 
in several applications, including nucleic acid delivery(A. C. Bonoiu, et al., 2009; Song, 
Du, Sun, Zhang, & Wang, 2010; M. Thomas & A. M. Klibanov, 2003). Gold nanorods 
(GNRs), have been widely investigated in (bio)sensing(Castellana, et al., 2011; L. Guo, et 
al., 2011; H. C. Huang et al., 2008), imaging(Ding, et al., 2007; Ha, et al., 2011; Pan, et 
al., 2010), photothermal therapy(Choi, et al., 2011; X. H. Huang, et al., 2006; von 
Maltzahn, et al., 2009), and gene and drug delivery(Braun, et al.; C. Chen, et al., 2006; 
Salem, et al., 2003). Two-photon induced luminescence in GNRs has been shown to be 
highly efficient, both in vitro and in vivo(Durr, et al., 2007). In addition, due to their 
ability to absorb near infrared (NIR) light, excitation wavelengths in this region can be 
used in vivo due to minimal tissue scattering and phototoxicity(J.-L. Li & Gu, 2010; H. F. 
Wang, et al., 2005). 
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We have recently described the use of combinatorial methods for generating 
libraries of linear polyamine-derived poly(aminoether) (PAE) cationic polymers(S. 
Barua, et al., 2009b; S. Barua et al., 2011b; Lucas Vu, et al., 2012) for transgene 
expression following delivery of plasmid DNA, as well as for enhancing adenoviral 
delivery to cells resistant to viral transduction(Kasman, et al., 2009a). In these studies, the 
PAE synthesized from 1,4-cyclohexanedimethanol diglycidyl ether (1,4C) and 1,4-bis(3-
aminopropyl) piperazine (1,4Bis) or 1,4C-1,4Bis emerged as a lead candidate for non-
viral transgene expression following plasmid DNA delivery. 1,4C-1,4Bis had comparable 
molecular weight values (Mn=3.9 kDa, Mw=23.5 kDa, and polydispersity (PD)=5.96) 
when compared to branched pEI25k (Mn=10 kDa, Mw=25 kDa, and PD=2.5). This 
polymer demonstrated lower cytotoxicity and higher transgene expression efficacy than 
pEI25k at higher polymer to plasmid DNA ratios(S. Barua, et al., 2009b) in PC3-PSMA 
prostate cancer cells when compared to branched pEI25k. In a previous study, gold 
nanorods were coated with polymers from this library using a layer-by-layer deposition 
approach (Figure 3.1), resulting in PAE-GNR nanoassemblies(H.-C. Huang, et al., 2009; 
Lucas Vu, et al., 2012) capable of transgene delivery, hyperthermia, and two-photon 
induced luminescence imaging. We previously reported that plasmid DNA-loaded PAE-
GNR nanoassemblies, based on the 1,4C-1,4Bis polymer (i.e. 1,4C-1,4Bis-GNR 
nanoassemblies), demonstrated higher luciferase expression efficacy and lower 
cytotoxicity in PC3 prostate cancer cells in vitro when compared to PEI25k-GNR 
nanoassemblies(Ramos & Rege, 2012b). Based on these findings, 1,4C-1,4Bis-GNR 
assemblies (‘nanoassemblies’) were investigated for delivery of plasmids that express 
shRNA molecules (‘shRNA plasmids’) for silencing genes in prostate cancer cells in the 
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current study. While several strategies, including those based on gold nanoparticles have 
been explored for siRNA delivery(A. Bonoiu, et al., 2011; A. C. Bonoiu, et al., 2009; 
Mahajan, et al., 2012; Masood, et al., 2012; W. Zhang, et al., 2011), non-viral strategies 
for shRNA plasmid delivery are largely under-explored despite several potential 
advantages of this approach. In this study, we demonstrate the efficacy of PAE-GNR 
nanoassemblies for the delivery of shRNA plasmids for gene silencing, and additionally 
examine their theranostic potential for live-cell imaging using two-photon induced 
luminescence facilitated by gold nanorods. 
 
Figure 3.1. Simplified schematic of nanoassembly generation and shRNA plasmid 
loading. Positively charged CTAB-templated GNRs are first modified with an anionic 
polymer, poly(styrene sulfonate) or PSS coat via electrostatic interactions,  resulting in 
PSS-GNR nanoassemblies with a net negative charge. PSS-GNRs are then coated with a 
cationic 1,4C-1,4Bis poly(amino ether) resulting in positively charged nanoassemblies. 
This then allows for loading of anionic shRNA plasmids on the nanoassemblies for gene 
silencing. 
 
MATERIALS AND METHODS 
Generation of Gold Nanorods (GNRs) . The seed-mediated method(Johnson, 
Dujardin, Davis, Murphy, & Mann, 2002; Nikoobakht & El-Sayed, 2003) was used for 
the synthesis of cetyltrimethyl ammonium bromide (CTAB)-templated gold nanorods 
(CTAB-GNRs). Briefly, a seed solution was prepared by adding 5 ml of 0.2 M CTAB to 
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5 ml of 0. 5 mM auric acid (HAuCl4.3H20). Iced water-cooled 10 mM sodium 
borohydride (0.6 ml) was added to reduce the solution. The growth solution was prepared 
by adding 5 ml of 1 mM auric acid to 5 ml of 0.2 M CTAB containing 250 µl of 4 mM 
silver nitrate. The growth solution was reduced by the addition of 70 µl of 0.0788 M L-
ascorbic acid. Seed solution (12 µl) was added to the growth solution and continuously 
stirred for four hours to allow for the generation of the gold nanorods. The concentration 
of silver nitrate in the growth solution was modulated in order to generate CTAB-GNRs, 
with absorbance maxima at different wavelengths (750-900 nm) in the near infrared 
(NIR) region of the absorption spectrum. 
Synthesis of the 1,4C-1,4Bis poly(aminoether). Synthesis of the 1,4C-1,4Bis 
polymer was carried out as described previously(S. Barua, et al., 2009b). Briefly 1,4-
cyclohexanedimethanol diglycidyl ether (1,4C) and 1,4-bis(3-aminopropyl) piperazine 
(1,4Bis) were reacted in equimolar amounts at room temperature in 20 mL glass 
scintillation vials for 16 h leading to the generation of the 1,4C-1,4Bis polymer. 
Following the reaction, polymers were dissolved at a concentration of 10 mg/mL in 
phosphate-buffered saline (0.01 X PBS), and the solution pH was adjusted to 7.4 using 
30% hydrochloric acid in deionized (DI) water in order to compensate for the basicity of 
the cationic polymer. The extent of polymerization was determined by comparing 
reactive amine concentrations at initial mixing of monomer reagents (time – 0h) and after 
16 hours polymerization using the ninhydrin assay as described previously(S. Barua, et 
al., 2009b; Kasman, et al., 2009a). A decrease in amine concentration by ~60% was used 
as an indicator of polymer formation.    
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Generation of 1,4C-1,4Bis-GNR Assemblies (‘Nanoassemblies’). Dispersions 
of GNRs with an optical density of 0.5 at the maximal absorbance wavelength were 
centrifuged at 6000 rpm for 10 minutes in 1.5 mL microcentrifuge tubes using a 
Microfuge 18 centrifuge (Beckman Coulter, Brea, CA), in order to remove excess CTAB 
surfactant. The supernatant was removed, and the GNRs were redispersed in 100 µL 
poly(styrene sulfonate) (PSS) solution (10 mg/mL in 0.01X PBS; ~1.5 mM salt 
concentration). This dispersion was immediately sonicated for 30 minutes to allow for the 
formation of PSS-coated GNRs (PSS-CTAB-GNRs). Excess PSS was removed by 
centrifugation at 6000 rpm for 10 minutes and the supernatant was discarded. PSS-
CTAB-GNRs were then re-dispersed in 300 µL nanopure water, and 200 µL 1,4C-1,4Bis 
polymer (10 mg/mL in 0.01X PBS) were added to the dispersions. These were 
immediately sonicated for 30 min to allow for the formation of the 1,4C-1,4Bis-PSS-
CTAB-GNR nanoassemblies. Excess 1,4C-1,4Bis polymer was removed by 
centrifugation at 6000 rpm for 10 minutes and the supernatant was discarded. The 
nanoassemblies were finally resuspended in serum-free media (SFM) for use in cell-
based experiments. 
Generation and Characterization of Expression Vector-loaded Nanoassemblies 
Expression Vectors. Luc25 and Luc29 shRNA plasmid expression 
vectors(Grimm, et al., 2006) were generous gifts from Professor Mark A. Kay, Stanford 
School of Medicine, Palo Alto, CA. In these vectors, sdsAAV vector plasmid was 
engineered such that it contained the U6 promoter followed by unique Bbs I restriction 
enzyme sites, allowing insertion of shRNAs as annealed oligonucleotides with 
appropriate overhangs. Hairpins were designed such that the sense came before the 
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antisense strand separated by a 7 to 9 nucleotide loop. Luc25 contained a 25 nucleotide 
stem length with the sense strand (5’-3’): GGTGGCTCCCGCTGAATTGGAATCC and 
antisense strand (3’-5’): GGATTCCAATTCAGCGGGAGCCACC, separated by a 
loop sequence of (5'-3’) TCAAGAG.  Luc29 contained a 29 nucleotide stem length with 
the sense strand (5’-3’): ATCGGGCGGCTCTCGCTGAGTTGGAATCC and antisense 
strand (3’-5’): GGATTCCAATTCAGCGGGAGCCACCTGAT separated by a loop 
sequence of (5’-3;) GAAGCTTG, with underlined nucleotides denoting mismatches 
between the strands. Residues in bold-face font are common to both, Luc25 and Luc 29, 
and participate in RISC formation leading to gene silencing. Luc 29 has additional four 
bases (TGAT) in the antisense strand compared to Luc 29. The dc-H1121GFPshRNA-SR 
expression vector was a generous gift from Dr. Matthias Eder(M Scherr, et al., 2003) of 
Hannover Medical School, Hannover, Germany and is denoted as shEGFP for this study. 
The pEGFP plasmid consisting of a 4.7 kbp reporter vector pEGFP-C1 encoding 
enhanced green fluorescent protein (EGFP) under the control of the cytomegalovirus 
(CMV) promoter was purchased from Clontech (Palo Alto, CA). Competent DH5α E. 
coli cells were transformed with the expression vectors and cultured overnight in 
presence of the ampicillin for Luc25, Luc29, and shEGFP and kanamycin for pEGFP 
plasmids (16h, 37°C, 150 rpm) in 5 mL Terrific Broth (MP Biomedicals, LLC, Solon, 
OH) in 15 mL tubes (Fisher, Waltham, MA) in a shaker-incubator. The cultures were 
then centrifuged at 6000  rpm and 4°C for 10 min. Plasmid DNA was purified according 
to the QIAprep Miniprep Kit (Qiagen, Valencia, CA) protocol and DNA concentration 
and purity were determined based on absorbance readings at 260 nm and 280 nm, 
determined using a NanoDrop spectrophotometer (ND-1000; NanoDrop Technologies, 
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Wilmington, DE). Plasmid DNA concentrations were set between 150-300 ng/µL, and 
volumes were adjusted in order to load between 10-100 ng of shRNA plasmid on 
nanoassemblies prior to transfections.  
shRNA plasmid Expression Vector Loading on Nanoassemblies. 
Nanoassemblies (optical density 0.1 a.u. at 800 nm) were incubated with different 
amounts (10-100 ng) of Luc25, Luc29, pEGFP, or shEGFP expression vectors for 30 min 
in serum-free media, leading to the formation of vector-loaded nanoassemblies. The 
amount of shRNA plasmid expression vector remaining in the supernatant after 
centrifugation was determined using ethidium bromide, a DNA intercalating dye. 
Ethidium Bromide (1 µg of 0.5 mg/ml; Sigma-Aldrich, St. Louis, MO) was added to each 
sample. Solutions were transferred to a black 96 well plate, and fluorescence was 
measured using excitation at 320 nm and emission at 600 nm with a plate reader 
(Synergy 2 Multi-Mode Microplate Reader, BioTek, Winooski, VT ), similar to methods 
previously described(K. Rege, S. Hu, J. A. Moore, J. S. Dordick, & S. M. Cramer, 2004; 
Rege, et al., 2005a). Known plasmid DNA amounts in solution were used as standards for 
calibration of the assay. The amount of shRNA plasmid loaded on the nanoassemblies 
was determined using mass balance by subtracting the amount of shRNA plasmid in the 
supernatant from the initial amount used for loading.  
Determination of Hydrodynamic Diameter of Nanoassemblies. Unloaded and 
shRNA plasmid-loaded nanoassemblies were generated in serum-free media as described 
above. The hydrodynamic diameter of nanoassemblies was determined via dynamic light 
scattering (DLS) using a particle sizer (Corrvus Advanced Optical Instruments). The 
hydrodynamic diameter was reported in nanometers (nm). 
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Determination of Zeta Potential of Nanoassemblies. Nanoassemblies were 
prepared as described above, set to an optical density of 0.1, and co-incubated with 0, 10, 
15, 20, 25, 50 or 100 ng of Luc25, Luc29, pEGFP or shEGFP expression vectors. 
Dispersions (in serum-free media) were transferred to the manufacturer’s reusable zeta 
cell (Beckman Coulter, Brea, CA) and zeta potential values were determined using a 
Delsa™ Nano Submicron Particle Size and Zeta Potential Particle Analyzer (Beckman 
Coulter, Brea, CA). Zeta Potential values were reported in millivolts (mV). 
Nanoassembly-mediated shRNA plasmid Delivery to Human Prostate Cancer Cells 
Cell Culture. The 22Rv1-Luc human bone-metastatic prostate cancer cell 
line(Sramkoski et al., 1999) constitutively expresses the firefly luciferase gene, and was a 
generous gift from Professor Christina Voelkel-Johnson, Medical University of South 
Carolina, Charleston, SC as part of an ongoing collaboration. RPMI 1640 with L-
glutamine and HEPES (RPMI-1640 medium), Pen-Strep solution: 10000 units/mL 
penicillin and 10mg/mL streptomycin in 0.85% NaCl, and fetal bovine serum (FBS), 
were purchased from Hyclone. Serum-free medium (SFM) consisted of RPMI-1640 
medium plus 1% Pen-Strep (1000 units/mL penicillin and 1mg/mL streptomycin), and 
serum-containing medium (SCM) consists of SFM plus 10% FBS. Cells, as received, 
were cultured in a 5% CO2 incubator at 37
oC using RPMI-1640 medium containing 10% 
heat-inactivated FBS and 1% antibiotics (Pen-Strep).  
Nanoassembly Cytotoxicity. Stable nanoassemblies in SFM were prepared as 
described above and set to an optical density of 0.1 at 800 nm. 22Rv1-Luc human 
prostate cancer cells were seeded in 96 well plates at a density of 8,400 cells/well and 
allowed to attach overnight in a 37oC, 5% CO2 incubator. Volumes ranging from 3.75 µL 
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to 37.5 µL of shRNA plasmid expression vector loaded nanoassemblies were added to 
each well, and the final well volume was brought up to 150 µL with serum-free media. 
The final GNR O.D. ranged from 0.0025 to 0.025 a.u. in each well, resulting in a dose-
response study. The cells were then incubated for 6 hours after which, serum-free media 
was replaced with serum-containing media. After 72 hours incubation, cell viability was 
determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) cell proliferation assay kit (ATCC CA# 30-1010k, Manassas, VA). This assay 
involves the enzymatic conversion of the MTT substrate to purple-colored formazan in 
metabolically active cells, and is widely employed as an indicator of cell viability and 
proliferation(Hayon, et al., 2003). Loss of metabolic activity, determined from the MTT 
assay, was employed as an indirect indicator of loss of cell viability upon nanoassembly 
treatment. Following addition of the MTT reagent (2 h at 37°C), cells were treated with a 
lysis buffer from the kit and kept at room temperature in the dark for 2 h in order to lyse 
cells and solubilize the MTT product. The absorbance of each well was measured using a 
plate reader (Synergy 2 Multi-Mode Microplate Reader, BioTek, Winooski, VT) at 570 
nm to assay for the blue-colored MTT product. Absorbance readouts were normalized to 
the live (untreated) and dead (5 µL of 30% hydrogen peroxide treated) controls in order 
to obtain toxicity data for different nanoassemblies.  
Luciferase Silencing using shRNA plasmid-loaded Nanoassemblies and Mirus 
TransIT®-LT1-shRNA plasmid complexes. 22Rv1-Luc human prostate cancer cells 
were cultured as described above and seeded in 96-well plates (Costar, Washington DC) 
at a density of 8,400 cells/well. Cells were allowed to attach to the plates overnight in a 
37oC, 5% CO2 incubator. Experiments with Mirus- TransIT
®LT1 were carried out in 
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order to compare the efficacy of our nanoassemblies with a commercially available 
transfection agent; the Mirus TransIT®-LT1 reagent was a generous gift from Dr. Joshua 
LaBaer, Biodesign Institute, Arizona State University, Tempe, AZ. The shRNA plasmid 
was complexed at a ratio of 100 ng plasmid to 0.3 µL of Mirus TransIT®-LT1stock 
solution, based on the manufacturer’s recommendation. Different sub-toxic amounts of 
shRNA plasmid-loaded nanoassemblies and Mirus TransIT®-LT1-shRNA plasmid 
complexes were added to each well in presence of serum-free media for 6 h, resulting in a 
dose response study. The media was then replaced with serum-containing media for 72 h 
following which, cells were permeabilized with 50 µL 1X cell lysis buffer (Promega, 
Madison, WI). Luciferase activity in cell lysates was measured using a luciferase assay 
kit (Promega, Madison, WI) using a plate reader (Synergy 2 Multi-Mode Microplate 
Reader, BioTek, Winooski, VT). Relative luminescence units (RLU) readouts from the 
assay were normalized with respect to protein concentration in the corresponding cell 
lysates; protein amounts were measured using the Pierce BCA Protein Assay Kit (Pierce 
Biotechnology, Rockford, IL). Gene silencing efficacy was based on luciferase activity in 
cell lysates, which was expressed as relative light units (RLU) per milligram (mg) (RLU / 
mg) of protein. EGFP fluorescence expression in 22Rv1-Luc cells treated with pEGFP 
plasmid DNA was visualized using an Inverted Epifluorescent Microscope 
(AxioObserver D1, Zeiss, Oberkochen, Germany) following 72 hours of treatment. All 
transfection experiments were performed at least in triplicate. 
Two-Photon Induced Luminescence Imaging of Nanoassemblies. 22Rv1-Luc 
cells were seeded at a density of 50,000 cells/well in 500 µL serum-containing media on 
glass cover slips placed at the bottom of a 24 well plate, and allowed to attach overnight 
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in a 37oC, 5% CO2 incubator. Nanoassemblies, with or without loaded shRNA plasmids, 
were dispersed in serum-free media at a final optical density of 0.0025 a.u. Cells were 
treated with nanoassemblies for 6 hours in serum-free medium, which was then replaced 
with serum-containing medium. Glass coverslips were then removed from the 24 well 
plate and submerged in 4 mL of 1X PBS in a 6 well plate and a femtosecond Ti:Sapphire 
laser (Spectra Physics, Mai Tai) set to a wavelength of 800 nm and 18 mW was used to 
visualize the two photon luminescence of GNRs. Luminescence signals were acquired 
using an Ultima IV In Vivo Laser Scanning Microscope (Prairie Technologies, 
Middleton, WI) with a 63X water immersion objective. Following image acquisition, the 
same linear adjustments to brightness and contrast were applied to the entirety of each 
image using Axiovision processing software to highlight the two-photon signal of the 
nanoassemblies. All data represented in the original image were presented in the 
modified image. 
Statistical Analysis. All experiments were carried out at least in triplicate. 
Statistical significance between the control and each experimental test condition was 
determined using the two-tailed Student’s t-test; p values < 0.05 were considered 
statistically significant. Data are represented as mean ± standard error. 
RESULTS AND DISCUSSION 
Two distinct shRNA plasmid expression vectors, Luc25 or Luc29 (described in the 
experimental section), targeted against the sequence for luciferase mRNA, were 
employed in the current study. Both vectors contain the same core 25 nucleotide 
antisense (targeting) sequence, with the primary difference being the addition of four 
nucleotides in the Luc29 expression vector(Grimm, et al., 2006). This results in a stem 
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length of 25 and 29 nucleotides for the Luc25 and Luc29 expression vectors, 
respectively. It has been observed that shRNA constructs with poor efficacies can be 
improved by increasing construct stem length(J. Yu, Taylor, DeRuiter, Vojtek, & Turner, 
2003), and that longer hairpins are more active due to improved processing by the Dicer 
protein(D. Kim et al., 2005; Paddison, Caudy, Bernstein, Hannon, & Conklin, 2002; Rose 
et al., 2005; Siolas et al., 2005). In addition to the difference in stem length, the Luc29 
construct also contains mismatched bases in the sense strand. In some cases, mutations 
have been observed to arise following introduction of the expression constructs into E. 
coli(Miyagishi, Sumimoto, Miyoshi, Kawakami, & Taira, 2004). It has been reported that 
designing constructs with mutations already incorporated in the sense strand can both 
allow for easier sequencing as well as decreasing instances of bacterially-derived 
mutations(McIntyre & Fanning, 2006; Miyagishi, et al., 2004). However, introduction of 
increased amounts of mutations has been observed to affect the shRNA transcript’s 
suppression activity. It has been observed that introduction of more than 3-7 C to T, 3 A 
to G, 5 G to A, and/or 4 A to C swaps in the sense strand can decrease the shRNA 
suppression activity(McIntyre & Fanning, 2006; Miyagishi, et al., 2004). Conversely, 
introduction of minimal mismatches has also been observed to increase suppression 
activity of the shRNA constructs(H. Wu et al., 2011).  Similar observations were 
observed with siRNA; decrease in suppression activity was not observed until the 
introduction of up to 3-5 mismatched in the sense strand(Hamada et al., 2002). However, 
siRNA suppression activity was also found to increase depending on the position and 
number of mismatches(H. Wu, et al., 2011). As the focus of the current study is to 
investigate the potential of the nanoassemblies to delivery plasmid shRNA, we employed 
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two distinct and previously investigated shRNA expression vectors, Luc25 and Luc29.  
Of relevance to the current studies, higher silencing levels were observed with viral 
Luc29 constructs in mice, while silencing with viral luc25 constructs was comparably 
lower in a previous study which developed these transcripts(Grimm, et al., 2006). A 
pEGFP expression vector plasmid (plasmid DNA), which expresses the enhanced green 
fluorescent protein (EGFP), was employed as one control in the current study, due to its 
lack of silencing capabilities. In addition, an expression vector encoding shRNA targeted 
to GFP was used since it possesses no silencing capabilities against the luciferase gene, 
but to a different target, namely GFP. Silencing studies were carried out in 22Rv1-Luc 
cells, a human bone-metastatic prostate cancer cell line engineered to constitutively 
express luciferase. 
The maximum longitudinal near infrared (NIR) GNR optical density (O.D.), 
measured in absorbance units (a.u.), is used as a surrogate for concentrations in case of 
nanoassemblies. Previous results in our laboratory, using inductively coupled plasma 
optical emission spectrometry (ICP-OES), demonstrated a linear relationship between 
O.D. and gold concentration for gold nanorods with a maximum longitudinal absorption 
peaks at 750 or 800 nm(Ramos & Rege, 2012b), indicating that the peak NIR O.D. was 
an excellent surrogate for GNR concentration. 
Characterization of Expression Vector Loading on Nanoassemblies. Previous 
results in our laboratory indicated that nanoassemblies demonstrated high binding 
efficacies for plasmid DNA(Ramos & Rege, 2012b). We therefore reasoned that these 
nanoassemblies might be able to bind Luc25, Luc29, pEGFP, and shEGFP expression 
plasmid vectors with appreciable efficacies. Ratios of 10 ng shRNA plasmid to 0.0025 
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a.u. nanoassemblies, 25 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, or 100 ng 
shRNA plasmid to 0.0025 a.u  nanoassemblies were first employed in the loading 
experiments. As seen in Table 3.1, nanoassemblies were able to bind almost 100% of the 
initially loaded expression vectors in all cases. Following these observations, we 
considered that 100% of the expression vectors initially employed for loading was bound 
to the nanoassemblies under the conditions studied. 
Table 3.1. Percentage of initial amount of expression vector loaded on nanoassemblies at 
different loading ratios. Data are presented as mean values ± standard error (n=3). 
 
Expression Vector 
Loaded onto 1,4C-
1,4Bis-GNRs 
Expression Vector (ng): 1,4C-1,4Bis-GNRs (a.u.) 
10ng to 
0.0025a.u.  
25ng to 
0.0025a.u.  
100ng to 
0.0025a.u.  
Luc25 100 ± 0 (%) 100 ± 0 (%) 99.9 ± 0.01 (%) 
Luc29 100 ± 0 (%) 100 ± 0 (%) 99.9 ± 0.02 (%) 
pEGFP 100 ± 0 (%) 100 ± 0 (%) 100 ± 0.04 (%) 
shEGFP 100 ± 0 (%) 99.8 ± 0.2 (%) 99.8 ± 0.3 (%) 
 
 Hydrodynamic diameters of shRNA plasmid-loaded nanoassemblies were then 
measured in order to determine if their size would be suitable for cellular uptake / gene 
silencing. It is acknowledged that DLS reports for spherical morphologies, and therefore, 
the sizes for gold nanorod-based assemblies were primarily used as indicators. 
Bare/unloaded nanoassemblies were 12 ± 0.5 nm (Figure 3.2) in diameter, while the 
hydrodynamic diameters were in the range of 62 ± 3 to 84 ± 6 nm following loading of 
10 ng shRNA plasmid on 0.0025 a.u. nanoassemblies. This increase in the nanoassembly 
hydrodynamic diameter can be attributed to the loading of the expression vectors. The 
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hydrodynamic diameter of all nanoassemblies increased to a range of 79-92 nm at a 
loading ratio of 15 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, 125-141 nm at a 
loading ratio of 20 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, 128-175 nm at a 
loading ratio of 25 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, and 185-360 nm at 
a loading ratio of 50 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, all of which 
indicate loading of increasing amounts of the expression vectors. Hydrodynamic 
diameters of ~209 ± 9 nm and ~258 ± 13 nm were observed when 0.0025a.u 
nanoassemblies were loaded with 100ng Luc 25 and Luc29 shRNA plasmid, respectively, 
indicative of the higher loading of the expression vectors. However, at this loading ratio, 
the pEGFP- and shEGFP-loaded nanoassemblies had hydrodynamic diameters of ~1041 
± 65 nm and ~458 ± 114 nm, respectively. This significant increase in size is indicative 
of aggregation of the nanoassemblies following expression vector loading, likely due to 
bridging between nanoassemblies in the dispersion, although the exact reasons for these 
increases are not clear. Since transfection agents are generally effective at particle sizes 
of 200 nm or less(Lai, Bae, Yoshida, Kataoka, & Kwon, 2010; Y. H. Wang et al., 2011), 
we hypothesized that delivery efficacy would likely be reduced when 100 ng shRNA 
plasmid were loaded on 0.0025 a.u nanoassemblies, and continue to be diminished if 
additional amounts of expression vectors were added. As a result, 0-100ng expression 
vectors were loaded on 0.0025 a.u. nanoassemblies for subsequent studies. 
54 
 
 
Figure 3.2. Hydrodynamic diameters of shRNA plasmid (expression vector)-loaded 
nanoassemblies at different shRNA plasmid (ng) to nanoassembly (optical density in a.u.) 
ratios measured using dynamic light scattering (DLS). Data represent mean of the 
hydrodynamic size in nanometers (nm) ± standard error (n=3). 
 
Cytotoxicity of Expression Vector-Loaded Nanoassemblies. Nanoassemblies, 
set to an optical density of 0.0025 a.u. in SFM, were loaded with 0-100 ng of Luc25, 
Luc29, pEGFP or shEGFP. 22Rv1-Luc cells were treated with these expression vector-
loaded nanoassemblies for 72 hours, after which, cell viability was determined using the 
MTT assay. Minimal loss of cell viability was observed in all cases of loaded 
nanoassemblies (Figure 3.3); a loss of cell viability of less than 30% was deemed as the 
upper limit of cytotoxicity that could be tolerated in our experiments. For the case of 
Luc25-loaded nanoassemblies, the greatest loss of cell viability was approximately 15% 
at a loading amount of 25 ng. Luc29-loaded nanoassemblies demonstrated the greatest 
loss of cell viability with ~18% loss at a loading amount of 20 ng. Both pEGFP and 
shEGFP loaded nanoassemblies also exhibited the greatest loss of cell viability 
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(approximately 25% and 22%, respectively) for 20 ng loading. However, no single 
treatment condition exhibited a decrease in cell viability above 30% and thus, all 
conditions were employed in further studies. Since losses in cell viability may result in 
decrease in gene expression, luciferase expression values were normalized to the 
percentage of viable cells following shRNA plasmid delivery using nanoassemblies in all 
cases. 
 
Figure 3.3. Viability of 22Rv1-Luc cells following treatment of 0.0025 a.u. 
nanoassemblies loaded with 0-100ng of different expression vectors (indicated in the 
legend). Cell viability was determined 72 hours post treatment using the MTT assay. 
Data represent mean of experimentally determined cell viability values relative to 
untreated control ± standard error (n ≥ 3 independent experiments). 
 
Nanoassembly-mediated Delivery of shRNA plasmid Expression Vectors. 
Nanoassemblies, set to an optical density of 0.0025 a.u. in SFM, were loaded with 0-100 
ng of Luc25, Luc29, pEGFP, or shEGFP, similar to the cytotoxicity experiments 
described above. 22Rv1-Luc cells were treated with nanoassemblies, and luciferase 
expression was determined 72 hours post treatment in order to investigate the efficacy of 
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the gene silencing treatment. Luciferase expression is expressed as a percentage of the 
untreated control following correction for cell viability. Nanoassemblies loaded with 10 
ng, 15 ng, 20 ng, 25 ng and 50 ng Luc29 shRNA plasmid showed a statistically 
significant decrease in luciferase expression (Figure 3.4a). However, cells treated with 
nanoassemblies loaded with Luc25 showed statistically significant decrease only at 
loading amounts of 10ng, 25 ng, and 50 ng. The maximum decrease in luciferase 
expression was seen for Luc29 loading of 20 ng, which resulted in approximately 53% 
luciferase gene knockdown, compared to untreated control. These results are consistent 
with reports in the literature in which, mice injected with Luc29 expression vectors 
demonstrated rapid and effective luciferase repression, whereas luciferase repression 
following Luc25 injection was comparatively lower(Grimm, et al., 2006). Statistically 
significant differences were not observed for cells treated with nanoassemblies loaded 
with control plasmids (EGFP expressing plasmid or shRNA plasmid against EGFP), or 
unloaded nanoassemblies, when compared to the untreated control. Higher qualitative 
EGFP expression was observed for loading amounts of50 ng and less when compared to 
100ng, similar to the observed decrease in luciferase expression.  
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Figure 3.4. (a) Luciferase expression in 22Rv1-Luc cells following (a) treatment of 
nanoassemblies loaded with different plasmid amounts, and (b) treatment with Mirus 
TransIT®-LT1 at manufacturer’s recommended complexation ratios.  Statistical 
significance is reported relative to the untreated control and is denoted by asterisks (* 
p<0.05; ** p<0.01; Student t-test). Luciferase expression was determined 72 hours post 
treatment, and is expressed as a percentage of untreated controls following correction 
for loss of cell viability. Data represent mean ± standard error (n ≥ 3 independent 
experiments).  
 
22Rv1-Luc cells were also treated with Mirus TransIT®-LT1-shRNA plasmid 
complexes. Mirus TransIT®-LT1 is a commercially available, broad spectrum, 
transfection reagent that has previously been used for delivery of shRNA(Dallas et al., 
2012). These studies enabled us to compare the efficacy of our nanoassemblies with a 
commercially available transfection reagent. Approximately 30-40% decrease in 
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luciferase expression was observed following delivery of Luc25 shRNA plasmid using 
different doses of the Mirus TransIT®-LT1 agent (Figure 3.4b). These values are similar 
to the maximum luciferase silencing levels obtained using nanoassemblies (0.0025 a.u.) 
loaded with 25 ng Luc 25 shRNA plasmid. A decrease in luciferase expression of 
approximately 50-60% was observed following Mirus TransIT®-LT1-mediated delivery 
of Luc29 shRNA plasmids. Similar values were obtained with our nanoassemblies loaded 
with 15 ng and 20 ng Luc 29 shRNA plasmid. Although the Mirus TransIT®-LT1 agent 
was effective over a larger shRNA plasmid dose range, the levels of maximal luciferase 
silencing were similar for both cases.  
As described previously, a dose-dependent trend in luciferase silencing was 
observed for cells treated with Luc29-loaded nanoassemblies; luciferase protein 
expression decreased as the amount of Luc29 shRNA plasmid delivered increased to 20 
ng, after which, it returned to the expression level observed for the untreated control. A 
similar dose-dependent trend in efficacy was observed in our previous studies when using 
PAE-GNR assemblies for transgene delivery and expression(Ramos & Rege, 2012b). 
This dose dependence can be correlated with changes in zeta potential values observed 
for nanoassemblies loaded with different amounts of expression vectors. Unloaded 
nanoassemblies demonstrated a zeta potential value of ~37± 8 mV (Figure 3.5). Loading 
Luc25 and Luc29 shRNA plasmids at ratios of 10 ng shRNA plasmid to 0.0025 a.u. 
nanoassemblies, 15 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, 20 ng shRNA 
plasmid to 0.0025 a.u. nanoassemblies, 25 ng shRNA plasmid to 0.0025 a.u. 
nanoassemblies and 50 ng shRNA plasmid to 0.0025 a.u. nanoassemblies, did not result 
in statistically significant differences in zeta potential values; positive zeta potential 
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values, ranging from 14-31 mV were observed in all cases (Figure 3.5). However zeta 
potential values greatly decreased to -0.7 mV and +2.9 mV for Luc25 and Luc29-loaded 
nanoassemblies, respectively, at a loading ratio of 100 ng shRNA plasmid to 0.0025 a.u. 
nanoassemblies. This is likely due to the increased loading of the anionic shRNA plasmid 
molecules on the nanoassemblies, which shields the positive charge of the 1,4C-1,4Bis 
polymer coating.  
 
 
Figure 3.5. Zeta potential values of nanoassemblies loaded with different amounts of 
Luc25 and Luc29 shRNA plasmids. Statistical significance is reported compared to 
unloaded nanoassemblies (i.e. without shRNA plasmid), and is denoted by asterisks (*p < 
0.05, Students t-test). Data represent mean zeta potential ± standard error (n=3 
independent experiments). 
 
It is well established that there is a strong correlation between nanoparticle 
surface potential and cellular uptake efficacy; uptake is greater for nanoparticles with 
strongly positive charged surfaces as it facilitates interactions with cell surfaces that 
possess negative surface potential(Liang. Chen, Joseph M. Mccrate, James C-M. Lee, & 
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Hao. Li, 2011; Zhao et al., 2012). Thus, the greatly reduced zeta potential of 
nanoassemblies with higher shRNA plasmid loadings is likely to reduce their cellular 
uptake. This results in decreased delivery of the shRNA plasmid payload which, in turn, 
may be attributed to lower luciferase silencing efficacies. Taken together, the efficacy of 
nanoassembly-mediated gene silencing can be tailored by a careful balance between 
cytotoxicity, shRNA plasmid loading, and surface charge.  
Nanoassembly-mediated Delivery of Increased shRNA plasmid Payloads 
The above results indicated that 22Rv1-Luc cells treated with 15 ng, 20 ng, and 25 ng 
Luc29 shRNA plasmid loaded on 0.0025 a.u. nanoassemblies, displayed the most 
significant silencing efficacies, likely due to retention of positive surface charge. Based 
on these findings, these ratios of shRNA plasmid to nanoassemblies were held constant, 
while nanoassembly-shRNA plasmid concentrations used for treating 22Rv1-Luc cells 
was increased by 2, 3, 4, 5, and 10 fold, in order to deliver higher amounts of the shRNA 
plasmids to cells. Based on cytotoxicity data (Figure 3.6), Luc25 and Luc29 loaded 
nanoassemblies with ODs greater than 0.0075 (i.e. three-fold higher concentration of the 
nanoassemblies in the original screening experiment) resulted in >30% loss of cell 
viability, and were thus not studied further. Interestingly, nanoassemblies loaded with 
pGL3 and shEGFP nucleic acids exhibited greater loss of cell viability than those loaded 
with luciferase shRNA, although the reasons behind this are not explicitly clear.  
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Figure 3.6. Viability of 22Rv1-Luc cells following treatment with increased 
concentrations of nanoassemblies at loading ratios of 15ng, 20 ng, and 25 ng expression 
vector to 0.0025 nanoassembly ratios for Luc25 (top left), Luc29 (top right), pEGFP 
(bottom left) and shEGFP (bottom right). X-axis values indicate different amounts (O.D.) 
of nanoassemblies, which are loaded with different amounts of expression vectors in 
order to maintain the loading ratios. Cell viability was determined 72 hours post 
treatment using the MTT assay. Loss of > 30% cell viability was deemed too toxic for 
further investigations. Consequently, only 0.0025a.u., 0.005a.u., and 0.0075a.u. were 
investigated subsequently. Data represent mean of experimentally determined cell 
viability values relative to untreated control ± standard error (n ≥ 3 independent 
experiments). 
 
Based on the above cytotoxicity data, 22Rv1-Luc cells were treated with 
nanoassemblies with GNR ODs = 0.005 and 0.0075 (i.e. 2 and 3 times the concentration 
of nanoassemblies in the original screening shown in Figure 3.5) keeping the original 15 
ng, 20 ng, and 25 ng shRNA plasmid to 0.0025 a.u. nanoassembly ratios constant. A 
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statistically significant decrease in luciferase expression was originally observed in case 
of 25ng shRNA plasmid to 0.0025a.u. nanoassemblies loading ratio for Luc25 (Figure 
3.7 top left). At this ratio, ~32% decrease in luciferase expression was observed upon 
delivery of the nanoassembly at an O.D. of 0.0025. However, further decrease in 
luciferase expression, i.e. ~38% and  ~45%, was observed when the nanoassembly 
concentration (or OD) was increased by 2- and 3-fold respectively at the same shRNA 
plasmid to nanoassembly ratio. Cells treated with the other loading conditions showed no 
significant decrease in luciferase expression.  
 
Figure 3.7. Luciferase expression in 22Rv1-Luc cells following treatment of increased 
concentrations of 1,4C-1,4Bis-GNRs at loading ratios of 15ng shRNA plasmid:0.0025a.u. 
1,4C-1,4Bis-GNRs, 20ng shRNA plasmid:0.0025a.u. 1,4C-1,4Bis-GNRs, and 25ng 
shRNA plasmid:0.0025a.u. 1,4C-1,4Bis-GNRs with Luc25 (top left), Luc29 (top right), 
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pEGFP (bottom left) and shEGFP (bottom right). Statistical significance to the untreated 
(‘no treatment’) control, and is denoted by asterisks (* p<0.05; ** p<0.01; Student t-
test). Luciferase expression was determined 72 hours post treatment, and is expressed as 
a percentage of untreated controls following correction for loss of cell viability. Data 
represent mean ± standard error (n ≥3).  
 
In case of the Luc29 shRNA plasmid (Figure 3.7 top right), a maximum decrease of 
luciferase expression of approximately 55% was observed, at the three-fold higher 
concentration (i.e. 0.0075a.u.). In all cases, no statistically significant change in luciferase 
expression was observed when either pEGFP or shEGFP (Figure 3.7 bottom left and 
bottom right respectively)-loaded nanoassemblies were delivered at increased 
concentrations, indicating that silencing  was observed only in cases of plasmids 
expressing shRNA targeted against the luciferase protein. 
Polymeric and lipid-based delivery systems demonstrate between 20%-90% gene 
silencing after delivery of siRNA or shRNA expression vectors in vitro(S. H. Kim, Jeong, 
Cho, Kim, & Park, 2005; J.-M. Lee, Yoon, & Cho, 2013; Navarro, Sawant, Essez, Tros 
de Ilarduya, & Torchillin, 2011; Waite & Roth, 2009). In addition, gold nanoparticle 
based delivery systems have reported gene suppression between ~40%-90% following 
siRNA (A. Bonoiu, et al., 2011; A. C. Bonoiu, et al., 2009; Braun, et al.; Song, et al., 
2010) and shRNA delivery(Ryou, et al., 2010; Ryou, et al., 2011). However, 
investigations for the delivery of plasmid shRNA with gold nanoparticle systems are 
uncommon, indicating that our approach demonstrates comparable efficacy and is a novel 
delivery vehicle for shRNA plasmids. 
Visualization of Luc29-Nanoassembly Uptake in 22Rv1-Luc Cells using Two-
Photon induced Luminescence Imaging. GNRs demonstrate highly efficient two-
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photon induced luminescence both in vitro and in vivo(Durr, et al., 2007). In particular, 
the ability of GNRs to absorb excitation wavelengths in the near infrared (NIR) region of 
the absorption spectrum can allow minimal tissue scattering and phototoxicity compared 
to other fluorescent based imaging techniques(J.-L. Li & Gu, 2010; H. F. Wang, et al., 
2005). Cellular uptake of Luc29 shRNA plasmid-loaded nanoassemblies in 22Rv1-Luc 
cells was visualized using two-photon luminescence in order to demonstrate their 
theranostic potential. Following treatment of 22Rrv1-Luc cells with unloaded 
nanoassemblies and with 10 ng, 15 ng, 20 ng, 25 ng, 50 ng, and 100 ng shRNA plasmid 
loaded on 0.0025a.u. nanoassemblies, live cells, in the absence of additional stains, dyes, 
or fixatives, were imaged using two-photon induced luminescence. No signal was seen in 
case of 22Rv1-Luc cells untreated with nanoassemblies. Excellent two photon 
luminescence signal was seen from 22Rv1-Luc cells in treated with nanoassemblies 
(Figure 3.8). Unfortunately, due to the set-up of the two-photon microscope used, we 
were unable to acquire any phase-contrast or DIC microscopy images for simultaneous 
overlay with the two-photon microscopy images. 22Rv1 cells grew in clusters, and the 
two-photon luminescence signal from the nanoassemblies can be observed throughout the 
cluster. Larger spots are likely clusters or aggregates of the nanoassemblies.  
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Figure 3.8. Live cell, two-photon induced luminescence (pseudo-colored green) images 
of 22rv1-Luc cells after treatment with nanoassemblies (a) without shRNA plasmids, and 
loaded with Luc29 shRNA plasmid at ratios of (b) 10ng, (c) 15ng, (d) 20ng, (e) 25ng , (f) 
50ng, (g) 100ng shRNA plasmid to 0.0025 a.u. nanoassemblies and (h) untreated cells. 
Scale bar = 50 µm.  No luminescence signal was seen in untreated 22Rv1 cells (h). 
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The use of two-photon luminescence for visualization of our nanoassemblies 
highlights the theranostic potential of these delivery vehicles for simultaneous imaging 
and gene silencing. When compared to commercially available transfections agents, such 
as the Mirus TransIT®-LT1, the nanoassemblies investigated in this study possess 
advantages. They were found to have similar maximum silencing efficacies when 
compared to Mirus TransIT®-LT1, however they are also able to be used for live cell 
imaging. This theranostic capability of the nanoassemblies can be used for tracking, 
diagnosis, or targeted/triggered delivery of payloads for specific cell types or diseases. 
Additionally, due to the ease of modification and/or surface functionalization of gold 
nanoparticles, aspects of the polymer/surface coating can be tuned and further 
investigated to further enhance the delivery efficacies. These modification include using 
targeting molecules to facilitate their delivery to specific cell types. The use of gold 
nanoparticles for optical coherence tomography(T. Wang, Mancuso, Sapozhnikova, et al., 
2012), photoacoustic tomography(Y. W. Wang, et al., 2004; X. M. Yang, et al., 2007), 
and X-Ray-CT opens up different theranostic possibilities with these vehicles.  In 
addition to gene silencing, it is possible to use GNR-based nanoassemblies for 
hyperthermic ablation of cancer cells using near infrared lasers(Dickerson, et al., 2008; 
Niidome et al., 2009), as has been investigated for primary and metastatic liver(Gough-
Palmer & Gedroyc, 2008; Vogl, Straub, Eichler, et al., 2004; Vogl, Straub, Zangos, et al., 
2004) and lung cancer diseases(Rosenberg, et al., 2009).  
CONCLUSIONS 
We generated 1,4C-1,4Bis-GNR poly(amino ether)-based nanoassemblies loaded 
with shRNA plasmids for silencing luciferase protein expressed constitutively in 22Rv1-
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Luc human prostate cancer cells. We also demonstrated two-photon luminescence based 
imaging of these nanoassemblies in live cells. Our studies indicate the utility of this 
platform for delivering plasmid-based expression vectors that encode shRNA molecules 
for gene silencing applications. Up to 55% silencing of the original luciferase signal was 
observed when shRNA plasmid-loaded nanoassemblies were used, and these efficacies 
were similar to those observed with a commercially available plasmid DNA transfection 
agent. Nanoassembly-mediated silencing efficacies were consistent with observations 
related to their cellular uptake and surface charge.  
Several strategies may be employed for further enhancing gene silencing 
efficacies of these nanoassemblies, one of which involves the judicious selection and 
optimization of effective shRNA sequences and expression vectors. Further 
enhancements in gene silencing may also be observed when these assemblies are used to 
treat cells in combination with chemotherapeutics or other drugs that can help overcome 
intracellular resistance to plasmid delivery (S. Barua & K. Rege, 2010). Additionally, it is 
possible to design expression cassettes that express multiple shRNA sequences under the 
control of the same or different promoters in a single vector. This allows for a 
combinatorial RNA interference (co-RNAi) approach in which an increase in gene 
suppression is achieved via the targeting of single and/or multiple genes via preventing 
escape of mutation-prone transcripts and/or addressing increased expression of a 
supplementary gene in response to suppression of another(Lambeth, Van Hateren, 
Wilson, & Nair, 2010; Motegi et al., 2011; Nagao et al., 2008). This is a significant 
advantage over siRNA-based approaches. Further optimization may be possible by 
investigating different polymers coated on GNR surfaces. Combinatorial synthesis and 
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parallel screening approaches(S. Barua, et al., 2011b), like those employed in our 
laboratory, can lead to the identification of polymer candidates that demonstrate higher 
silencing efficacies when interfaced with GNRs. Taken together, imaging, hyperthermia 
and gene silencing properties of shRNA plasmid-loaded nanoassemblies make them 
attractive in image-guided gene silencing and photothermal treatments for different 
diseases, including cancer.   
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CHAPTER 4 
PARALLEL SYNTHESIS OF POLY (AMINO ETHER)-TEMPLATED PLASMONIC 
NANOPARTICLES FOR TRANSGENE DELIVERY 
 
Plasmonic metal-based nanomaterials have been widely investigated as 
therapeutics and imaging agents(Ghosh, et al., 2008; H. C. Huang, et al., 2011; T. Wang, 
Mancuso, Kazmi, et al., 2012) in biomedical studies, and have also found applications in 
sensing and catalysis. In particular, gold nanoparticles (GNPs) have been increasingly 
investigated for separations(Gross, Nelson, Grate, & Synovec, 2003), sensing(Dos Santos, 
Goulet, Pieczonka, Oliveira, & Aroca, 2004; Faulds, Littleford, Graham, Dent, & Smith, 
2004), delivery of chemotherapeutic drugs(Ramos, et al., 2012) / nucleic acids(Conde, et 
al., 2012; Chu Hu, et al., 2010; S. T. Kim, et al., 2012b; Ramos & Rege, 2012a; Mini 
Thomas & Alexander M Klibanov, 2003) and bioimaging(Bardhan, Lal, Joshi, & Halas, 
2011; Huang-Chiao Huang, Ramos, Grandhi, Potta, & Rege, 2010; Sokolov et al., 2003). 
In addition, they exhibit high surface-area-to-volume ratios and biocompatibility, are 
candidates for facile surface modification / functionalization and possess unique optical 
properties(X. Huang, et al., 2009). Silver nanoparticles (AgNPs) demonstrate antibacterial 
activity resulting in potential application in treatments against microbial infections, burns, 
diabetic skin ulcers, and medical devices; the antimicrobial spectrum of AgNPs is 
considered to be broader than that of most common antibiotics(C. You, et al., 2012). 
AgNPs have also been investigated as antifungal agents(Esteban-Tejada, et al., 2009) and 
as effective virucidal agents(Panacek, et al., 2009). However, broad use of silver 
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nanoparticles is somewhat limited due to concerns regarding their toxicity(S. Singh, et al., 
2010; Sotiriou & Pratsinis, 2011).  
Both, GNPs and AgNPs have been synthesized using diverse methods including 
chemical(Al-Thabaiti, Al-Nowaiser, Obaid, Al-Youbi, & Khan, 2008; Nguyen, Kim, So, 
& Kim, 2010; Shimmin, Schoch, & Braun, 2004) / photochemical(Eustis & El-Sayed, 
2006; Eustis, Hsu, & El-Sayed, 2005; Jia, Zeng, Song, An, & Zhao, 2006) reduction, and 
one-pot synthesis methods where a polypeptide(Walker et al., 2013) or polymer acts as 
both, a reducing as well as a capping agent(J.D.S. Newman & Blanchard, 2006; Sakai & 
Alexandridis, 2005; Song, et al., 2010). Combinatorial / parallel synthesis methods allow 
exploration of diverse chemical space, leading to the rapid generation of molecular species 
for diverse applications. Although combinatorial methods have been widely employed for 
synthesis of small and macromolecules, their utility for nanoparticle synthesis is 
underexplored.  
Amine-containing compounds, including amino acids and polymers, have been 
utilized as both, reducing as well as stabilizing agents, for the synthesis of GNPs(Bhargava, 
Booth, Agrawal, Coloe, & Kar, 2005; J.D.S. Newman & Blanchard, 2006; J.D.S Newman 
& Blanchard, 2007; Selvakannan et al., 2004). We have recently reported the synthesis and 
use of polyamine-based poly(amino-ether) (PAE) cationic polymers(S. Barua, et al., 
2009b; S. Barua, et al., 2011b; L. Vu, J. Ramos, T. Potta, & K. Rege, 2012) for transgene 
expression following delivery of plasmid DNA, and for enhancing adenoviral delivery to 
cells resistant to viral transduction(Gosnell et al., 2014; Kasman, et al., 2009a). In this 
report, we investigate the efficacy of a small set of cationic PAEs to template the formation 
of gold and silver nanoparticles in a one-pot, parallel synthesis reaction scheme under 
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ambient conditions, and compare nanoparticle formation efficacy to that observed with 25 
kDa poly(ethylene imine) of pEI25k. The identification of polymers that can template 
nanoparticle synthesis under ambient conditions, without the necessity of additional 
reducing agents, derivatization chemistries, or harsh synthesis conditions, is a significant 
advantage over other existing methods, particularly over pEI25k. Poly(amino ether)-
templated gold nanoparticle assemblies were also employed for transgene delivery and 
expression in mammalian cells. Taken together, our current approach resulted in the 
identification of poly(amino ethers) that can simultaneously template nanoparticle 
formation and stabilize them in aqueous media, resulting in the formation of PAE-GNP 
nanoassemblies, which, in turn, can deliver nucleic acids to mammalian cells. 
  
MATERIALS AND METHODS 
Poly(amino ether) (PAE) Polymer Synthesis. A small set of eight PAE polymers, 
synthesized as described previously(S. Barua, et al., 2009b; L. Vu, et al., 2012), was used 
to demonstrate the combinatorial synthesis approach. Briefly 1,4-cyclohexanedimethanol 
diglycidyl ether (1,4C) was reacted in equimolar amounts with 1,4-bis(3-aminopropyl) 
piperazine (1,4Bis), 3,3'-diamino-n-methyldipropylamine (3,3’), pentaethylenehexamine 
(PHA), 1,3-diaminopropane (1,3DPP), and 2-methylpentane-1,5-diamine (2M1,5P), 
resulting in the formation of 1,4C-1,4Bis, 1,4C-3,3’, 1,4C-PHA, 1,4C-1,3DPP, and 1,4C-
2M1,5P poly(amino ethers), respectively. Neopentylglycol diglycidyl ether (NPDGE) was 
reacted in equimolar amounts with 1,4Bis, 3,3’, PHA, and 1,3DPP to generate NPGDE-
1,4Bis, NPGDE-3,3’, NPGDE-PHA, and NPGDE-1,3DPP respectively. Amine monomers 
employed in this study are shown in Figure 4.1a. The polymerization reaction was carried 
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out in 20 ml glass scintillation vials for 16 hours. Following the reaction, polymers were 
dissolved at a concentration of 10 mg/mL in phosphate-buffered saline (0.01 X PBS), and 
the solution pH was adjusted to 7.4 using 30% hydrochloric acid in deionized (DI) water, 
in order to compensate for the basicity of the cationic PAEs. The extent of polymerization 
was determined by comparing reactive amine concentrations at initial mixing of monomer 
reagents (time – 0h) and after 16 hours polymerization using the ninhydrin assay as 
described previously(S. Barua, et al., 2009b; Kasman, et al., 2009a). 
 
Figure 4.1. (a) Chemical structure of amine containing monomers used in synthesis of 
Poly(amino ether) polymers for nanoparticle formation. Abbreviations used in this study 
are in parenthesis. (b) Simplified schematic of GNP synthesis using Poly(amino ether) 
polymers. 
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Synthesis of Poly(amino ether)-Gold Nanoparticles  (PAE-GNPs) and Poly 
(amino ether)-Silver Nanoparticles (PAE-AgNPs) Synthesis. PAE-GNP and PAE-
AgNP syntheses was carried out in a one-pot reaction under ambient conditions. Briefly, 1 
mg of HAuCl4 or 0.1 mg of AgNO3 was co-incubated with each of the PAE polymers or 
branched pEI25k [25 kDa poly(ethyleneimine)] at polymer to metal salt weight ratios of 25 
to 1, 50 to 1, and 100 to 1. Reactions were allowed to proceed in the dark at room 
temperature for 5 or 4 days for GNP and AgNP, respectively. Nanoparticle synthesis was 
monitored by measuring the solution absorption spectra from 300 nm to 999 nm in 5 nm 
increments at various time points during the nanoparticle synthesis. After monitoring, 
PAE-nanoparticle dispersions were centrifuged for 20 min at 10,000 rcf in order to remove 
excess polymer and HAuCl4, re-dispersed in nanopure water, and filtered with a 0.22 µM 
filter for further characterization. 
UV irradiation. In order to determine the effect of UV irradiation on nanoparticle 
formation, 1 mg of HAuCl4 or 0.1 mg AgNO3 were co-incubated with each of the PAEs or 
branched pEI25k at polymer to metal salt weight ratios of 25 to 1, 50 to 1, and 100 to 1. 
Dispersions were then irradiated with a UV light using a handheld UV lamp (366 nm, 6 
W) for 24 or 3 hours at room temperature for GNP and AgNP respectively. Following 
irradiation, dispersions were allowed to sit for an additional 4 days or 21 hours in the dark 
at room temperature for GNP and AgNP, respectively.  The solution absorption spectra 
were monitored from 300nm to 999 nm in 5 nm increments at various time points, in order 
to monitor nanoparticle formation. After 5 days or 24 hours for GNP and AgNPs 
respectively, dispersions were centrifuged for 20 min at 10,000 rcf in order to remove 
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excess polymer and HAuCl4, redispersed in nanopure water, and filtered with a 0.22 µM 
filter for further characterization. 
Transmission Electron Microscopy. Following synthesis, PAE-GNP and PAE-
AgNPs were visualized using Transmission Electron Microscopy (TEM), carried out using 
a JEOL-JEM-2000FX microscope, operating at 200 kV. Specimen samples for TEM were 
prepared by casting a drop of PAE-GNP or PAE-AgNP dispersions onto a carbon film on 
a 200 mesh copper mesh (Global Electron Microscopy Technology Co.) and dried in air. 
Dried samples were examined by TEM at 200 kV. 
 
Determination of Hydrodynamic Diameter and Zeta Potential of PAE-GNPs 
and PAE-AgNPs. The hydrodynamic diameters of PAE-GNPs and PAE-AgNPs were 
determined via dynamic light scattering (DLS) using a particle sizer (Corrvus Advanced 
Optical Instruments). Hydrodynamic diameters are reported in nanometers (nm). 1,4C-
1,4Bis-GNPs were synthesized at a ratio of 100 to 1 of 1,4C-1,4Bis to HAuCl4 under UV 
irradiation. Templated GNPs were set to concentrations of 4.9, 9.8, 24.4, 48.8, or 97.5 
µg/mL  and loaded with between 0-250 ng of pGL3 plasmid DNA. Dispersions were 
transferred into folded capillary zeta cells (Malvern, Westborough, MA). Zeta potential 
values were determined using a Zetasizer Nano ZS (Malvern). 
 
 
Determination of Primary and Secondary Amine Concentration of PAE-
GNPs. Ninhydrin (2,2-Dihydroxyindane-1,3-dione) reacts with free primary and 
secondary amines with a resulting deep blue or purple color, which can be measured and 
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compared to a standard for quantifying reactive (i.e. primary and secondary) amine 
concentrations. Glycine standards, with known amine concentrations (0, 50, 150, and 300 
µM), were prepared in nanopure water with a total volume of 200 µl. GNPs were 
synthesized as described above. Following synthesis, GNPs were dispersed in nanopure 
water, and their optical density was determined at the maximum absorbance wavelength. 
GNP dispersions of 200, 100, and 75 µL were prepared and filled up to 200 µL with 
nanopure water. Following addition of the ninhydrin reagent (100 µl), all samples were 
incubated in water at 100oC for ten minutes, following which, they were allowed to cool to 
room temperature. 500 µl of 95% ethanol was then added to each sample and the 
absorbance was measured at 570nm. Reactive amine concentrations were determined by 
comparing measured values to the glycine standard curve. Amine concentrations were then 
normalized to the respective GNP maximum absorbance (pseudo-concentration).       
 
Plasmid DNA Delivery using 1,4C-1,4Bis-GNPs  
Plasmid DNA. The pGL3 control vector (Promega Corp., Madison, WI), which 
encodes for the modified firefly luciferase protein under the control of an SV40 promoter, 
was used for transgene expression studies. E. coli (XL1 Blue) cells containing the pGL3 
plasmid DNA were cultured overnight (16 h, 37°C, 150 rpm) in 15 mL tubes (Fisher) in 5 
mL of Terrific Broth (MP Biomedicals, LLC). The cultures were then centrifuged at 5400g 
and 4°C for 10 min. Plasmid DNA was purified according to the QIAprep Miniprep Kit 
(Qiagen) protocol. DNA concentration and purity were determined based on absorbance at 
260 and 280 nm using a NanoDrop spectrophotometer (ND-1000; NanoDrop 
Technologies). Plasmid DNA concentrations of 200-300 ng/µL were typically obtained, 
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and volumes were adjusted in order to load between 10-200 ng of pGL3 plasmid DNA on 
1,4C-1,4Bis-GNPs prior to transfections. 
Cell culture. 22Rv1 human prostate cancer cells and MB49 murine bladder cancer 
cells were both generous gifts from Professor Christina Voelkel-Johnson of the Medical 
University of South Carolina as part of an existing collaboration. RPMI-1640 with L-
glutamine and HEPES (RPMI-1640 medium), DMEM with high glucose, L-Glutamine, 
and HEPES, Pen-Strep solution: 10000 units/mL penicillin and 10000 µg/mL streptomycin 
in 0.85% NaCl, and fetal bovine serum (FBS), were purchased from Hyclone. Serum-free 
medium (SFM) consisted of RPMI-1640 or DMEM medium plus 1% Pen-Strep (1000 
units/mL penicillin and 1000 µg/mL). Serum-containing medium (SCM) consists of SFM 
plus 10% FBS. 22Rv1 cells, as received, were cultured in a 5% CO2 incubator at 37
oC 
using RPMI-1640 medium containing 10% heat-inactivated FBS and 1% antibiotics (Pen-
Strep). MB49 cells, as received, were cultured in a 5% CO2 incubator at 37
oC using DMEM 
containing 10% heat-inactivated FBS and 1% antibiotics (Pen-Strep).  
Cytotoxicity. Cytotoxicity of 1,4C-1,4Bis-GNPs was determined in 22Rv1 and 
MB49 cells. Cells were seeded at a density of 8,400 cells/well in 150 μL serum-containing 
medium in a 96-well plate and allowed to attach overnight. Plasmid DNA encoding the 
luciferase protein, pGL3, was diluted to a concentration of 50 ng/μL using Tris EDTA 
buffer (10 mM Trizma and 1mM EDTA, Thermo Fisher Scientific, Rockford, IL). 1,4C-
1,4Bis-GNPs were dispersed in SFM at concentrations of 4.9, 9.8, 24.4, 48.8, or 97.5 
µg/mL 1,4C-1,4Bis-GNP dispersions were then co-incubated with 0, 25, 50, 75, 100, 125, 
150, 200, or 250 ng of pGL3 plasmid DNA for 30 min. Following incubation, pGL3 
plasmid-loaded 1,4C-1,4Bis-GNPs were used to treat 22Rv1 or MB49 cells in serum-free 
77 
media for 6 hours, in an incubator under humidified air containing 5% CO2 at 37°C. 
Subsequently, the medium was replaced with fresh serum-containing medium. 
Lipofectamine3000 complexes were prepared according to manufacture’s protocol at same 
plasmid DNA amounts used for 1,4C-1,4Bis-GNP experiments and used to treat cells. 
Following incubation for 48 hours, cell viability was determined using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assay kit 
(ATCC). This assay involves the enzymatic conversion of the MTT substrate to purple-
colored formazan in metabolically active cells. This activity is widely employed as an 
indicator of cell viability and proliferation(Hayon, et al., 2003); loss of metabolic activity 
was used as an indirect indicator of loss of cell viability. Following addition of the MTT 
reagent (2 h at 37°C), cells were treated with a lysis buffer from the kit and kept at room 
temperature in the dark for 2 h in order to lyse cells and solubilize the MTT product. The 
absorbance of each well was measured using a plate reader (BioTek Synergy 2) at 570 nm 
to assay for the blue MTT product. Absorbance readouts were normalized to the live 
(untreated) and dead (5 µL of 30% hydrogen peroxide treated) controls in subsequent data 
analyses.  
Transgene Delivery and Expression. MB49 and 22RV1 cells were transfected 
using pGL3 plasmid loaded 1,4C-1,4Bis-GNPs as described above. Prior to transfection, 
cells were seeded at a density of 8,400 cells/well in 150 μL serum-containing medium in a 
96-well plate and allowed to attach overnight. The pGL3 plasmid, encoding the luciferase 
protein, was diluted to a concentration of 50 ng/μL using Tris EDTA buffer (10 mM Trizma 
and 1mM EDTA, Thermo Fisher Scientific, Rockford, IL). 1,4C-1,4Bis-GNPs were 
dispersed in SFM at concentrations of 4.9, 9.8, 24.4, 48.8, or 97.5 µg/mL. 1,4C-1,4Bis-
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GNP dispersions were then co-incubated with 0, 25, 50, 75, 100, 125, 150, 200, or 250 ng 
of pGL3 plasmid DNA for 30 min. Following incubation, pGL3 loaded 1,4C-1,4Bis-GNPs 
were used to treat 22Rv1 or MB49 cells in serum free media for 6 hours in an incubator 
under humidified air containing 5% CO2 at 37°C. Subsequently, the medium was replaced 
with fresh serum-containing medium and allowed to incubate for an additional 48 hours. 
Lipofectamine3000 complexes were prepared according to manufacture’s protocol at same 
plasmid DNA amounts used for 1,4C-1,4Bis-GNP experiments and used to treat cells. 
Luciferase protein expression, expressed in terms of relative luminescence units or RLU, 
was determined using the luciferase assay kit according to the manufacturer’s protocol, 48 
hours after transfection; luminescence measurements were carried out using a plate reader 
(Bio-Tek Synergy 2). The protein content (mg protein) in each well was determined using 
the BCA Protein Assay Kit. Transgene (luciferase) expression in all cell lines was 
calculated, normalized with the protein content and expressed as RLU per milligram (mg) 
protein (RLU/mg protein). Transfection experiments were performed at least in triplicate. 
Statistical Analysis. For cytotoxicity and transgene delivery single factor ANOVA 
with Bonferroni correction was performed for data across each individual plasmid DNA 
loading conditions. For zeta potential experiments single factor ANOVA with Bonferroni 
correction was performed across each individual GNP concentration. Similar letters denote 
no significant statistical significance.   
 
RESULTS AND DISCUSSION 
A focused library of poly(amino ethers) was previously synthesized, characterized, and 
investigated for their transgene delivery capabilities(S. Barua, et al., 2009b; L. Vu, et al., 
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2012). It was found that several of the novel poly(amino ethers) synthesized in our 
laboratory demonstrated higher transgene expression efficacy compared to 25kDa 
poly(ethylene imine) or pEI25k. In addition, due to the facile synthesis of this class of 
polymer and the ease with which amine containing monomers can be substituted to obtain 
poly(amino ethers) with varying chemical structures we employed these  polymers for the 
combinatorial synthesis of plasmonic nanoparticles (GNP and AgNPs) under ambient 
conditions, without the need for energy intensive conditions. Poly(amino ethers) were able 
to template and cap nanoparticles, leading to stable dispersions in aqueous media. The 
diversity in poly(amino ether) chemistry translates to differences in the yield and kinetics 
of formation of these nanoparticles. Poly(amino ether)-templated gold nanoparticles were 
employed for transgene delivery and expression in mammalian cells. 
 
Kinetics of Nanoparticle Formation. Gold Nanoparticle (GNP) Formation. GNP 
formation was observed for all polymers and conditions following incubation of PAEs with 
HAuCl4 for 5 days (Figure 4.2). Nanoparticle formation was visualized by a change in 
color from a pale yellow solution to red-maroon-colored dispersion. This color change was 
corroborated by a light absorption peak maximum at approximately 520 nm, which is 
characteristic of spherical GNPs(Song, et al., 2010). The mechanism of gold nanoparticle 
formation is hypothesized to occur by metal ion binding to the amines present in PAEs. 
Following binding, transfer of electrons from the amines to metal ions(J.D.S. Newman & 
Blanchard, 2006) causes reduction of the latter to zero-valent ions. This leads to nucleation, 
growth and subsequent nanoparticle formation. As a result, PAEs are integral to this 
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process since they can template as well as cap nanoparticle formation, leading to the 
formation of stable dispersions in aqueous media.  (Figure 4.1b). 
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Figure 4.2. Comparison of PAE-GNP kinetics of formation monitored at maximum 
absorption peak (between 500-540 nm) by weight ratio and the difference in nanoparticle 
kinetics of formation with and without UV-irradiation for PAEs based on 1,4C. 
Nanoparticles were monitored for 5 days, however only the first 24 hours are shown. 
Data points represent the mean absorbance ± standard error (n=3). Lines connecting 
data points are included for visualization only. 
 
As seen in Figure 4.2, the extent of nanoparticle formation depends on the polymer 
chemistry employed. These observed differences in PAE-templated nanoparticle formation 
rates can, in turn, be correlated to the chemical composition of the amine monomers used 
for the polymer synthesis (Figure 4.1). Both, 1,4Bis and 3,3’-based polymers exhibited the 
fastest rates of nanoparticle formation. The 1,4Bis, monomer contains two primary amines 
(with one or both converted to a secondary amine following polymer synthesis), as well as 
two tertiary amines. Similarly, 3,3’ contains two primary amines (with one or both 
converted to a secondary amine following polymer synthesis) as well as a tertiary amine. 
It is accepted that tertiary amine binding to metals is weaker compared to primary or 
secondary amines(Golub, Zilbermann, Cohen, & Meyerstein, 1996). The presence of 
tertiary amines in these polymers likely results in faster dynamics of binding, reduction, 
and release of gold ions. Faster nucleation and growth of gold nanoparticles is therefore 
likely observed in cases of polymers that have moderate affinities of interacting with gold, 
or those with an increased number of tertiary amines. PHA, and pEI25k, are both 
dominated by primary and secondary amines, whereas 1,3DPP has two primary amines. 
The high amine / charge density in pEI25k and PHA, and the presence of primary amines 
in 1,3DPP may result in stronger binding to gold ions, resulting in decreased de-solvation 
and thus decreased nucleation explaining the decreased kinetics of nanoparticle formation. 
In addition, complexation has been found to lower the redox potential of metal ions 
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resulting in decreased reducibility (Tan, Lee, & Wang, 2010). Thus increased complexation 
times compared to the polymers that possess higher amounts of tertiary amines will also 
result in decreased reducibility.  These results suggest that polymers that are dominated 
with strong metal binding moieties (primary and secondary amines will result in decreased 
kinetics of nanoparticle synthesis. This is due to their decreased de-solvation resulting in a 
decrease in the metal ion reducibility and the reduced metal ions nucleation.  By identifying 
or synthesizing amine-containing polymers or molecules with an increased ratio of tertiary 
amine, it is likely that enhanced nanoparticle kinetics can be observed. The tertiary amines 
will increase the de-solvation of the metal ions which will allow for faster nucleation 
kinetics as well as increased reduction. It is also possible that by modifying polymers such 
as pEI25k with weaker metal binding moieties can result in increased nanoparticle 
synthesis kinetics. These observations also allow for the synthesis of polymers with 
controllable reducing properties for tunable nanoparticle growth kinetics.  However, 
sophisticated molecular modeling methods (e.g. molecular dynamics simulations) will be 
necessary to delve deeper into the mechanisms of PAE-templated nanoparticle formation.  
Increase in the polymer to metal salt ratio resulted in retardation in the kinetics of 
nanoparticle formation, indicating that additional reduction / templating and capping sites 
did not promote faster kinetics (Figure 4.3). This difference in nanoparticle formation 
was observed during the first 12 hours of incubation, whereas after 24 hours, the effective 
concentrations of the GNP dispersions were comparable for a given templating polymer. 
This decrease in nanoparticle formation kinetics is likely due to polymer entanglement at 
higher concentrations. It has been reported that entanglement of polymer chains can 
decrease complexation rate of polymers with metal ions(Sakai & Alexandridis, 2005), 
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which in turn, can result in decreased reduction rates of metal ions and therefore, 
subsequent nanoparticle formation. This indicate that not only the identification of an 
ideal amine containing polymer with suitable chemical composition is necessary for 
optimal nanoparticle formation, but the reaction conditions need to be carefully 
controlled as well. Reaction conditions can also be used as an additional method to tune 
nanoparticle growth kinetics. It has been observed that increasing the reaction 
temperature can result in faster nanoparticle formation,(Yan, Blacklock, Li, & Mohwald, 
2012) and modifying the reaction pH(C. Li, Li, Wan, Xu, & Hou, 2011) or reagent 
addition rate(Mualidharan, Subramanian, Nallamuthu, Santhanam, & Kumar, 2011) can 
result in different formation mechanism. Here we see that by controlling polymer 
concentration nanoparticle kinetics can be modified. Reaction conditions add additional 
tunability to control of nanoparticle growth rates.  
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Figure 4.3. Comparison of PAE-GNP kinetics of formation monitored at maximum 
absorption peak (legend parenthesis) by weight ratio and the difference in nanoparticle 
kinetics of formation with and without UV-irradiation. Nanoparticles were monitored for 
5 days, however only the first 24 hours are shown. All particles were synthesized in 
triplicate and data points represent the mean absorbance ± standard error. Lines were 
included for visualization only.  
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Figure 4.3 continued 
 
Ultraviolet (UV) irradiation has been employed for photochemical reduction of 
both, gold and silver ions for nanoparticle formation(Eustis & El-Sayed, 2006; Eustis, et 
al., 2005; Harada, Inada, & Nomura, 2009; H. Zhang et al., 2012). Exposure to UV 
irradiation for 24 hours indeed resulted in an increase in GNP formations in case of all 
PAEs employed, but was particularly effective in the case of 1,3DPP and pEI25k polymers 
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(Figure 4.3). In presence of UV irradiation, formation of GNPs likely occurs through a co-
reduction mechanism, where gold ions are simultaneously reduced by both, photo and 
chemical means. It has been proposed that nanoparticle formation following UV exposure 
occurs in a multi-step process(Kurihara, Kizling, Stenius, & Fendler, 1983). The proposed 
mechanism begins with excitation of Au3+ by the incident UV radiation, which is followed 
by subsequent reduction to an unstable Au2+ form. This results in disproportionation of 
Au2+ resulting in the formation of Au1+ and Au3+. The Au1+ ions then absorb an additional 
photon and is again photo-reduced to Au0 or zero-valent gold ions, which nucleate and 
grow to form gold nanoparticles.  
It is likely that UV radiation enhances the kinetics of PAE-templated nanoparticle 
formation via mechanisms similar to those previously proposed(Eustis & El-Sayed, 2006; 
Eustis, et al., 2005). We also investigated the formation of nanoparticle formation in 
presence of an anionic polymer, poly(styrene sulfonate) or PSS. To the best of our 
knowledge, PSS has no known inherent metal reducing capabilities, although the polymer 
has been employed as a stabilizing reagent in the presence of a reducing agent for 
nanoparticle synthesis(Dorris, Rucareanu, Reven, Barrett, & Lennox, 2008; Cw Hu, 
Huang, & Tsiang, 2009; Kumar, Kumar, Mathiyarasu, & Phani, 2007). Gold nanoparticle 
formation was observed following UV-based photo-reduction of HAuCl4 in presence of 
PSS after 24 hours; no change in color (i.e. no nanoparticle formation) was observed when 
the gold salt was incubated with PSS in the absence of UV light. These results indicate UV 
irradiation can induce nanoparticle formation (metal reduction) in presence of a suitable 
capping agent, and that the observed increase in PAE nanoparticle formation during UV 
irradiation is most likely due to additional metal reduction via UV-photoreduction. In 
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contrast to PSS, PAEs can template the formation of gold nanoparticles by themselves in 
the absence of UV radiation. However, GNP kinetics and yield, is further enhanced by 
exposure to UV radiation via a co-reduction effect. All else being same, exposure to UV 
radiation resulted in higher yields of GNPs than PAEs alone, as demonstrated by higher 
final optical densities (surrogate for nanoparticle concentration).  
Control over the presence or absence of UV irradiation adds further tunability over 
nanoparticle growth rate. This is most evident, as previously mentioned, in the case of 
pEI25k and the 1,3DPP-based polymers which both exhibited slow nanoparticle formation 
kinetics. However, by exposing them to UV irradiation, nanoparticle synthesis kinetics 
were vastly improved. This suggests that it if an appropriate capping agent, with slow or 
no nanoparticle synthesis kinetics, is wanted on the surface of the nanoparticle UV 
irradiation can be used to enhance nanoparticle synthesis. UV irradiation can also be used 
as an alternative to chemical reducing agents for nanoparticle synthesis with capping agents 
that have no reducing properties.  
 
Silver nanoparticle (AgNP) formation. AgNP formation was observed for all PAE 
polymers and conditions following incubation of PAEs with AgNO3 for three days at 
polymer to AgNO3 weight ratios of 25 to 1, 50 to 1 and 100 to 1; interestingly AgNP 
formation was not observed in case of   (Figure 4.4). Formation of silver nanoparticles was 
visually observed by a change in solution color from clear to a yellow color, which was 
reflected in the appearance of a maximum absorption peak at approximately 420 nm. 
However, the yields of AgNPs were lower than that of GNPs, and the times required for 
nanoparticle formation were significantly longer. This may be a result of amines showing 
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stronger affinities to silver compared to gold(Nath et al., 2006) resulting in stronger 
binding, decreased de-solvation, and decreased nanoparticle nucleation. Additionally, 
silver has lower reduction potential and higher electro-chemical potential compared to gold 
which may also explain the decreased nanoparticle formation(Hoppe, Lazzari, Pardinas-
Blanco, & Lopez-Quintela, 2006).     With the exception of 1,4C-3,3’, PAE-based system 
showed moderate increase in absorbance at approximately 420 nm; in fact, a reduction 
maximal absorbance was observed from 24 to 48h, likely due to aggregation and 
precipitation of the nanoparticles. Interestingly, color change or appearance of an 
absorbance peak indicative of AgNP formation was not observed for pEI25k under any of 
the conditions investigated. It is likely that this is due to strong binding of the metal ions 
to the primary and secondary amines of pEI25k, which does not allow for subsequent de-
solvation and nanoparticle nucleation. Previous reports on pEI25k-templated AgNP 
formation employed a strong reducing agent (e.g. NaBH4)(H. Lee et al., 2001) or high incubation 
temperatures(Shin & Kim, 2011). Here, we demonstrate that PAEs generated in our 
laboratory are capable of synthesizing AgNPs in a one-pot synthesis method at room 
temperature without the use of an additional reducing agent. Again the importance of 
identifying a polymer or amine containing system is highlighted. Due to no observed AgNP 
synthesis for pEI25k under ambient conditions it is unsuitable for this application. 
Identification of polymers with weaker metal binding, or modification ofpEI25k to allow 
for weaker binding may allow for pEI25k templated AgNP synthesis.  
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Figure 4.4. Kinetics of PAE-AgNP synthesis monitored at maximum absorption peak 
(between 400-430 nm) at polymer to AgNO3 weight ratios of (top) 25 to 1, (middle) 50 to 
1, and (bottom) 100 to 1. Nanoparticles were monitored for 4 days. Data points represent 
the mean absorbance ± standard error (n=3). Lines connecting data points are included 
for visualization only. 
 
 
90 
 As with GNPs, PAE-mediated AgNP synthesis was investigated in presence of 
UV-irradiation to determine if photo-reduction could increase the kinetics and yield of 
nanoparticles. Whereas observable PAE-AgNP synthesis took 1-2 days without UV-
irradiation, AgNP formation began within 1-5 minutes in presence of UV irradiation 
(Figure 4.5). Interestingly, AgNP formation was not observed in case of pEI25K even in 
presence of UV irradiation, as indicated by a lack of color change, as well as lack of an 
absorption peak at 420 nm in the spectrum. In order to study effects over a longer period 
of time and to allow for maximal AgNP formation, PAE-AgNO3 solutions were exposed 
to UV radiation for a maximum of 3 hours (Figure 4.5), during which, AgNP formation 
proceeded with fast kinetics. However, negligible levels of nanoparticle formation were 
observed once the UV irradiation was removed and the nanoparticles were kept in the 
dark for an additional 21 hours. These results indicate that the efficacy of photoreduction 
is significantly higher than that of chemoreduction for AgNP formation. However, 
similar to observations with GNPs, AgNP formation occurred most rapidly at lower 
polymer-to-metal salt weight ratios. All PAEs demonstrated similar efficacies for 
templating and capping AgNPs, and aggregation / precipitation of AgNPs was not 
observed when UV-irradiation was employed, unlike in the absence of radiation. 
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Figure 4.5. Kinetics of PAE-AgNP synthesis monitored at maximum absorption peak 
(legend parenthesis) at different polymer to AgNO3 weight in the presence of UV-
irradiation. Nanoparticles were monitored for 24 hours with the initial 3 hours under UV 
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irradiation. All particles were synthesized in triplicate and data points represent the 
mean absorbance ± standard error. Lines are included for visualization only. 
 
Figure 4.5. Continued 
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PAE-Nanoparticle Characterization. Transmission Electron Microscopy. 
Following synthesis in the absence of UV-irradiation and removal of excess polymer and 
metal salts via centrifugation 1,4C-1,4Bis-GNPs, NPGDE-1,4Bis-GNPs, pEI25k-GNPs, 
and NPGDE-1,4Bis-AgNPs were characterized by transmission electron microscopy 
(TEM); these polymers were chosen since 1,4Bis-based PAEs demonstrate the fastest 
kinetics or GNP formation. 1,4C-1,4Bis-GNPs, NPGDE-1,4Bis-GNPs, and pEI25k-GNPs 
possessed spherical metal cores in the sub-20 nm range (Figure 4.6 a-i). Despite the 
observed differences in the initial kinetics of nanoparticle formation, the metal cores 
exhibit similar sizes across the three different weight ratios tested. However, 
aggregation/bridging of some metal cores was observed in case of pEI25k-GNPs. NPGDE-
1,4Bis-AgNPs demonstrate metal cores that are larger than 20 nm, with similar sizes across 
the three different tested weight ratios (Figure 4.6 j, k, and l). Some aggregation and 
interestingly, formation of nanorods, was observed in case of NPGDE-1,4Bis-AgNPs.  
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Figure 4.6. TEM images of 1,4C-1,4Bis-GNPs at a weight ratio of (a) 25 to 1, (b) 50 to 1, 
(c) 100 to 1; NPGDE-1,4Bis-GNPs at weight ratios of (d) 25 to 1, (e) 50 to 1, (f) 100 to 
1; PEI25k-GNPs at weight ratios of (g) 25 to 1, (h) 50 to 1, (i) 100 to 1; and NPGDE-
1,4Bis-AgNPs at weight ratios of (j) 25 to 1, (k) 50 to 1, (l) 100 to 1 polymer to HAuCl4. 
All scale bars indicate 20 nm.  
 
Hydrodynamic Diameter. The hydrodynamic diameters of all PAE-GNPs were in 
the sub-150 nm range (Figure 4.7a). The hydrodynamic diameter for a given PAE-GNPs 
did not vary significantly with different PAE to gold salt weight ratios.  However, the 
hydrodynamic diameter increased moderately with an increase in the weight ratio for 1,4C-
1,4Bis and 1,3DPP PAE-based gold nanoparticles. Interestingly, the hydrodynamic 
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diameters decreased with increasing weight ratios for PHA based polymers. With the 
exception of 1,4C-1,4Bis-GNPs the hydrodynamic diameters of PAE-GNPs synthesized 
with and without UV-irradiation are comparable. pEI25k-GNPs exhibited the smallest 
hydrodynamic diameters in the 25-35 nm range, which was similar to the size observed via 
TEM. The hydrodynamic diameters of 1,4C-1,4Bis-GNPs and NPGDE-1,4Bis-GNPs 
(non-UV-irradiated) were much larger than the metal cores observed via TEM. This is 
likely due to the presence of the polymer / PAE coat, which was not observed in TEM 
analysis.  
All PAE-AgNPs exhibited hydrodynamic diameters in the sub-120 nm range 
(Figure 4.7b); no measurements were obtained in case of pEI25K due to lack of 
nanoparticle formation. As opposed to GNPs, less clear trends in hydrodynamic diameter 
size were seen with respect to synthesis conditions (i.e. change in weight ratios or UV 
irradiation) in case of PAE-AgNPs. For example, in case of 1,4C-1,4bis, 1,4C-1,3DPP, and 
NPGDE-PHA polymers, AgNPs synthesized in presence of UV-irradiation are smaller in 
size than those synthesized in absence of the radiation. However, the opposite trend was 
observed in case of other PAEs such as, 1,4C-3,3’ and NPGDE-1,3DPP. Finally, diameters 
of AgNPs were comparable for some PAEs including, 1,4C-PHA, NPGDE-1,4Bis, and 
NPGDE-3,3’. 
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Figure 4.7. Hydrodynamic diameter of (a) PAE-GNPs and (b) PAE-AgNPs following 
synthesis at different weight ratios, with and without UV-irradiation, and purified via 
centrifugation. Hydrodynamic diameters were measured in triplicate and data points 
represent the mean hydrodynamic diameter ± standard error. 
Amine Content. PAE-GNPs were further characterized for amine content using the 
ninhydrin assay in order to further confirm the presence of the cationic polymer; higher 
amine content is used as an indicator of increased polymer content. Similarly to the trend 
in hydrodynamic diameters, at increased weight ratios of PAE to HAuCl4, 1,4C-1,4Bis-
GNPs exhibited slightly increased amine content (i.e. increased polymer coating) (Figure 
4.8). In addition, the amine content for PHA-based polymers decreased with an increase in 
weight ratios, which is in agreement with the decrease in hydrodynamic diameters observed 
for these polymers (Figure 4.7). Taken together, the amine content can be used as an 
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indicator of extent of polymer coating, and follows similar trends as that of the measured 
hydrodynamic diameters.  
 
Figure 4.8. Primary and secondary amine concentration of PAE-GNPs determined by 
ninhydrin assay. Amine concentration (µM) is normalized by the maximum absorbance 
(a.u.) of the PAE-GNPs. All measurement were done in triplicate and data points 
represent the mean measurement ± standard error. 
  
Biological Activity of PAE-Templated Nanoparticles: Transgene Delivery and 
Expression. Previous studies from our laboratory demonstrated that 1,4C-1,4Bis 
polyplexes(S. Barua, et al., 2009b; S Barua & K Rege, 2010), and 1,4C-1,4Bis-coated gold 
nanorods(Ramos & Rege, 2012a), were able to deliver plasmid DNA leading to transgene 
expression  or gene silencing(Ramos & Rege, 2013b) in mammalian (e.g. cancer) cells. In 
these previous investigations 1,4C-1,4Bis polyplexes exhibited decreased cytotoxicity and 
up to 80 fold enhancement in transfection efficacies in PC3-PSMA cells. Additionally, 
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PAEs were employed to coat pre-made gold nanorods using a layer-by-layer deposition 
approach. These nanoparticles exhibited up to 165-fold enhancement compared to 
similarly modified pEI25k gold nanorods. Due to previous investigations identifying 1,4C-
1,4Bis-based polymer systems s highly efficient non-viral gene delivery vehicles,  1,4C-
1,4Bis-GNPs (i.e. PAE-templated GNPs) were investigated for their ability to deliver 
plasmid DNA leading to transgene expression. 1,4C-1,4Bis-GNPs were synthesized at a 
weight ratio of 100 to 1 (1,4C-1,4Bis to HAuCl4) in presence of UV irradiation. They were 
then dispersed in serum-free media (SFM) at different concentrations, and loaded with 1-
250 ng of pGL3 plasmid DNA, which expresses the luciferase protein. Plasmid-loaded 
1,4C-1,4Bis-GNPs or ‘nanoassemblies’ were delivered to 22Rv1 human prostate cancer 
and MB49 murine bladder cancer cells. Lipofectamine 3000 (Lipo3000) was also 
investigates as a commercially available delivery vehicle. The nanoassemblies exhibited 
greater cytotoxicity in 22Rv1 cells (Figure 4.9a) when compared to MB49 cells (Figure 
4.9b). Lower concentrations of 1,4C-1,4Bis-GNPs were therefore used for delivery to 
22Rv1 cells (concentrations of 4.9, 9.8, 24.4, and 48.8 µg/mL) than in the case of MB49 
cells (concentrations of 9.8, 24.4, 48.8, and 97.5 µg/mL). Lipo3000 was found to 
significantly less toxic in 22Rv1 cell when compared to the 24.4 and 48.8 µg/mL 
concentration. In MB49 cells it exhibited similar cytotoxicity for the majority of 
conditions, though it was significantly more toxic than some conditions in the 50-200 ng 
plasmid DNA range.  
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Figure 4.9. Cell viability of (a) 22Rv1 and (b) MB49 cells, and luciferase expression 
(RLU/mg) in (c) 22Rv1 and (d) MB49 cells following delivery of 1,4C-1,4Bis-GNPs 
synthesized at a weight ratio of 100 to 1 1,4C-1,4Bis to HAuCl4 with UV irradiation. The 
concentrations of 1,4C-1,4Bis-GNPs were adjusted to 4.9, 9.8, 24.4, or 48.8 µg/mL for 
22Rv1 cells and 9.8, 24.4, 48.8 or 97.5 µg/mL in MB49 cells, and loaded with varied 
amount of pGL3 plasmid DNA for transgene expression. Lipo3000 was also investigated 
as a control. Cell viability and luciferase expression were determined 48 hours following 
transfection. Data points represent the mean measurement ± standard error (n≥3). Same 
letters within a loading condition indicate no statistical significant difference, absence of 
letter indicated no statistical significant difference within the loading condition for all 
concentrations and Lipo3000 (ANOVA w/Bonferroni correction). 
 
The highest observed luciferase transgene expression was at ~9.2 million RLU/mg, 
at a treatment condition of 4.9 µg/mL of 1,4C-1,4Bis-GNPs and plasmid loading of 25 ng 
in 22Rv1 cells (Figure 4.9c) and was found to not be statistically significant from 
Lipo3000 at this loading conditions. Luciferase expression decreased with increasing 
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plasmid loading on the nanoparticles. A similar trend was observed when 9.8 µg/mL GNPs 
were employed for delivering plasmid DNA. However, at this concentration, the 
nanoparticles were significantly higher than Lipo3000 at loading conditions of 50 and 75 
ng. It is likely that the decrease in luciferase expression is due to a decrease in the 
nanoassembly zeta potential since negatively charged plasmids can shield the positively 
charged polymer coating with increasing loading amounts, as seen previously(Ramos & 
Rege, 2012a). Zeta potential measurements of 1,4C-1,4Bis-GNPs were found to decrease 
for all nanoparticle concentrations as the amount of plasmid DNA loaded increased to 250 
ng (Figure 4.10). In some instances a reversal of the positive charge was observed, likely 
due to excess negative charge of the plasmid DNA shielding the positive charges from the 
amines in these PAEs.  
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Figure 4.10. Zeta potential values of 1,4C-1,4Bis-GNPs synthesized at a weight ratio of 
100 to 1 1,4C-1,4Bis to HAuCl4 with UV irradiation, and subsequently loaded with 
varying amounts of pGL3 plasmid DNA (ng plasmid DNA indicated in the figure legend). 
Values represent the mean zeta potential ± standard error (n=3). All plasmid loading 
conditions were found to be statistically significant to the unloaded condition (student t-
test p<0.05). Same letters within a loading condition indicate no statistical significant 
difference, absence of letter indicated no statistical significant difference within the 
loading condition for all concentrations and Lipo3000 (ANOVA w/Bonferroni 
correction). 
 
Use of higher concentrations of 1,4C-1,4Bis-GNPs (i.e. 24.4, 48.8, and 97.5 
µg/mL) can result in increased luciferase expression, most likely due to an increase in the 
effective polymer concentration. Although increased polymer concentration can allow for 
increased interactions with cells leading to greater uptake, cell viability was observed to be 
less than 50% under these conditions. As a consequence of this toxicity at higher doses, 
luciferase expression levels did not reach the maximum observed in case of the 4.9 µg/mL 
dose condition.  
In MB49 cells, the highest observed luciferase expression was ~50 million RLU/mg 
at a GNP concentration of 24.4 µg/mL and plasmid loading of 75 ng (Figure 4.9d) 
However this was not found to be statistically significant from Lipo3000. At a 
concentration of 48.8 µg/mL and 50 ng plasmid loading, GNPs exhibited a significantly 
higher transfection efficacy than Lipo3000. Additionally, the levels of luciferase 
expression observed in MB49 cells were significantly higher than those observed in 22Rv1 
cells. Similar to 22Rv1 cells there was an observed decrease in luciferase expression at 
higher plasmid loading conditions. This is likely due to the observed decrease in zeta 
potential (Figure 4.10) as a result of shielding of the positive charges on the PAEs(Ramos 
& Rege, 2012a). It is likely that intermediate loadings of pGL3 (25-100ng) are likely ideal 
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conditions where zeta potential is positive enough to allow for cell interaction and uptake, 
and enough plasmid DNA is loaded for effective transgene delivery and expression.  
The facile synthesis method and chemical diversity of the poly(amino ether) 
polymers have elucidated certain design principles that could help in engineering future 
amine containing polymeric systems for efficient one-pot synthesis of gold and silver 
nanoparticle systems. As can be observed from our results, polymers with higher amounts 
of tertiary amines resulted in the fastest nanoparticle growth. Similar observations have 
been reported, where when increasing the ratio of tertiary amines to gold-salt resulted in a 
decrease in time for observable gold nanoparticle synthesis using PAMAM succinamic 
acid dendrimers(Vasile et al., 2014). The ability of tertiary amines to result in faster 
nanoparticle formation kinetics is likely due to two reasons. First, the binding of tertiary 
amines bind to metal ions is weaker than that of secondary or primary amines. This is 
important as it allows for binding, reduction, and quick release of the metal ions for 
nucleation and nanoparticle growth. Second, tertiary amines have a higher oxidation 
potential than secondary or primary amines(Lewis & Crompton, 2004) which allows for 
them to more readily give up electrons resulting in faster reduction of the metal ions. 
Though tertiary amines are favorable for reduction, release, of metal ions, secondary and 
primary amines have the same function, only at slower rates. Thus optimization of 
primary, secondary, and tertiary amines within a polymer can allow for tunability of 
nanoparticle growth, depending on specific requirements. It has been reported that 
change in nanoparticle reduction/nucleation rates can affect the size and optical 
properties of nanoparticles(X. Sun, Dong, & Wang, 2005). This change in nanoparticle 
formation rate can also be a result of reaction conditions. As observed here, an increase in 
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polymer concentration led to the decrease in nanoparticle formation kinetics (Figure 3). 
This also shows the importance of using an appropriate capping agent that can not only 
stabilize nanoparticles in aqueous media, but also impart the desired functionality for a 
given application. Specifically, PAE-templated gold nanoparticles synthesized in this 
study were used for transgene delivery; thus, PAEs were simultaneously able to template 
nanoparticle formation, stabilize them in aqueous media, carry and deliver plasmid DNA 
to mammalian (cancer) cells.   
PAE-templated gold and silver nanoparticle formation reported here is a facile 
and attractive method for synthesis of these plasmonic nanoassemblies, and is either 
competitive to or better than other existing methods employed for nanoparticle 
generation. Polypeptides have also been used as reducing and capping agents for 
facilitating nanoparticle formation from metal salts; it was found that the formation of 
metal nanoparticles by short peptides depends on both the reducing capability and the 
capping / binding properties of the peptide(Tan, et al., 2010). Polypeptide-nanoconjugates 
have been used to template the synthesized of gold nanoparticles for in a one-pot method 
and have been used for transgene delivery(Yan, et al., 2012) as well as antiviral- and 
anticancer drug delivery(Shirazi et al., 2012) in vitro. We have previously demonstrated 
that cysteine-containing elastin-like polypeptides can be employed for templating the 
formation of gold nanoparticle synthesis within 18h, although upwards of 175Gy of 
ionizing (X-ray) radiation are required for obtaining significant levels of 
nanoparticles(Walker, et al., 2013). 
Polymers have also been investigated for the synthesis of gold nanoparticles. For 
example, PVP has been used as a capping agent for nanoparticles synthesized via reduction 
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by  gycerol(Grace & Pandian, 2006). Thiol-modified pEI2 (pEI with a molecular weight 
of 2kDa) was used for capping of gold nanoparticles following chemical reduction and 
demonstrated efficient gene delivery(Mini Thomas & Alexander M Klibanov, 2003). 
Excessive modifications were necessary in order to thiolate the pEI and NaBH4 was 
required to induce nanoparticle formation. In addition, pEI25k-silvernanoaprticles have 
been synthesized, however, they required chemical reduction or high temperatures for 
efficient nanoparticle synthesis(H. Lee, et al., 2001; Shin & Kim, 2011). PEI25k has been 
investigated previously for the one-pot synthesis of gold nanoparticles(X. Sun, et al., 2005) 
and pEI25k- gold nanoparticles demonstrated efficient delivery of siRNA for gene 
silencing(Song, et al., 2010). However, as demonstrated here, and previously by us, several 
poly (amino ethers) demonstrate either higher transgene expression efficacies(Ramos & 
Rege, 2012a), (S. Barua, et al., 2009b; L. Vu, et al., 2012) or nanoparticle templating 
activities or both compared to pEI25k. 
 
CONCLUSIONS 
 In this report, we demonstrated a facile, one-pot, combinatorial synthesis method 
for the generation of both, gold and silver nanoparticles under ambient conditions using a 
small set of poly(amino ethers) generated in our laboratory. PAEs were able to 
simultaneously act as both, reducing and capping agents for nanoparticle synthesis, and did 
not require the use of any additional reagents (e.g. reducing agents) or subsequent 
derivatization, which are significant advantages over several existing methods. Poly(amino 
ethers) from our library demonstrated faster kinetics of gold nanoparticle formation 
compared to 25 kDa branched poly(ethylene imine) or pEI25k. Significantly, all PAEs 
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were able to template formation of silver nanoparticles, whereas this was not observed with 
pEI25k.  
The rate of nanoparticle formation is dependent on the chemical composition of the 
polyamine monomers used in the polymer synthesis. Particularly, 1,4-bis(3-aminopropyl) 
piperazine (1,4Bis), and 3,3'-diamino-n-methyldipropylamine (3,3’) - based polymers, 
which are likely to have high content tertiary amines, demonstrated the fastest kinetics of 
nanoparticle formation, possibly due to increased solvation of amine-metal complexes that 
facilitates nanoparticle nucleation(Tan, et al., 2010). Nanoparticle synthesis was dependent 
on the polymer concentration relative to the metal ion concentration. Exposure to UV 
irradiation significantly enhanced the kinetics of nanoparticle formation; of particular 
significance, the time required for silver nanoparticle synthesis was greatly reduced from 
several days to only a few minutes in presence of UV radiation. Hydrodynamic diameters 
of less than 150 nm were seen for all nanoparticles, while the metal cores were spherical 
and approximately 20 nm in diameter in most cases. We demonstrated that 1,4C-1,4Bis-
templated gold nanoparticles were able to deliver plasmid DNA leading to transgene 
(luciferase) expression in two different cancer cell lines. The ease of synthesis of PAE-
templated plasmonic nanoparticles, stability in biologically relevant media, presence of 
amines for further functionalization, and biological activity (e.g. nucleic acid delivery), 
make this an attractive approach for several applications in biotechnology and medicine.  
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CHAPTER 5 
COMPARISON OF IN VITRO POLYMER AND NANOPARTICLE SYSTEMS FOR 
TRANSGENE DELIVERY: POLYPLEXES, GOLD NANOROD NANOPLEX, AND 
GOLD NANOSPHERE NANOPLEX  
 
Viruses have been employed for transgene delivery to various cell lines, both in 
vitro (Kasman, Barua, Lu, Rege, & Voelkel-Johnson, 2009b; Y. Park et al., 2010; 
Simeone, Cascarelli, & Logsdon, 1997; Varga et al., 2005) and in vivo (Jounaidi, Chen, 
Veal, & Waxman, 2006; Jounaidi & Waxman, 2004) due to high levels of transgene 
expression. However, concerns with  immunogenicity and insertional 
mutagenesis(Merdan, Kopecek, & Kissel, 2002) have motivated investigations into non-
viral vectors, including cationic polymers, as potentially safer alternatives. In addition, 
ease of synthesis, scale up, versatility, and in some cases, biocompatibility and 
biodegradability (Elsabahy, Nazarali, & Foldvari, 2011), make cationic polymers 
attractive delivery vehicles. Cationic polymers are able to bind and complex with 
negatively charged plasmid DNA (pDNA), resulting in the formation of polymer/pDNA 
complexes also known as polyplexes. These polyplexes typically retain a positive charge 
and are thus able to interact with negatively charged cell membranes and other surface 
proteins. Polyplex-membrane interactions facilitate endocytosis into cell and delivery to 
intracellular endosomal compartments. Successful delivery vehicles are then able to 
escape endosomes, presumably in part due to endosomal buffering by cationic 
polymers(Akinc, Thomas, Klibanov, & Langer, 2005; Berthold, Shiraishi, & Nielsen, 
2010; Boussif et al., 1995). Following uncomplexing in the cytoplasm, a fraction of the 
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delivered pDNA in the cytoplasm enters the nucleus where they are transcribed leading to 
translation in the cytoplasm, and ultimately expression of the transgene. 
Polyethylenimine (PEI), (Boussif, et al., 1995; Cherng, Hung, & Kao, 2011; Chumakova 
et al., 2008; Coll et al., 1999; Gabrielson & Pack, 2009; Kang, Kang, & Bae, 2011; M. 
Lee, 2007; Mishra, Kang, & Bae, 2011; Y. H. Wang, et al., 2011), poly amido-amines 
(Emilitri, Ranucci, & Ferruti, 2005; S. T. Guo et al., 2011), and chitosan (Jean, Alameh, 
Buschmann, & Merzouki, 2011; Sarkar, Srivastava, Chatterji, & Kundu, 2011) are among 
the commonly employed cationic polymers for plasmid DNA delivery. However, 
observed low efficacies of polymer-mediated transgene expression has resulted in 
engineering of novel polymer and polymeric-based delivery vehicles with higher 
efficacies.  
In addition to polymeric vehicles, inorganic nanoparticles, including gold 
nanoparticles, have been widely explored for drug and gene delivery to cells(Conde, et 
al., 2012; H.-C. Huang, et al., 2010; H. C. Huang, et al., 2011; S. T. Kim et al., 2012a; 
Masood, et al., 2012; Ramos, et al., 2012; Zhao, et al., 2012). Particle properties play a 
significant role in determining the efficacy of vehicles for transgene delivery and 
expression. However, despite the significance of particle physicochemical 
properties(Champion, Ktare, & Mitragotri, 2007), a head-to-head comparison of different 
gene delivery vehicles, specifically polymeric and nanoparticle-derived vehicles has been 
elusive. We have previously employed ring-opening polymerization of diglycidyl ethers 
and polyamines for the combinatorial generation of a library of poly(amino ethers) 
(PAEs) for transgene delivery and expression (S. Barua, et al., 2009b; S. Barua et al., 
2011a). The1,4 C-1,4 Bis polymer, generated from 1,4-cyclohexanedimethanol diglycidyl 
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ether (1,4C) and 1,4-bis(3-aminopropyl) piperazine) (1,4Bis) monomers demonstrated 
higher levels of transgene expression than 25 kDa PEI depending on the polymer:pDNA 
weight ratios (S. Barua, et al., 2009b; S. Barua & K. Rege, 2010). Additionally, the 1,4C-
1,4Bis polymer has been employed for gold nanorod modification for effective transgene  
and shRNA plasmid delivery, resulting in both exogenous transgene expression and 
endogenous gene silencing efficacies(Ramos & Rege, 2012a, 2013a). We recently have 
employed the 1,4C-1,4Bis polymer for the one-pot synthesis of gold nanoparticles. These 
previous studies offer us a unique opportunity to compare different gene delivery systems 
in a head-to-head fashion. Here, we investigate the transgene expression efficacies of 
1,4C-1,4Bis polymer, 1,4C-1,4Bis-templated gold nanoparticles, and 1,4C-1,4Bis-coated 
gold nanorods  in different cancer cell lines.  
MATERIALS AND METHODS 
1,4C-1,4Bis Poly(amino ether) Polymer Synthesis. Polymer synthesis was 
carried out as described previously (S. Barua, et al., 2009b). Briefly 1,4-
cyclohexanedimethanol diglycidyl ether (1,4C) was reacted in equimolar amounts to 1,4-
bis(3-aminopropyl) piperazine (1,4Bis), to generate 1,4C-1,4Bis, The polymerization 
reaction was carried out in 20 ml glass scintillation vials for 16 hours. Following the 
reaction, polymers were dissolved at a concentration of 10 mg/mL in phosphate-buffered 
saline (1 X PBS) and the solution pH was adjusted to 7.4 using 30% hydrochloric acid in 
deionized (DI) water in order to compensate for the basicity of the cationic polymer. The 
extent of polymerization was determined by comparing reactive amine concentrations at 
initial mixing of monomer reagents (time – 0h) and after 16 hours polymerization using 
the ninhydrin assay as described previously (S. Barua, et al., 2009b; Kasman, et al., 
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2009a). Following polymerization, purification was carried out by dialysis using a 1000 
Da molecular weight cut off (MWCO) membrane. The polymers were dialyzed against 
Nanopure water for 48 hours and fresh water was replaced every 12 hours. After 48 hours 
of purification, the polymer solutions were lyophilized, reconstituted in 1X PBS. 
 
Generation of Gold Nanorods (GNRs). The seed-mediated method(Johnson, et 
al., 2002; Nikoobakht & El-Sayed, 2003) was used for the synthesis of cetyltrimethyl 
ammonium bromide (CTAB) or CTAB-templated gold nanorods (CTAB-GNRs). Briefly, 
a seed solution was prepared by adding 5 ml of 0.2 M CTAB to 5 ml of 0. 5 mM auric 
acid (HAuCl4.3H20). The addition of 0.6 ml of iced water-cooled 10mM sodium 
borohydride was used to reduce the solution. The growth solution was prepared by 
adding 5 ml of 1mM auric acid to 5 ml of 0.2 M CTAB containing 250 µl of 4mM silver 
nitrate. The growth solution was reduced by the addition of 70 µl of 0.0788 M L-ascorbic 
acid. Seed solution (12 µl) was added to the growth solution and continuously stirred for 
four hours to allow for the generation of the gold nanorods. The concentration of silver 
nitrate in the growth solution was modulated in order to generate CTAB-GNRs, with 
absorbance maxima at different wavelengths (750-900 nm) in the near infrared (NIR) 
region of the absorption spectrum. 
 
Generation of 1,4C-1,4Bis-GNR Nanoassemblies (‘GNRs’). Dispersions of 
GNRs with an optical density of 0.5 at the maximal absorbance wavelength in 1.5 mL 
microcentrifuge tubes were centrifuged at 6000 rcf for 10 minutes using a Microfuge 18 
centrifuge (Beckman Coulter, Brea, CA), in order to remove excess CTAB surfactant. 
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The supernatant was removed and the GNRs were redispersed in 100 µL of a 
poly(styrene sulfonate) (PSS) solution (10 mg/mL in 0.01X PBS; ~1.5 mM salt 
concentration). This dispersion was immediately sonicated for 30 minutes to allow for the 
formation of PSS-coated GNRs (PSS-CTAB-GNRs). Excess PSS was removed by 
centrifugation at 6000 rcf for 10 minutes and the supernatant was discarded. PSS-CTAB-
GNRs were then re-dispersed in 300 µL nanopure water, and 200 µL 1,4C-1,4Bis 
polymer (10 mg/mL in 0.01X PBS) were added to the dispersions. These were 
immediately sonicated for 30 min to allow for the formation of the 1,4C-1,4Bis-PSS-
CTAB-GNR nanoassemblies. Excess 1,4C-1,4Bis polymer was removed by 
centrifugation at 6000 rcf for 10 minutes and the supernatant was discarded. The 
nanoassemblies were finally resuspended in serum-free media (SFM) for use in in vitro 
experiments.  
 
1,4C-1,4Bis-Gold Nanospheres (GNS) Synthesis. 1,4C-1,4Bis-Gold 
Nanosphere synthesis was carried out in a one pot reaction under UV irradiation (366 nm, 
6 W) and otherwise ambient conditions. Briefly, 1 mg of HAuCl4 was co-incubated with 
100 mg of 1,4C-1,4Bis. Reactions were allowed to proceed for 16 hours. GNP synthesis 
was confirmed by a reddish color and maximal absorption at approximately 520 nm, 
characteristic of gold nanospheres. After synthesis 1,4C-1,4Bis-Gold Nanosphere 
dispersions were centrifuged for 20 min at 10,000 rcf in order to remove excess polymer 
and HAuCl4 and redispersed in nanopure water. 
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Ninhydrin Assay for Amine Content Determination. Following synthesis of 
1,4C-1,4Bis, 1,4C-1,4Bis-GNRs, and 1,4C-1,4Bis-GNS samples were prepared for a 
ninhydrin assay to determine amine content. Ninhydrin (2,2-Dihydroxyindane-1,3-dione) 
reacts with free primary and secondary amines with a resulting deep blue of purple color 
which can be measured and compared to a standard for amine concentration 
quantification. Glycine standards with known amine concentrations (0, 50, 150, and 300 
µM) were prepared in 1XPBS at a pH of 7.4 with a total volume of 200 µl. 1,4C-1,4Bis 
in 1XPBS at a pH of 7.4 was prepared at concentrations of 0.1 mg/ml, 0.05 mg/ml, and 
0.025 mg/ml with a total volume of 200 µl. 1,4C-1,4Bis-GNRs and GNS were 
synthesized as previously described and dispersed in 200 µl nanopure water. Their 
absorbance spectra of the samples was measured in order to determine maximum 
absorbance. To these samples, 100 µl of ninhydrin reagent was added and samples were 
incubated in water at 100oC for ten minutes, following which they were allowed to cool 
to room temperature. 500 µl of 95% ethanol was added to each sample and the 
absorbance measured at 570nm. Following correction for absorbance of gold 
nanoparticles at 570nm for the appropriate samples, primary and secondary amine 
concentration was determined via comparing measured values to the glycine standard 
curve.   
    
Transgene Delivery. Plasmid DNA. The pGL4.5 control vector (Promega Corp., 
Madison, WI), which encodes for the modified firefly luciferase protein was used for 
transgene expression studies. E.coli (XL1 Blue) cells containing the pGL4.5 plasmid 
DNA were cultured overnight (16 h, 37 °C, 150 rpm) in 15 mL tubes (Fisher) in 5 mL of 
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Terrific Broth (MP Biomedicals, LLC). The cultures were then centrifuged at 5400g and 
4°C for 10 min. Plasmid DNA was purified according to the QIAprep Miniprep Kit 
(Qiagen) protocol and DNA concentration and purity were determined based on 
absorbance at 260 and 280 nm, determined using a NanoDrop spectrophotometer (ND-
1000; NanoDrop Technologies). Plasmid DNA concentrations of 200-300 ng/µL were 
typically obtained and volumes were adjusted in order to load between 10-200 ng of 
plasmid DNA on PAE-GNRs prior to transfections. 
Cell culture. 22Rv1 bone-metastatic prostate cancer cells and MB49 murine 
bladder cancer cells were both generous gifts from Professor Christina Voelkel-Johnson 
of the Medical University of South Carolina. MDA-MB-231 breast cancer cells were a 
generous gift from Dr. Josh Lebear of Arizona State University. RPMI-1640 with L-
glutamine and HEPES (RPMI-1640 medium), DMEM with high glucose, L-Glutamine, 
and HEPES, Pen-Strep solution: 10000 units/mL penicillin and 10000 µg/mL 
streptomycin in 0.85% NaCl, and fetal bovine serum (FBS), were purchased from 
Hyclone. Serum-Free medium (SFM) consisted of RPMI-1640 or DMEM medium plus 
1% Pen-Strep (1000 units/mL penicillin and 1000 µg/mL). Serum containing medium 
(SCM) consists of SFM plus 10% FBS. 22Rv1 cells, as received, were cultured in a 5% 
CO2 incubator at 37
oC using RPMI-1640 medium containing 10% heat-inactivated FBS 
and 1% antibiotics (Pen-Strep). MB49 and MDA-MB-231 cells, as received, were 
cultured in a 5% CO2 incubator at 37
oC using DMEM containing 10% heat-inactivated 
FBS and 1% antibiotics (Pen-Strep). 
Cytotoxicity. Cells were seeded at a density of 8,400 cells/well in 150 μL serum-
containing medium in a 96-well plate and allowed to attach overnight. Plasmid DNA 
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encoding the luciferase protein, pGL4.5, was diluted to a concentration of 50 ng/μL using 
Tris EDTA buffer (10 mM Trizma and 1mM EDTA, Thermo Fisher Scientific, Rockford, 
IL). 1,4C-1,4Bis, 1,4C-1,4Bis-GNRs, and 1,4C-1,4Bis-GNS were adjusted to a reactive 
amine concentration of either 0.5 or 1 µM in 1XPBS. These were then added to between 
0 and 300 ng of pGL4.5 plasmid DNA. Complexes were incubated for 20 minutes at 
room temperature prior to use. Cells were treated with delivery vehicles in serum 
containing media for 6 hours in an incubator under humidified air containing 5% CO2 at 
37°C. Subsequently, the medium was replaced with fresh serum-containing medium. 
Following 48 hour incubation, cell viability was determined using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assay kit 
(ATCC). This assay involves the enzymatic conversion of the MTT substrate to purple-
colored formazan in metabolically active cells. This activity is widely employed as an 
indicator of cell viability and proliferation(Hayon, et al., 2003); loss of metabolic activity 
was used as an indirect indicator of loss of cell viability upon polyplex treatment. 
Following addition of the MTT reagent (2 h at 37 °C), cells were treated with a lysis 
buffer from the kit and kept at room temperature in the dark for 2 h in order to lyse cells 
and solubilize the MTT product. The absorbance of each well was measured using a plate 
reader (BioTek Synergy 2) at 570 nm to assay for the blue MTT product. For data 
analysis, absorbance readouts were normalized to the live (untreated) and dead (5 µL of 
30% hydrogen peroxide treated) controls.  
Transgene Delivery. MB49, MDA-MB-231, and 22RV1 cells were transfected 
using DNA/polymer complexes (polyplexes) and DNA/nanoparticle complexes 
(nanoplexes) consisting of pGL4.5 plasmid DNA and the synthesized polymers. Prior to 
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transfection, cells were seeded at a density of 8,400 cells/well in 150 μL serum-
containing medium in a 96-well plate and allowed to attach overnight. Plasmid DNA 
encoding the luciferase protein, pGL4.5, was diluted to a concentration of 50 ng/μL using 
Tris EDTA buffer (10 mM Trizma and 1mM EDTA, Thermo Fisher Scientific, Rockford, 
IL). 1,4C-1,4Bis, 1,4C-1,4Bis-GNRs, and 1,4C-1,4Bis-GNS were adjusted to a reactive 
amine concentration of either 0.5 or 1 µM in 1XPBS. These were then added to between 
0 and 300 ng of pGL4.5 plasmid DNA. Complexes were incubated for 20 minutes at 
room temperature prior to use. Cells were then treated with the delivery vehicles in 
serum-containing medium for 6 hours in an incubator under humidified air containing 5% 
CO2 at 37°C. Subsequently, the medium was replaced with fresh serum-containing 
medium and allowed to incubate for an additional 48 hours. Luciferase protein 
expression, expressed in terms of relative luminescence units or RLU, was determined 
using the luciferase assay kit according to the manufacturer’s protocol 48 hours after 
transfection; luminescence measurements were carried out using a plate reader. The 
protein content (mg protein) in each well was determined using the BCA Protein Assay 
Kit. Transgene expression in all cell lines was calculated and normalized with the protein 
content and expressed as RLU per milligram (mg) protein (RLU/mg protein). 
Transfection experiments were performed at least in quadruplicate using 2 separate 
batches of synthesized polymers. 
Determination of Hydrodynamic Diameter of PAE-GNPs and PAE-AgNPs. 
Polyplexes, GNRs and GNS’s were generated as described above and set to a reactive 
amine concentration of 1 µM and co-incubated with 0, 50, 100, 200, or 300 ng of pGL4.5 
plasmid DNA. Dispersions (in 1XPBS) were measured for hydrodynamic diameters via 
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dynamic light scattering (DLS) using a Delsa™ Nano Submicron Particle Size and Zeta 
Potential Particle Analyzer (Beckman Coulter, Brea, CA). The hydrodynamic diameter 
was reported in nanometers (nm). 
Determination of Zeta Potential of Nanoassemblies. Polyplexes, GNRs and 
GNS’s were generated as described above and set to a reactive amine concentration of 1 
µM and will be co-incubated with 0, 50, 100, 200, or 300 ng of pGL4.5 plasmid DNA. 
Dispersions (in 1XPBS) were transferred to the manufacturer’s reusable zeta cell 
(Beckman Coulter, Brea, CA) and zeta potential values were determined using a Delsa™ 
Nano Submicron Particle Size and Zeta Potential Particle Analyzer (Beckman Coulter, 
Brea, CA). Zeta Potential values were reported in millivolts (mV). 
Statistical Analyses. All experiments will be carried out at least in triplicate 
unless mentioned otherwise. Statistical significance was determined using a single factor 
ANOVA with Bonferroni correction across groups at specific plasmid DNA loading 
amounts. Reported values represent the mean ± standard error.  
 
RESULTS AND DISCUSSION 
Previous studies from our laboratory demonstrated that polyplexes based on the 
1,4C-1,4Bis poly(amino ether) polymer(S. Barua, et al., 2009b; S Barua & K Rege, 2010) 
were efficient transgene delivery vehicles. 1,4C-1,4Bis polyplexes exhibited up to 80 fold 
enhancement in transfection efficacies in PC3-PSMA cells compared to pEI25k at 
polymer:pDNA weight ratio of 25:1(S. Barua et al., 2009a). In related studies, the 1,4C-
1,4Bis polymer was employed to coat pre-made gold nanorods using a layer-by-layer 
deposition approach. The 14C-1,4Bis-GNRs were able to deliver plasmid DNA leading 
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to transgene expression exhibited up to 165-fold enhancement compared to pEI25k gold 
nanorods(Ramos & Rege, 2012a). Similarly 1,4C-1,4Bis-GNRs were investigated for 
delivery of shRNA expressing plasmid and demonstrated efficient gene silencing in 
mammalian (e.g. cancer) cells(Ramos & Rege, 2013a). The 1,4C-1,4Bis polymer also 
demonstrated the ability to template the synthesis of gold nanospheres using a one-pot 
synthesis approach similar to previously reported methods(Song, et al., 2010). 1,4C-
1,4Bis polymer-templated gold nanospheres also demonstrated transgene delivery in 
different cancer cell lines. Following up on the versatility of the 1,4C-1,4Bis polymer, we 
generated three unique non-viral gene delivery vehicles, each of which has individually 
demonstrated efficient transgene delivery. These three delivery vehicles, 1,4C-1,4Bis 
polyplexes, 1,4C-1,4Bis-gold nanorod-nanoplexes (GNRs), and 1,4C-1,4Bis-gold 
nanosphere-nanoplexes (GNS’s), were investigated and compared for their transgene 
expression efficacy. Physicochemical differences including the presence of a metal core 
vs. a polymer system, as well as in shape between GNRs and GNS’s we reasoned that a 
head-to-head comparison could enable a thorough understanding of the efficacy of these 
different gene delivery systems.  
The concentration of reactive amines was used as the basis of comparison 
between transgene delivery efficacies of polyplexes, GNRs, and GNS’s. Protonation of 
amines results in cationic character of these delivery vehicles, which is important for 
electrostatic binding with anionic pDNA molecules (Rege et al., 2005b); higher 
nanoparticle zeta potential values can result in stronger binding to nucleic acids(Munier, 
Messai, Delair, Verrier, & Atamon-Onal, 2005), which can also protect them from 
nuclease degradation. The amines will also be responsible for the vehicle surface charge 
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which can greatly influence cell-vehicle binding and uptake. Due to non-specific delivery 
of these vehicles (i.e. no antibodies present), electrostatic based uptake will be largely 
influenced by the surface amines. Retaining a positive charge is desired as nanoparticles 
with stronger positive charges have demonstrated higher transfection efficacies in in vitro 
studies5(Chen et al., 2007; Munier, et al., 2005).  It is well-established that there is a 
strong correlation between nanoparticle surface potential and cellular uptake efficacy; 
where cellular uptake is greater for nanoparticles with strongly positive charged surfaces 
as it facilitates interactions with cell surfaces that possess negative surface potential, and 
subsequent endocytosis (Liang Chen, Joseph M Mccrate, James C-M Lee, & Hao Li, 
2011; Frohlich, 2012; Yue et al., 2011; Zhao, et al., 2012). Though lower charged, 
neutral, or negatively charged particles have been observed to be taken up by cells, most 
observations conclude that strongly positive nanoparticles are more readily internalized 
by cells (J. Liu et al., 2010). Additionally, the surface charge of the vehicles can also play 
a role in the cytotoxicity of the vehicles. In consideration of their higher uptake 
efficacies, in some cases, it has been reported that strongly cationic nanoparticles result in 
higher cytotoxicity in cells in vitro, when compared to similar neutral or negative forms. 
This can be attributed to toxicity resulting from positively charged functional groups (i.e. 
amines) that give the particle its positive charge, or as a result of  higher uptake tending 
to greater biological effects(Frohlich, 2012). Additionally, one study has reported that 
when comparing similar particles with different charges (strongly negative, strongly 
positive, and near-neutral), following cellular internalization, positively charged 
nanoparticles were able to escape the endosomes, while the negatively charged and 
neutral particles were found preferentially in lysosomes(Yue, et al., 2011). Endosomal 
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escape is a crucial step for delivery of nucleic acids for transfection studies(S. Barua & 
K. Rege, 2010). Thus, the available amines on the delivery vehicles will play a critical 
role in their transfection efficacies.  
The ninhydrin assay was used in order to quantify the concentration of reactive 
amines for the three individual delivery vehicles. Following quantification, a linear 
relationship describing the amine concentration versus the polymer concentration and the 
GNR and GNS optical densities (pseudo concentration) was identified (Figure 5.1). 
Using these linear relationships, an amine concentration can be chosen and the 
corresponding concentration or optical density of the delivery vehicles can be calculated.  
 
Figure 5.1. Relationship between (left) 1,4C-1,4Bis-GNR, (middle) 1,4C-1,4Bis-GNS, 
and (right) 1,4C-1,4Bis polymer pseudo/concentration and amine concentration 
determined via ninhydrin assay (n≥9across at least 3 independent polymer batches) 
 
Amine concentrations of 0.5 µM and 1 µM were chosen in order to investigate the 
cytotoxicity and transgene delivery efficacies of the delivery vehicles. The different 
vehicles were set to these concentrations and complexed with varying amounts of pGL4.5 
plasmid DNA. Following complexation, they were used to treat 22Rv1 human prostate 
cancer cells, MDA-MB-231 human breast cancer cells, and MB49 murine bladder cancer 
cells.  Following 48 hours of treatment, the three different vehicles were observed to have 
similar cytotoxicity profiles at similar treatment conditions in each cell lines (Figure 5.2). 
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For no cell line did the cell viability drop below ~65% of the control and the majority of 
conditions were found to be between 70-100% of the control. These was deemed suitable 
values for further investigations for transgene delivery. The similarities in the 
cytotoxicity profiles are likely due to the similar amount of amines present for each 
delivery vehicle. In addition, due to the lack of any major differences in the cytotoxicity 
profile, it will be safe to conclude that any differences in the transgene delivery efficacies 
will not be due to excessive toxicity of a particular delivery vehicle.   
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Figure 5.2. Cytotoxicity of 1,4C-1,4Bis-based poly/nanoplexes loaded with 
between 0-300 ng of pGL4.5 plasmid DNA in 22Rv1 cells at (A) 0.5 µM amine 
concentration and (B) 1 µM amine concentration, in MDA-MB-231 cells at (C) 0.5 µM 
amine concentration and (D) 1 µM amine concentration, and in MB49 cells at (E) 0.5 
µM amine concentration and (F) 1  µM amine concentration. Cell viability was 
determined 48 hours following treatment with the plasmid DNA loaded delivery vehicles 
(n=9 across 3 independently synthesized polymer batches). Lines were added for 
visualization only 
 
At each amine concentration, the three cell lines exhibited similar transgene dose- 
dependent responses based on the amount of plasmid DNA loaded (Figure 5.3). At the 
0.5 µM amine concentration, luciferase expression appeared to be highest for the three 
different delivery systems in between the 25-50 ng range with a decrease in luciferase 
expression observed at loading conditions above 150 ng. At the 1 µM concentration, 
maximum luciferase expression was observed in the 75-100 ng plasmid DNA range, with 
a less pronounced decrease in luciferase expression as the amount of plasmid DNA 
complexed with the delivery vehicles increased.   
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Figure 5.3. Transgene delivery of 1,4C-1,4Bis-based poly/nanoplexes loaded with 0-300 
ng of pGL4.5 plasmid DNA in 22Rv1 cells at (A) 0.5 µM amine concentration and (B) 1  
µM amine concentration, in MDA-MB-231 cells at (C) 0.5 µM amine concentration and 
(D) 1  µM amine concentration, and in MB49 cells at (E) 0.5 µM amine concentration  
and (F) 1  µM amine concentration. Transgene delivery was determined 48 hours 
following treatment with the plasmid DNA loaded delivery vehicles (n=9 across 3 
independently synthesized polymer batches). Asterisks denotes statistical significance 
(single factor ANOVA with Bonferroni correction). 
 
Statistically significant differences in transgene expression efficacies were not 
observed between the three different vehicles in 22Rv1 cells at any of the different 
plasmid loading conditions at either amine concentration (Figure 5.3 A and B). The 
same was observed in MDA-MB-231 cell at the 0.5 µM amine concentration (Figure 5.3 
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C), however at the 1 µM amine concentration (Figure 5.3 D) at plasmid loading amounts 
of 250-300 ng, the GNRs were found to be statistically significantly different than both 
the polyplexes and the GNS’s with higher luciferase expression values. MB49 cells 
demonstrated statistically significant difference between the three vehicles at the 0.5 µM 
amine concentration (Figure 5.3 E), with both, GNRs and GNS’s demonstrating higher 
luciferase expression values than the polyplexes at a loading amount of 10 ng, and the 
polyplex having a higher value than the GNS’s at a loading of 150 ng. At the 1 µM amine 
concentration in MB49 cells (Figure 5.3 F), GNRs were found to be significantly higher 
than the polyplexes at loading conditions of 175, 200, 225, 275, ad 300 ng. Though there 
were some significant differences, for the majority of the conditions tested in the three 
different cell lines the three delivery vehicles had similar efficacies. These results 
indicate that there is, for the most part, no decrease in efficacy of the transgene delivery 
capabilities of the 1,4C-1,4Bis polymer following its use for synthesis or modification of 
nanoparticles. Several classes of polymers have been used for the synthesis or 
modification of gold nanoparticles for several different applications(A. C. Bonoiu, et al., 
2009; Cui et al., 2011; Ghosh, et al., 2008; Song, et al., 2010). However there has been a 
lack of investigations detailing or comparing efficacies following the step from a purely 
polymeric system to a nanoparticle system. To the best of our knowledge, here we show 
one of the first comprehensive comparisons of purely polymeric to nanoparticle systems 
from transgene delivery. The minimal differences in transgene delivery between the three 
systems suggest that using efficient gene delivery polymeric systems to modify or 
synthesis metal nanoparticles will not result in a loss of efficacy. At certain conditions it 
may even increase efficacies as seen in MB49 and MDA-MB-231 cells.   
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Though, there was minimal change in efficacies, we wished to determine factors 
that may influence the observed significant differences. Though not widely investigated 
until recently, differences in morphology of nanoparticle delivery systems has been found 
to play an important role in influencing cellular uptake and efficiency of delivery of 
desired payload(Sutapa Barua et al., 2013; Champion, et al., 2007; Chithrani, Ghazani, & 
Chan, 2006; X. Huang, Teng, Chen, Tang, & He, 2010; Y. Liu, Tan, Thomas, Ou-Yang, 
& Muzkantov, 2012). In addition to geometry, orientation of the delivery vehicle’s 
interaction with cells have been found to play a role in uptake. Differences in polyplex 
aspect ratios has been found to affect cellular internalization and transfection efficacy as 
well, where polyplexes with smaller aspect ratios outperforming those with larger aspect 
ratios(Shi et al., 2013). Previous studies have demonstrated that antibody coated nanorods 
had higher cellular uptake efficacies than nanospheres(Sutapa Barua, et al., 2013; Kolhar 
et al., 2013). However, the same studies reports that uncoated nanospheres were found to 
have higher cellular entry than uncoated nanorods likely due to unspecific binding 
interaction such as hydrophobic binding of polystyrene to the cell membrane(Sutapa 
Barua, et al., 2013). Though the delivery vehicles in our investigation are not targeted to 
the cell, they do interact with the cells via electrostatics. For instances where 
electrostatics are the primary influence on cell binding and uptake it has been found that 
rod shapes have an advantage. This is likely due to the large surface area to volume ratio 
allowing for multivalent cationic interaction with the cell surface(Gratton et al., 2008). 
For conditions where GNRs (Rod shaped) outperformed the GNS and polyplex (sphere 
shaped) it is reasonable to conclude that there is some shape-induced enhancement for 
transgene delivery at certain conditions. However, there are likely other factors that also 
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influence the increased transgene efficacy of the GNRs at the higher pDNA loading 
conditions.      
The three delivery vehicles were also characterized for zeta potential values. As 
previously mentioned surface properties, including surface charge have been found to 
play a major role in nanoparticle – cellular interactions. It has been found that for 
efficient binding to cellular surfaces, which are primarily negatively charged, a delivery 
system with a strong positive charge is desirable(Liang Chen, et al., 2011; Frohlich, 
2012; Osaka, Nakanishi, Shanmugam, & Zhang, 2009; Yue, et al., 2011). Following 
complexation of all vehicles with between 0-200 ng all vehicles were found to have 
positive zeta potential values for loading conditions between 0-200 (Figure 5.4). For all 
three delivery vehicles, as the amount of plasmid DNA loaded increased the zeta 
potential was found to decrease. This decrease continued to the 300 ng loading amount 
where all the vehicles exhibited a charge reversal to a negative value. This observed 
decrease in zeta potential and the subsequent charge reversal is likely due to the negative 
charge of the plasmid DNA shielding the positive charge of the cationic polymer-based 
systems(Ramos & Rege, 2012a). For pDNA loading conditions between 0-100 ng and the 
loading condition of 300 ng there was found to be no significant differences. However, at 
a loading condition of 200 ng, the GNRs were found to be statistically significant to both 
the GNS’s and the polyplexes with a higher zeta potential value. This may also influence 
the observed differences in the transgene delivery efficacies of the three systems. Likely 
due to the increased surface area to volume ratio for the rod shaped vehicles there is less 
surface coverage with the plasmid. This results in retaining a stronger positive charge as 
they are complexed with increased amounts of plasmid. As previously discussed stronger 
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positive charged are desired in order to facilitate cellular binding and subsequent uptake. 
In the conditions below ~200 ng where all three vehicles exhibit the no significant 
differences in zeta potential we see a similar trend in transfection efficacies. However at 
loading conditions at higher than 200 (in MB49 and MDA-MB-231 cells) the GNRs are 
observed to maintain a stronger positive charge at higher plasmid loading amounts, these 
are similar to the conditions where the GNRs outperform either the GNS’s the polyplex 
or both. Maintaining this positive charge likely results in the GNRs having more efficient 
cell binding as cell internalization. Shape may not be the only factor influencing the 
differences that were observed, but zeta potential also will play an important role.  
 
Figure 5.4. Zeta Potential (mV) of 1,4C-1,4Bis-based poly/nanoplexes (1µM) with 
different amounts of pGL4.5. Measurements were taken in 1XPBS in order to mimic cell 
growth media salt conditions. Asterisks denotes statistical significance (single factor 
ANOVA with Bonferroni correction). 
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The three systems were further characterized for hydrodynamic diameter 
following complexation with varying amounts of plasmid DNA (Figure 5.5). Size of 
delivery systems has been shown to influence cellular uptake, with sizes below 200 nm 
being desirable for efficient cellular uptake of nanoparticles(He, Hu, Yin, Tang, & Yin, 
2010; K. Huang et al., 2012).   For the vehicles alone the GNRs, GNS’s, and polymer 
were found to have hydrodynamic diameters of approximately 60, 100, and 150 nm 
respectively, though there was found to be no statistically significant difference across 
the group. It should be noted that due to the non-particle nature of the polymer alone high 
polydispersity was observed. Additionally, it is acknowledged that DLS reports for 
spherical morphologies, and therefore, the hydrodynamic diameters of the GNRs were 
primarily used as indicators of size change. 
 
Figure 5.5. Hydrodynamic diameter (nm) of 1,4C-1,4Bis-based poly/nanoplexes (1µM) 
with different amounts of pGL4.5. Measurements were taken in 1X PBS in order to mimic 
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cell growth media salt conditions. Asterisks denotes statistical significance (single factor 
ANOVA with Bonferroni correction). 
 
 At increasing plasmid loading of 50-300 nm the GNRs were found to be 
significantly different than the GNS’s, with smaller hydrodynamic diameters. At both 50 
and 300 nm the polyplexes were also significantly different than the GNS with smaller 
hydrodynamic diameters. Though we do see significant differences in size change, it is 
likely that the change in size have less influence on the transgene delivery efficacies for 
the different systems. We see that all delivery vehicles remain primarily in the sub-200 
nm range. However, the differences observed in the hydrodynamic diameter do not 
correlate with the similarities or differences observed for the transgene delivery efficacy, 
thus it is likely that the zeta potential and the shape are the two factors influencing any 
differences observed in transfection efficacies.  
 
In comparing the three unique delivery systems, there was no significant difference in 
their transgene delivery capabilities, with the exception of a few conditions. This is 
largely attributed to similar trends observed in the zeta potential values at similar 
conditions. These results are promising as they demonstrate that using polymeric system 
that have previously been shown to be efficient for modification of gold nanoparticles 
does not result in a loss of efficacy. In some cases its efficacy increased in addition to 
introducing the polymer system to a new realm of applications.  
Differences in morphology of nanoparticle delivery systems has been found to play 
an important role in influencing cellular uptake and efficiency of delivery of desired 
payload(Sutapa Barua, et al., 2013; Champion, et al., 2007; Chithrani, et al., 2006; X. 
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Huang, et al., 2010; Y. Liu, et al., 2012). Using the polymer system described here, 
nanoparticles of different shapes can be synthesized or modified in order to increase the 
transgene delivery efficacy.  In addition to geometry, orientation of the delivery vehicle’s 
interaction with cells have been found to play a role in uptake. Differences in polyplex 
aspect ratios has been found to affect cellular internalization and transfection efficacy as 
well, where polyplexes with smaller aspect ratios outperforming those with larger aspect 
ratios(Shi, et al., 2013). In addition, for instances where electrostatics primarily influence 
cell binding and uptake it has been found that rod shapes have an advantage. This is 
likely due to the large surface area to volume ratio allowing for multivalent cationic 
interaction with the cell surface(Gratton, et al., 2008). Using the 1,4C-1,4Bis polymer to 
modify and maintain a rod shape and adjusting the aspect ratio can also result in 
increasing the transgene efficacy.       
 Nanoparticles systems possess an inherent advantage over the pure polymeric 
system in that they can be used as a theranostic platform.  Polymers have been employed 
for the synthesis or modification or several classes of nanoparticles. For example, 
magnetic nanoparticles have been synthesized or modified with polymers for use as 
imaging agents (Kumagai et al., 2010) as well as for targeted gene delivery in 
magnetofection, where an electro-magnetic field is used to guide the nanoparticles to a 
desired location(Chertok, David, & Yang, 2010; Plank, Zelphati, & Mykhaylyk, 2011). 
Polymers have also been employed for the synthesis of silver nanoparticles(H. Lee, et al., 
2001; Shin & Kim, 2011; Tam, Erol, Attygelle, Du, & Sukhishvili, 2007) which have 
been found to have attractive antibacterial(C. You, et al., 2012), antifungal (Esteban-
Tejada, et al., 2009), and anti-viral(Panacek, et al., 2009) properties. Additionally, 
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plasmonic gold nanoparticles exhibit unique optical properties such as surface plasmon 
resonance which allows them to strongly absorb and scatter incident light(Link & El-
Sayed, 1999). This, has led to them being attractive as contrast agents since they can 
overcome detection limits, chemical and photo-stability typically associated with 
conventional contrast agents(Hahn, et al., 2011). Due to greater tissue depth penetration, 
minimal tissue scattering, and decreased phototoxicity NIR laser based imaging 
modalities have been increasingly investigated and gold nanoparticles, tuned to absorb 
NIR light, have been widely explored for use in multiple imaging modalities(Durr, et al., 
2007; J.-L. Li & Gu, 2010; H. F. Wang, et al., 2005). Some classes of gold nanoparticle 
are also able to convert resonant energy to heat following exposure of near infrared (NIR) 
light, electron-phonon and phonon-phonon interactions can convert incident light into 
heat (Jain, et al., 2007; Oldenburg, Jackson, et al., 1999). Thermal or hyperthermic 
therapy is an attractive alternate or co-approach for the ablation of diseased (e.g. cancer) 
tissue. Due to their unique optical properties several classes of gold nanoparticles have 
been engineered for use in NIR-based hyperthermic therapy(Chatterjee, et al., 2011; El-
Sayed, et al., 2005, 2006; Glazer & Curley, 2010; H.-C. Huang, et al., 2009; H.C. Huang, 
et al., 2010; Kennedy, et al., 2011; Ma, et al., 2009) for ablation of cancer cells (Cao, 
2004) and bacteria(Cortie, 2004). As the results of this study suggest, polymer efficacy 
was mainlined following synthesis or modification of nanoparticles. This allows for 
effective polymeric systems, such as 1,4C-1,4Bis, to be used for the modification or 
synthesis of nanoparticle systems and still maintain their efficacy. By introducing 
effective polymers to nanoparticle systems, their impact in biomedicine is enhanced as 
they will possess multi-modal capabilities.  
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CONCLUSIONS 
In this report, we investigated the head-to-head comparison of three unique non-
viral gene delivery vehicles based on the novel 1,4C-1,4Bis polymer that has previously 
been shown to be an efficient non-viral gene delivery vehicle. 1,4C-1,4Bis-polyplexes, -
gold nanorods, and -gold nanospheres were synthesized and compared for transgene 
delivery efficacies. Following treatment of three different cell lines the different systems 
were found to possess similar cytotoxicity profiles. In addition, a majority of treatment 
conditions demonstrated no significant difference in transgene delivery efficacies. The 
few conditions that did demonstrate a significant difference were likely due to similar 
trends in the difference observed in the zeta potential of the three systems. This results 
suggest that polymeric systems can be used for synthesis or modification of nanoparticle 
systems without compromising their efficacy. This allows for the use of successful 
polymeric systems for the generation of attractive theranostic systems.    
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CHAPTER 6 
FUTURE DIRECTIONS: NIR LASER ENHANCED TRANSGENE DELIVERY FOR 
1,4C-1,4BIS-GNRS 
INTRODUCTION 
 The primary objective of the presented research is to investigate and engineer 
efficient non-viral gene delivery vehicles. In previous reports we have demonstrated the 
efficient transgene delivery of the 1,4C-1,4Bis poly(amino ether) polymer. Furthermore, 
1,4C-1,4Bis has been used to modify gold nanorods and found to not lose its delivery 
efficacy. The theranostic potential of polymer modified GNR nanoplexes has also been 
highlighted through its use in bioimaging(Lucas Vu, et al., 2012). Being able to deliver a 
therapeutic payload and couple it with live bioimaging give the nanorod based 
transfection vehicle a clear advantage over traditional polyplex based systems. 
Additional, gold nanorods have unique optical properties that allows them to strongly 
absorb and scatter incident light, such as their ability to absorb near infrared (NIR) light. 
This gives them further advantage over other nanoparticle based systems lacking NIR 
adsorption properties. In addition to imaging, the ability of NIR adsorbing nanoparticles 
to transform photons into heat energy has resulted in investigation using them for 
triggered release or relevant therapeutic payloads including drugs and nucleic 
acids(Agasti et al., 2009; Braun, et al.; Han et al., 2006; Wijaya, Schaffer, Pallares, & 
Hamad-Schifferli, 2009).  
 Here we hypothesis that by using 1,4C-1,4Bis-GNRs for delivery of transgenes as 
we have previously shown, delivery efficacies can be increased via irradiating the treated 
cells with pulsed NIR light. There are several obstacles a delivery vehicle must overcome 
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when being used for transgene delivery. The first such obstacle is cellular uptake(can der 
Aa et al., 2007). 1,4C-1,4Bis-GNRs that maintain strongly positive zeta potential 
following plasmid DNA loading will be able to bind to the negative cell membranes. It is 
hypothesized that if GNRs are irradiated while they are binding to cells it is likely that a 
weakening of the cell membrane may occur, allowing for easier uptake and transport. The 
second obstacle following uptake is for the delivery vehicle to escape the endosomes 
prior to being trafficked for degradation(Khalil, Kogure, Akita, & Harashima, 2006). It is 
hypothesized that if cells are exposed to NIR irradiation at an appropriate time following 
cellular uptake it can result in a “burst” of the endosomal compartment resulting in 
increased endosomal escape of the nanoplexes(Braun, et al.). Lastly, pulsed NIR 
irradiation has also been shown to induce shape change in gold nanorods from a rod to a 
spherical shape. This shape change has been used to trigger release of conjugated 
molecules(Wijaya, et al., 2009). This shape change can also be used in our case for 
triggered release of nucleic acids. In order to determine if NIR irradiation can increase 
transfection efficacies, cells treated with 1,4C-1,4Bis-GNRs loaded with plasmid DNA 
will be irradiated with pulsed NIR irradiation as different times after treatment and 
transfection efficacies will be compared to non-irradiated controls. 
 By determining whether or not laser irradiation can increase transfection efficacy 
will allow for further optimization of transfection systems. Additionally, by correlating 
the time at which the irradiation occurs with the cellular location of the nanoassemblies 
can allow for us to determine which step in the transfection process can be overcome. 
Additional methods can then be investigated to overcome other steps/barriers in cellular 
uptake through to transgene expression.  
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EXPERIMENTAL DESIGN 
TEM to Determine Shape Change of 1,4C-1,4Bis-GNRs. Transmission 
Electron Microscopy (TEM) will be used in order to determine the shape change, if any, 
the gold nanorods assemblies undergo following exposure to NIR irradiation. 1,4C-
1,4Bis-GNRs will be synthesized as previously described. Solutions will be exposed to 
near infrared (NIR) pulsed laser irradiation for 15 minutes (800 nm 20 W/cm2). Non 
irradiated dispersions will be used as a control. Following, they will be characterized by 
Transmission Electron Microscopy (TEM) using a JEOL-JEM-2000FX microscope 
operating at 200 kV. JEOL-JEM2000FX TEM is equipped with a thin-window, light-
element sensitive X-ray spectrometer for high spatial resolution microanalysis, and a low-
drift-rate, double-tilt cryostage for microbeam experiments. Specimen samples for TEM 
will be prepared by casting a drop of the nanoassembly dispersions onto a carbon film on 
a 200 mesh copper mesh (Global Electron Microscopy Technology Co.) and air dried. 
Dried samples were examined by TEM at 200 kV and shape change if any will be 
determined. 
Ethidium Bromide Assay for DNA Release. In order to determine if there NIR 
irradiation can facilitate transgene release from the 1,4C-1,4Bis-GNRs, an ethidium 
bromide assay will be used. 1,4C-1,4Bis-GNRs will be synthesized as previously 
described and will be incubated with different amounts (10-100 ng) of pGL3 and pEGFP 
expression vectors for 30 min in serum-free media, leading to the formation of vector-
loaded nanoassemblies. Following nanoplex formation, samples will be irradiated with 
near infrared (NIR) pulsed laser irradiation for 15 minutes (800 nm 20 W/cm2). Non-
irradiated samples will be used as controls. Following irradiation, samples will be 
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immediately centrifuged to separate nanoparticles from any free DNA. The amount of 
plasmid expression vector remaining in the supernatant after centrifugation was 
determined using ethidium bromide, a DNA intercalating dye. Ethidium Bromide (1 µg 
of 0.5 mg/ml; Sigma-Aldrich, St. Louis, MO) will added to each sample. Solutions will 
be transferred to a black 96 well plate, and fluorescence will be measured using 
excitation at 320 nm and emission at 600 nm with a plate reader (Synergy 2 Multi-Mode 
Microplate Reader, BioTek, Winooski, VT), similar to methods previously described(K. 
Rege, et al., 2004; Rege, et al., 2005a). Known plasmid DNA amounts in solution will be 
used as standards for calibration of the assay. The amount of plasmid loaded on the 
nanoassemblies will be determined using mass balance by subtracting the amount of 
plasmid in the supernatant from the initial amount used for loading.  
 
1,4C-1,4Bis-GNR Pulsed NIR Laser Transfection. 1,4C-1,4Bis-GNRs will be 
synthesized as previously described and the optimum transfection condition (to be 
identified based on previous proposed results) will be used to further investigate pulsed 
NIR laser transfection efficacies. 22Rv1 and MB49 cells will be treated with the 
nanoplexes loaded with pGL3 DNA as previously described. Cells will be irradiated with 
pulsed NIR laser (800 nm 20 W/cm2) for 15 minutes immediately after treatment, 3, 6, 
and 24 hours after treatment. No laser irradiation will be used as a control. Luciferase 
expression will be determined 48 hours after initial treatment as previously described. 
Due to possible cell death from thermal ablation, luciferase expression will be normalized 
to the amount of viable cells determined by MTT assay (previously described).  
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By determining whether or not laser irradiation can increase transfection efficacy 
will allow for further optimization of transfection systems. Additionally, by correlating 
the time at which the irradiation occurs with the cellular location of the nanoassemblies 
can allow for us to determine which step in the transfection process can be overcome. 
Additional methods can then be investigated to overcome other steps/barriers in cellular 
uptake through to transgene expression. 
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